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I. INTRODUCTION I 
This progress report from the Biomedical Computer Laboratory (BCL) 
summarizes activities during the period from July 1, 1978 through June 30, 
·11979. The Biomedical Computer Laboratory collaborates with research investigators 
throughout the Washington University School of Medicine and its affiliated 
hospitals in the application of advanced computer techniques to problems in 
biology and medicine. This often requires work in areas stretching from basic I 
physiology through mathematical models to equipment design. Our orientation 
is interdisciplinary with the recognition that effective communication for 
workers with differing backgrounds comes only through extended collaboration Iand mutual respect. 
The vigorous development and evolution of specialized computer systems 
for use in the solution of research and clinical problems has continued to I 
be the central focus of BCL activities Several systems now in clinical useo 
have seen a progression from exploratory pilot studies, to major developmental 
project, to local clinical trial, to clinical trials in multiple locations, I 
to public availability through commercial manufacture. Perseverance in this 
sometimes tedious chain of development has found reward in the effective fielding ,of specialized computer systems to the medical community. 
One class of computer applications requires strong coupling of the 
computer to its environment for digital signal processing. These applications 
typically involve the use of commercially available minicomputers and micro~ I 
processors in conjunction with specialized hardware designed and built locally. 
We have pursued many such applications by bringing signals from hospital wards 
and research laboratories to BCL by means of either analog or digital tape I
recordings or telephone lines and, more frequently, by taking the computers 
to the investigator's laboratory or the patient's bedside. IFor those classes of applications dominated by information processing 
requirements, provisions have matured from telephone lines linking our mini­
computers to the IBM System/360-370 at the Washington University Computing 
Facilities, through development and support of a minicomputer based MUMPS I 
system, to the establishment of an independent Medical Computing Facility 
to serve the local medical complex. Diverse needs continue to be met by these 
various options while collaborative work continues on more advanced information­ Iprocessing developments. 
Still another class of applications requires extensive use of large 
scale computational services. Many investigators are assisted in their research I 
through the use of generalized numerical, non-numerical, and statistical routines. 
This work is carried out in part by staff members of BCL, but primarily by 
members of the Division of Biostatistics under the direction of Dr. Reimut 'I 










I The BCL enjoys collaborations with over 15 departmental divisions within the medical school but also finds support and enrichment through close ties 
with other facilities throughout the University. These arrangements are of 
benefit both to the BCL and to graduate students who find projects and employmentI among the activities in the laboratory. The Department of Computer Science is under the direction of Dr. Jerome R. Cox, Jr., past Director of the BCL. 
Close collaboration with the department currently emphasizes the area of in­
I formation systems. Strong ties with the Department of Electrical Engineering are	 sustained through the Engineering School's Biomedical Engineering Program 
and	 common interests in digital signal processing techniques. The Department 
I of Electrical Engineering is chaired by Dr. Donald L. Snyder, past Associate Director of BCL. 
The Washington University Computer Laboratories is a federation ofI two research laboratories and two working groups which brings together the interests and resources of major segments of the University. The Biomedical 
Computer Laboratory is a component of the Medical School. The Computer Systems 
I Laboratory is organizationally directly under the Chancellor. Both BCL and CSL	 share staff members with the Medical School and the School of Engineering 
and	 Applied Science. The Information Systems Group is housed within the De­
I partment of Computer Science and the Systems Design Aids Group is housed within the Department of Electrical Engineering. 
I 
The Coordinating Committee for the Washington University Computer Lab­
oratories is charged with the task of monitoring long-term interactions between 
programs 0 The present composition of the Coordinating Committee is: 
I J. R. Cox, Jr., (Chairman) Principal Investigator for the Resource and Chairman, Computer Science 
R.	 J. Benson, Director, University Computing Facilities and Assistant 
Vice ChancellorI S. B. Guze, Vice Chancellor for Medical Affairs E. L. MacCordy, Associate Vice Chancellor of Research 
J. M. McKelvey, Dean, School of Engineering and Applied Science 
I	 C. Eo Molnar, Director, Computer Systems Laboratory D. L. Snyder, Chairman, Electrical Engineering 
Lo J. Thomas, Jr., Director, Biomedical Computer Laboratory 
I	 D. F. Wann, Group Leader, System Design Aids To aid in long-range planning of the health-related activities of the 
Washington University Computer Laboratories, a National Advisory Panel meetsI periodically with the Coordinating Committee. Particular attention is given 
I 
to the confluence of important needs in biology and medicine with the technical 
advances capable of meeting these needs. Successful developments by WlTCL 
may suggest implementation on a larger, perhaps national scale. The present 










P.	 H. Abbrecht, Professor of Physiology and Internal Medicine, University 
of Michigan I
 
H. L. Bleich, Associate Professor of Medicine, Harvard University 
W. A. Clark, Consultant and former Director of CSL, Cambridge, Massachusetts 
J. N. Gray, IBM Research Laboratories, San Jose, California I
F. E. Heart, Bolt, Beranek & Newman, Cambridge, Massachusetts 
D.	 M. Kipnis, Professor and Chairman, Department of Internal Medicine, 
Washington University I
C. Mead, Professor of Electrical Engineering and Computer Science, 
California Institute of Technology 
F.	 M. Richards, Professor of Molecular Biophysics and Chemistry, Yale 
University I
J. M. Smith, Computer Corporation of America, Cambridge, Massachusetts 
E. A. Stead, Professor of Medicine, Duke University 


































During the period covered by this report the primary source of
 
support for the Biomedical Computer Laboratory was a grant from the National
 
Institutes of Health, Division of Research Resources.
 
RR 00396 A Resource for Biomedical Computing. 
I
 
I A research grant to study the relationship of arrhythmias and sudden
 
death sponsored by the National Heart, Lung and Blood Institute has continued,
 
in collaboration with the Department of Medicine and the Jewish Hospital.
 
HL 18808	 Prediction and Prevention of Sudden 
Cardiac Death. 
I 
I A subcontract was awarded by the American Heart Association under 
NHLBI Contract N01 HV 72989 to develop a database for arrhythmia detector 
evaluation. 
I 
Another subcontract was awarded by the University of Rochester under 
NHLBI grant HL 22982 to support establishment of a Multicenter Postcoronary 
Risk Stratification Program. 
NHLBI contract N01 HV 72941 was received to establish a HolterI Monitoring Core Laboratory to support a Multicenter Investigation of Limitation of Infarct Size. 
, Research efforts continued in support of activities for information 
exchange about MUMPS and MUMPS application transfers, and grant.HS 02760 was 
awarded to support Specification and Building of Ambulatory-Care Records 
I
 which utilize the ~ruMPS software.
 Collaborative research continues with St. Louis University, under 
I 
NHLBI Contract N01 HV 62960, 
Jewish Hospital of St. Louis 
Sandoz-Wander, Inc., and with 
a perinatal database under a 
to establish a data management system, with the 
for research sponsored by their contract with 
the St. Louis Children's Hospital in establishing 
grant from the States of Missouri and Illinois. 
I Collaboration with other investigators often involved work already 
supported by other grants. 
I 
AM 20579 
I CA 04483 





Public Health Services grants.
 
Diabetes Research and Training Center,
 
Effects of X-rays on Normal and Malignant Cells,
 
Factors Affecting Intraocular Pressure,
 

















Automated "Digital Processing of the Human Visual Field,
 
Multi Disciplinary Heart and Vascular Diseases,
 
Cyclotron Produced Isotopes in Biology and Medicine,
 
Study of Ischemic Heart Disease,
 
Preprocessor System for Cardiograms,
 
Myocardial Injury with Ultrasound,
 
Autonomic Determinants of Arrhythmia Due to Ischemia,
 
Engineering Development of an Ultrasonic Ventilometer,
 
Mental Health in the Aged: Biomedical Factors,
 
Auditory Communication and Its Disorders,
 
An Interdisciplinary Stroke Program,
 
Bioelectric Studies of Cerebral Cortex,
 
Regeneration and Functional Recovery in Cerebral Cortex,
 
Biomedical Research Support Grant.
 
National Science Foundation grant.
 





I II1. PERSONNEL 
I EMPLOYEES 
'I 
Personnel employed by the Biomedical Computer Laboratory during the 
period covered by this report were: 
Director 
I
 Lewis J. Thomas, Jr., M.D., and Associate Professor of Anesthesiology,
 Physiology and Biophysics, Biomedical Engineering, and Electrical 
Engineering 
I Assistant Directors 
G. James Blaine, III, D.Sc., and Senior Research Associate inI Computer Engineering V. W. Gerth, Jr., M.S. 
I Senior Research Associate 
t 
Jerome R. Cox, Jr., Sc.D., and Chairman, Computer Science, Professor 
of Computer Science, Electrical Engineering, and Biomedical 
Engineering in Physiology and Biophysics 
Business ManagerI Virginia M. Bixon, B.S. 
I Research Associates 
, Robert J. Arnzen, Ph.D., and Computer Systems Laboratory R. Martin Arthur, Ph.D., and Associate Professor of Electrical Engineering 
A. Maynard Engebretson, D.Sc., and Central Institute for the Deaf 
William F. Holmes, Ph.D., and Associate Professor of BiologicalI Chemistry 
I 
Kenneth B. Larson, Ph.D. 
Thomas F. Martin, M.D., and Assistant Professor of Clinical Medicine 
James G. Miller, Ph.D., and Associate Professor of Physics, and 
Associate Director for Biomedical Physics, Laboratory for Ultra­
Sonics, and Research Assistant Professor of Medicine 
I Donald L. Snyder, Ph.D., and Chairman and Professor of Electrical Engineering Bruce F. Spenner, D.Sc., and Lecturer in Electrical Engineering 
Joan Zimmerman, D.Phil. 
I Visiting Scientist 
I, Harold W. Shipton, C.Eng., and Electrical Engineering 
I
 
I - 12 ­
Research Assistants 
H. Dieter Ambos, and Medicine (Cardiology)
 
Gerald L. Armstrong, B.S.
 
Gary H. Brandenburger, M.S.
 




Nian C. Cheng, M.S.
 
Kenneth W. Clark, M.S. .
 
Stanley A. Garfield, B.S.
 
Alexander J. Gray, B.S.
 




Ronald W. Hagen, M.S., and Surgery (Cardiothoracic Surgery)
 
Ross K. Hartz, M.S.
 
Russell E. Hermes, B.S.
 
Richard E. Hitchens, B.S., and Lecturer in Computer Science
 
Janet A. Johnson, M.S.
 
Margaret C. Jost, M.S.
 




Charles N. Mead, M.D.
 
J. Philip Miller, A.B., and Assistant Professor of Biostatistics 
Preventive Medicine
 




Nizar A. Mullani, B.S., and Research Associate in Radiology
 
Michael A. Province, M.A.
 
Kenneth L. Ripley, M.S.
 
J. Alan Ritter, M.S.
 
Kenneth B. Schechtman, Ph.D.
 









Don L. Rempel, M.S.
 
Wayne R. Roloff, B.S.
 









William R. Hosmon, B.S.
 












Patrick W. McLear 
I
 Eric G. Melanson, B.A.
 Stephen M. Moore 
I 
John D. Myers 
Stephen J. Potter 
Tamar T. Rosen 
I 
Eufaula Thornton 
James S. Wallis 
Kenneth G. Williams 
Electronic Technicians 
I Theron R. George L. 
Louis F.I Joseph H. 
Librarian 
























I The following members from other departments and divisions have joint appointments with the Biomedical Computer Laboratory to facilitate 
collaboration and enhance interdisciplinary research: 
I 
I G. Charles Oliver, M.D., Associate in the Biomedical Computer 
Laboratory, Professor of Medicine and Chief, Cardiology Division, 
Jewish Hospital 
Rexford L. Hill, III, M.S., Research Associate in the Biomedical 
I 
Computer Laboratory and Assistant Professor of Computer Applications 
in Radiology 
Carol S. Higgins, A.B., Research Assistant in the Biomedical Computer 
Laboratory and Research Associate in Radiology 
I In addition, the following people worked at the laboratory for brief periods: 
I Todd L. Carpenter, B.S.
 Gary R. Cook, B.A.
 
Gary A. Davis 
I 
















 IThomas J. Marshall, M.S. 
J. Steve Massey, B.A.
 




Paul B. Webb 
RESEARCH COLLABORATORS I 
During the period covered by this report the following investigators 
from other laboratories, departments, or institutions, collaborated with IBCL staff members on problems of joint interest. 
J. Achtenberg, A.B., Medicine 
R. L. Allen, M.S., Electrical Engineering I 
W. E. Ball, D.Sc., Computer Science 
L. J. Banaszak, Ph.D., Biochemistry 
C. D. Barry, Ph.D., Computer Systems Laboratory I
D. Bauwens, M.D., Medicine 
B. Becker, M.D., Ophthalmology 
W. L. Becker, Ophthalmology IR. J. Benson, J.D., Computing Facilities 
S. R. Bergmann, Ph.D., Medicine 
D. R. Biello, M.D., Radiology 
W. G. Bowen, M.D., Medicine I 
S. B. Boxerman, D.Sc., Health Care Administration and Planning Program 
J. M. Branconi, M.D., Medicine 
C. A. Branyon, Ophthalmology IS. M. Brodarick, M.D., Medicine 
M. E. Cain, M.D., Medicine 
M. K. Campbell, R.N., Medicine IC. Carlson, Electrical Engineering 
N. J. Caston, M.Ed., Radiology 
I. Y. Christlieb, M.D., Cardiothoracic Surgery 
G. L. Clark, M.D., Medicine I 
R. E. Clark, M.D., Cardiothoracic Surgery 
L. A. Coben, M.D., Neurology 
P. B. Corr, Ph.D., Medicine and Pharmacology IW. A. Crafford, M.D., Medicine 
J. E. Davis, Ph.D., Medicine 
B. E. Ditzler, B.A., Ophthalmology IA. A. Ehsani, M.D., Medicine 
J. O. Eichling, Ph.D., Radiology 
D. L. Elliott, Ph.D., Systems Science and Mathematics 
R. A. Ellis, M.S., Computer Systems Laboratory I 










D. C. Ficke, B.S., Radiology 
I
 C. Frieden, Ph.D., Biochemistry
 M. H. Gado, M.D., Radiology E. M. Geltman, M.D., Medicine 
I,
 S. A. Golden, B.S., Neurological Surgery
 S. Goldring, M.D., Neurological Surgery R. A. Goldstein, M.D., Medicine 
M. O. Gordon, Ph.D., Ophthalmology 
I
 w. J. Grodzki, Jr., D.D.S., Ophthalmology
 R. L. Grubb, Jr., M.D., Neurological Surgery 
S. N. Hack, M.S., Medicine
 
I
 E. B. Hagelstein, B.S., Electrical Engineering
 J. Hanaway, M.D., Anatomy and Neurology w. M. Hart, Jr., M.D., Ph.D., Ophthalmology 
A. Hernandez, M.D., Pediatrics 
I
 R. R. Heye, Radiology
 J. O. Holloszy, M.D., Preventive Medicine 
J. T. Hood, B.S., Radiology 
I
 C. P. Hughes, M.D., Neurology
 S. Igielnik, Ph.D., Medical Computing Facilities 
A. S. Jaffe, M.D., Medicine 
L. Jarett, M.D., PathologyI G. C. Johns, B.S., Computer Systems Laboratory M. F. Johnson, Jr., M.L.S., Medical Library 
E. G. Jones, M.D., Ph.D., Anatomy
I
 R. G. Jost, M.D., Radiology
 L. I. Kahn, M.D., Health Care Research 
M. A. Kass, M.D., Ophthalmology 
I
 E. w. Kiebler, Radiology
 M. S. Klein, M.D., Medicine 
D. M. Kramer, Ph.D., Physics 
B. E. Laux, B.S., RadiologyI J. Y. Lee, Ph.D., Biostatistics R. Lerch, M.D., Medicine 
R. D. Livengood, B.S., Electrical Engineering
I
 J. P. Livingston, A.B., Ophthalmology
 P. A. Ludbrook, M.D., Medicine 
R. E. Marshall, M.D., Pediatrics 
I
 M. M. Maurer, M.D., Pediatrics
 M. L. McCartney, Sc.D., Electrical Engineering M. M. McCrate, B.S., Biostatistics 
J. W. Mimbs, M.D., MedicineI C. E. Molnar, Sc.D., Computer Systems Laboratory R. A. Moses, M.D., Ophthalmology 
M. O'Donnell, Ph.D., Physics 
I
 R. E. Olson, A.A.S., Computer Science and Computer Systems Laboratory
 J. M. Paine, B.A., Biostatistics 
C. A. Perez, M.D., Radiology 
I
 C. F. Pieper, M.S., Neurological Surgery
 S. C. Prasad, Ph.D., Radiology J. L. Price, Ph.D., Anatomy 
I 





J. A. Purdy, Ph.D., Radiology 
D. P. Ragan, Ph.D., Radiology 
M. E. Raichle, M.D., Radiology and Neurology IS. L. Rankin, B.S., Computer Science 
R. Roberts, M.D., Medicine 
A. Roos, M.D., Physiology and Biophysics IF. U. Rosenberger, D.Sc., Computer Systems Laboratory 
D. C. Sawyer, A.B., Radiology 
M. J. Schlessinger, Microbiology and Immunology 
D. P. Schreiter, B.S., Medical Computing Facilities I 
B. A. Siegel, M.D., Radiology 
D. E. Snyder, M.D., Medicine 
B. E. Sobel, M.D., Medicine IS. P. Sutera, Ph.D., Mechanical Engineering 
M. M. Ter-Pogossian, Ph.D., Radiology 
T. J. Tewson, Ph.D., Radiology IA. J. Tiefenbrunn, M.D., Medicine 
R. G. Tilton, Ph.D., Pathology 
L. J. Tolmach, Ph.D., Anatomy and Radiology 
D. A. Valenzuela, Ophthalmology I 
S. Von Rump, Radiology 
B. J. Walz, M.D., Radiology 
D. F. Wann, D.Sc., Electrical Engineering IM. J. Welch, Ph.D., Radiology 
C. S. Weldon, M.D., Cardiothoracic Surgery 
R. Wette, D.Sc., Biostatistics IJ. R. Williamson, M.D., Pathology 
L. L. Wilson, B.A., Medicine 
T. C. Winston, Barnes Hospital 
F. X. Witkowski, M.D., Medicine I 
K. F. Wong, M.S., Computer Science 
T. A. Woolsey, M.D., Anatomy 
C. P. Zobkiw, B.S., Electrical Engineering I 
Baptist Memorial Hospital, Memphis, Tennessee 
R. S. Gordon, B.A. I 
Central Institute for the Deaf, St. Louis, Missouri I
D. H. Eldredge, M.D. 
M. T. Hakkinen 
D. E. Hanpeter II. J. Hirsh, Ph.D. 
J. L. Lauter, M.S. 
J. D. Miller, Ph.D. 
R. B. Monsen, Ph.D. I 
D. A. Ronken, Ph.D. 
A. P. Rueter, B.S. 









P. F. Schroeder, B.S. 
J. W. Sharp 
N. R. Vemula, M.S. 
Columbia University, New York, New York 
J. T. Bigger, Jr., M.D. 
Creighton University, Omaha, Nebraska 
F. M. Nolle, D.Sc. 
A. Zencka, M.D. 
Duke University Medical Center, Durham, North Carolina 
D. B. Hackel, M.D. 
Indiana University School of Medicine, Indianapolis, Indiana 
C. Fisch, M.D. 
S. B. Knoebel, M.D. 
Jewish Hospital, St. Louis, Missouri 
L. L. Brandenburger, R.N. 
M. Broderson 
V. R. deMello, M.D. 
B. R. Hieb, M.D. 
J. R. Humphrey, R.N. 
R. E. Kleiger, M.D., 
R. J. Krone, M.D. 
M. T. Mitchell 
R. Ruffy, M.D. 
S. Thanavaro, M.D. 
Massachusetts General Hospital, Boston, Massachusetts 
H. K. Gold, M.D. 
H. W. Strauss, M.D. 
Mitchell Humphrey and Co., St. Louis, Missouri 
R. K. Stimac, B.S. 
The MITRE Corporation, Bedford, Massachusetts 
R. E. Zapolin, M.S. 
Pennsylvania State University, University Park, Pennsylvania 






Peter Bent Brigham Hospital, Boston, Massachusetts 
E. Braunwa1d, M.D. I 
Research Triangle Institute, Research Triangle Park, North Carolina IW. K. Poole, M.D. 
Roosevelt Hospital, New York, New York I 
H. M. Greenberg, M.D. 
St. Louis University, St. Louis, Missouri I 
S. M. Ayres, M.D. 
L. L. Brandenburger, R.N. IA. E. Dyer, R.N. 
R. G. Evans, B.A. 
S. A. Kaiser, R.N. 
H. S. Mueller, M.D. I 
St. Luke's HosEita1 East, St. Louis, Missouri IR. Paine, M.D. 
Shared Medical Systems, King of Prussia, New Jersey I 
D. K. Tao, D.Sc. 
University of Illinois at Chicago Circle, Chicago, Illinois I 
R. Langendorf, M.D. IUniversity of Iowa, Iowa City, Iow~ 
R. C. Arzbaecher, Ph.D. I 
University of Kentucky College of Medicine, Lexington, Kentucky 
B. Surawicz, M.D. I 
University of Louisville School of Medicine, Louisville, Kentucky IN. C. Flowers, M.D. 
University of Massachusetts Medical Center, Worcester, Massachusetts I 
J. Rothmeier, Ph.D. 
I 
I 





University of Nottingham, England 
I A. L. Rector, M.D.
 




I A. J. Moss, M.D.
 
University of Texas Health Science Center, Dallas, Texas
 
J. T. Willerson, M.D.
 
I University of Vermont College of Medicine, Burlington, Vermont
 
D. S. Raabe, M.D.
 
I 
I Previous years have seen occasional collaborative efforts with various 
computer firms and equipment manufacturers. This year projects of joint 
interest have involved: 
Mennen-Greatbatch, Clarence, New York and Hewlett-Packard, Waltham, 

















IV. PHYSICAL RESOURCES 
I 
On April 15, 1964, the Biomedical Computer Laboratory was formed 
and the original staff moved into 5,515 square feet (gross) of the laboratory 
space at 700 South Euclid Avenue, just across the street from the main building Iof the Washington University School of Medicine. During the intervening 
years, the floor space has been increased to 18,000 square feet by renovation 
and by occupation of rooms in adjacent buildings. Facilities for computa­
tional applications, laboratories, staff offices, and a WUCL reference room I 
occupy the various BCL spaces. Other laboratory facilities include a well­
stocked electronics shop, a large inventory of electronic and computer test 
equipment, a variety of digital system modules, and both analog and digital I 
tape recorders. Other space in the Medical School and Barnes Hospital Complex 
is frequently occupied by BCL staff members during collaborative projects. IThroughout the years the laboratory has steadily increased its computa­
tional capabilities with the addition of new computer systems. At the time 
the laboratory was formed, equipment then available for laboratory applications 
of digital computers was a single LINC (Laboratory Instrument Computer). I 
This small stored-program computer had been designed specifically for use 
in biological and medical laboratories where there is a requirement for 
strong coupling between the computer, the investigator, and other experimental I
equipment. That first LINC still provides a few service functions although 
now over 15 years old. IThe current complement of computing hardware includes a variety of 
minicomputer systems, microcomputer systems, and data terminals for access 
to the Washington University Computing Facilities IBM 360/370 and the Medical 
Computing Facilities MUMPS system. These systems include DEC PDP-II's, I 
Texas Instruments 980's, CALDATA l35's, Artronix PC-12's, an IBM System/7, 
and an MMS-X graphics system developed by the Computer Systems Laboratory. 
In addition to these systems under direct BCL supervision, there are installed Iat the Washington University Medical Center over one hundred minicomputer 
systems (representing twenty different makes and models) in which 














V. RESEARCH PROJECTS 
I Introductory Summary 
I, The goal of the Biomedical Computer Laboratory (BCL) is the application of digital computing techniques to problems in medicine and biology. This 
often requires work in areas stretching from basic physiology through 
I
 mathematical models and frequently to the design of specialized equipment.
 BCL's research program is organized into several major project areas with 
the staff grouped into teams whose interests are focused correspondingly. 
I This year, over 80 individual projects can be categorized in the seven areas into which the body of this report is divided. For each section, a one-page overview precedes the individual project reports. What follows 
here is a compressed summary of BCL activities. 
I 
I In the area of ischemic heart disease and ECG analysis, a new QRS 
detector/delineator shows major improvements in noise immunity and beat­
classification accuracy; frequency-domain analysis is being applied to 
QRS classification; and processing strategies for detecting supraventricular 
dysrhythmias have been developed for a national collaborative clinical 
trial. Three systems for high-speed processing of recorded ECGs (Argus/2H)I are in heavy use for several local and two multi-center clinical trials 
I 
involving a total of 13 different institutions. Also, BCL is collaborating 
with the American Heart Association to develop a database of international 
scope, for dysrhythmia-detector evaluation. For these activities, more 
than 800 24-hour, dual-channel recorded ECGs have undergone detailed analysis 
in the past year. In the general area of ischemic heart disease, the BCL 
I
 collaborates in 12 other individual research efforts with local investigators.
 Work in the area of tomography embraces systems developments using
 
two modalities (ultrasound and positron-emission) plus algorithm developments.




now make possible reconstructions from both velocity and attenuation parameters.
 
An analytic model provides important progress toward coping with signal
 




are being developed for error corrections. A long-standing collaboration
 
with the Division of Radiation Sciences has resulted in a new system for
 
positron-emission transaxial tomography (PETT V) which has been completed
 
and put into use. Important features include maximum circumferential detection
 
efficiency, flexible linear and angular sampling, and data acquisition
 
times down to one second. Meanwhile, PETT IV has been applied to clinical




and the blood pool. Recent advances have been made in the area of fan-beam
 













Major work in clinical pathophysiology and patient monitoring now 
focuses on the development of a Clinical Physiologic Research System (CPRS) 
which features a generalized approach to meeting a significant clasS of I
research needs with modular system elements and distributed processing. 
CPRS is being used to study physiologic responses to pulsatile perfusion 
and to acquire multiple extracellular cardiac potentials. Other work deals Iwith the acquisition and processing of machine-readable visual-field data. 
Also, a recently increased commercial interest in signal processing algorithms 
and information processing concepts has led to extended sharing. I 
Several databases for disease management and research are actively 
supported. A BCL-initiated Glaucoma-Center Patient Registry is now self­
sufficient and has moved to a separate service facility (Medical Computing IFacility) which was also spawned by the Laboratory. Meanwhile, a neonatology 
database for clinical research is beginning to mature and it's characteristics 
make it especially attractive as a test for implementation of a new database 
model which is at the found~tion of Information Systems Group work (v.i.). I 
Five other databases maintained through BCL are specifically addressed 
to collaborative research projects, all of which deal with the acute and 
chronic manifestations of ischemic heart disease. I 
Our commitment to MUMPS for medical information management has been 
sustained and expressed through active roles of BCL personnel in the MUMPS IUser's Group. Close ties with the Division of Biostatistics have yielded 
coherent approaches to data analysis using distributed resources. 
IDuring the past year BCL's primary contributions to speech and hearing 
research at the Central Institute for the Deaf (CID) have been in digital 
instrumentation for data acquisition and analysis. Three advanced random­
access, programmable digital recording systems for processing sampled speech I 
have been installed in renovated laboratories at CID. Also, a FORTRAN 
package ("Speech Microscope") has been developed to support speech-signal 
analysis. A recently developed mechanical model of the larynx and surrounding Itissues shows transfer characteristics which agree with those experimentally 
measured in humans. Other work explores electrocutaneous stimulation as 
an alternative sensory modality to hearing, the psychoacoustics of speech, 
and visual cues in lip reading. I 
In the area of central nervous system diseases and EEG analysis, 
the central-volume principle of tracer kinetics has been generalized to I 
the distribution of substances with multiple chemical species, thus advancing 
studies of blood-brain-barrier exchange and regional brain-blood flow. 
On other fronts, a system for digital acquisition and analysis of VER data Ihas been constructed and is being evaluated; for neuroanatomical studies, 
algorithms for autoradiographic-image processing are being studied; and 
work continues on an automated system for monitoring epileptic patients 













Supporting activities span exploratory biomedical applications,
 
system development aids, and digital hardware designs of general utility.
 
An especially promising application is a new approach to radiation-dose
 
calculation. It is based on a now validated mathematical model using scatter­
I. air ratios for precise absorbed-dose computation in inhomogeneous media irradiated via irregular fields. A microprocessor support system and a high-performance digital convolution filter are examples of accomplishments 




































Individual Projects IA. Ischemic Heart Disease and ECG Analysis 
The projects reported in this section continue longstanding work in 
real-time and high-speed ECG analysis. Many of the clinical studies detailed I 
below are natural outgrowths of the ECG analysis work, as are the strong 
interests in the evaluation of automated arrhythmia detectors. Modeling 
and signal-processing endeavors in the field of cardiology have taken the Iform of collaborations which address other aspects of ischemic heart disease, 
such as the kinetics of enzyme release, myocardial metabolism, and the electro­
physiologic characterization of abnormal myocardial depolarization. Digital 
techniques applied to clinical echocardiography are reported here, whereas I 
other ultrasonic work applied to tomography is considered in section B. 
A real-time computer-based arrhythmia monitoring system, called Argus, I 
in operation in the Barnes Hospital Coronary Care Unit from 1969-1975, was 
replaced in 1975 by "Argus/Sentinel," a commercially available version developed 
through collaboration with the Mennen-Greatbatch Company. The experience Igarnered with Argus, coupled with an evolving popularity of long-term ECG 
recordings from ambulant subjects, allowed us, in the early 1970's, to assemble 
a system, called Argus/H, for the high-speed (60 times real time) processing 
of those long-term recordings. Argus/H has since processed several thousand I 
recordings for a study of ventricular arrhythmias in survivors of myocardial 
infarction and several hundreds of recordings for a host of other studies. 
Extensive evaluations have verified the integrity of the analysis algorithms, I 
proven the value of the quantified results as compared to conventional manual­
scanning techniques, and confirmed the consistency of results on reprocessing. IBy the mid-1970's, it was apparent that, although we could continue 
to use Argus/H, that system, with special-purpose, limited, and expensive 
hardware, could not support rigorous algorithm development, could not efficiently 
process the now more-popular dual-channel recordings, and could not meet the I 
demand for the system from the growing volume of recordings resulting from 
recent interest in therapeutic trials of antiarrhythmic agents and interventions 
designed to protect the ischemic myocardium. A newer system, called Argus/2H, I
emerged in 1977 and was duplicated in 1978. The two Argus/2H systems process 
long-term ECGs for national multicenter clinical studies of interventions 
to limit infarct size and of post-infarction risk stratification. For such Istudies, the results of processing are usually saved for subsequent statistical 
analyses via the University's IBM System/360-370. The systems also provide 
the power and flexibility necessary for work on algorithm revision and on 
new signal-processing strategies and they also serve the analysis and documentation I 
needs of other internationally directed work to generate an annotated digital 
database for the evaluation of automated arrhythmia detectors. The Argus/H 
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During the past year, Argus algorithm development has centered around 
continuing the revision of the original Argus processing algorithms (PR 13, 
A-I). Additionally, preliminary algorithmic development has been done in two 
related areas: 1) extraction and analysis of additional time- and frequency­
domain features; and 2) detection of selected supraventricular dysrhythmias. 
Argus Revision. Plans for a total revision of the original Argus ECG 
processing algorithms were made during the early part of 1978 and commenced 
with a rewrite of the Primitive QRS detector. As described in PR 13, the 
basis for the new Argus QRS detector was an algorithm originally written 
for QRS detection in the SICU.(l) The SICU detector, which was structured 
as a finite-state machine, had as one of ~ts principal features Automatic 
Threshold Control (ATC). ATC adjusted slope-acceptance thresholds based 
on the amplitude of previously detected QRS complexes, giving the SICU detector 
increased noise immunity when compared to fixed-threshold detectors. For 
implementation in the Argus system, the SICD detector was substantially 
modified to process Aztec rather than raw sample data, and to delineate 
as well as detect each QRS complex. The delineation logic was written in 
subsections to demarcate straightforward two- and three-slope complexes, 
more complicated multi-sloped waveforms such as those seen in bundle branch 
block, and troublesome very-large-amplitude PVCs. A preliminary evaluation 
done on approximately 100,000 QRS complexes, showed the new algorithm to 
be superior to Primitive with respect to both detecting and delineating 
QRS complexes in the presence of baseline or muscle artifact (data loss 
of approximately 1% as compared with 4% for Primitive), and to false-positive 
PVC classification. The latter finding was particularly significant in 
light of the decrease in data loss and the concomitant increase in the total 
number of complexes analyzed. However, the new detector showed a significant 
(more than two times) performance degradation with respect to PVC detection. 
The reasons for this decreased performance centered mainly around the ATC 
logic. It was therefore decided to have the output of the QRS detector 
(now called the STAGE I detector) passed to a second detector (STAGE II). 
STAGE II would specifically search the STAGE I data stream for mismeasured 
or missed beats based on a knowledge of the types of errors of commission 
and ommision that STAGE I could make. Additionally, STAGE II would have 






Normal-QRS duration .(passed from the beat classification section of the 
program) as an aid in determining whether a STAGE I error had occurred. 
The concept of a two-stage detector/delineator with communication between I 
the second stage and the beat classification algorithms represents a fundamental 
departure from the original Argus implementation. However, such a departure 
now seems possible because of increased machine speed and memory space. I 
At present, an extensive evaluation of the two-stage detector is underway. 
Preliminary results on 250,000 beats selected at random and specifically 
not part of the algorithm training set have shown the new detector to be Iat least as accurate as Primitive in PVC detection and far superior to 
Primitive in noise insensitivity and false positive beat classification. 
The final results of this evaluation will be presented at the Computers 
in Cardiology meeting in September 1979. I 
Now that the QRS detection/delineation section of Argus has been 
rewritten and is under evaluation, work has begun on reworking the beat I 
classification section (Cycle). Relevant to this revision is work done 
on various other QRS features which might be useful in beat classification, 
and algorithms for atrial arrhythmias, since Cycle should be able to classify Isupraventricular as well as ventricular dysrhythmias. 
Additional Argus Features. Mean Frequency--Cycle classifies beats 
as Normal, Borderline, PVC, etc. on the basis of four morphological features: I 
duration, height, offset, and area. The original Cycle logic placed substantial 
emphasis on duration since this is the attribute that an electrocardiographer 
most readily identified as abnormal in aberrantly conducted QRS complexes. IHowever, in automated ECG processing, it is the feature most sensitive to 
mismeasurement secondary to baseline or muscle artifact. A high percentage 
of Argus false-positive PVCs is the result of mismeasured duration. A recent 
paper by Kuo and Dilman(2) discussed the parameter MEAN FREQUENCY (=l/T I 
where T = 2n ~IVj 1/~IVj-Vj_ll) as a rapidly calculable time-domain descriptor 
for ventricular fibrillatlon. We investigated MF to determine the utility 
as a feature correlated with beat width but less sensitive to noise than I 
QRS duration. After examining several thousand QRS complexes to determine 
the optimal window length and beat-placement position (WL = 244 msec, BP = 
48 msec from window start), we analyzed 19 one-hour recordings from 19 patients I(approximately 100,000 QRS complexes). For each tape, MF for all human 
verified Normal and PVC complexes was plotted in histogram fashion. On 
16 of the 19 tapes, MF was able to correctly separate at least 95% of the 
Normals and PVCs. Overlap between the two clusters occurred when the signal I 
was heavily contaminated by low-frequency noise. The same tapes were then 
used to generate histograms of Normal versus PVC durations using the Argus­
assigned durations. It was found that duration separated Normals from PVCs I 
more accurately than MF on 18 of the 19 tapes. We concluded that MF was 
not a superior feature to QRS duration in the Argus signal processing environ­
ment. I 
TDIFF--Most ECG classification algorithms based on feature extraction 
examine only descriptors of the QRS complex per see Lovelace et al departed 
from this practice by utilizing a feature called TDIFF, (3) defined as the I 
least-squares linear approximation to a portion of the ST-T wave. Although 
I 






TDIFF ostensibly reflects activity during myocardial repolarization, it 
is, in fact, more exactly a measure of the relationship between depolarization 
and repolarization relative to a QRS fiducial point. More specifically, 
two QRS complexes with the same shaped ST-T wave have strikingly differentI,




least squares approximation is calculated for a fixed number of points be­

ginning a fixed time interval after the maximum negative slope of the QRS
 
(the fiducial point). We examined TDIFF for several thousand human-verified
 
Normals and PVCs and found it to be variably effective at separating the 
two groups of beats. However, no single feature can ever correctly separate 
all Normals from PVCs and, on closer analysis, we found TDIFF to be a helpful
I




fusion and septal PVCs). Furthermore, because the ST-T wave is a low-frequency
 
noise event relative to the QRS, TDIFF is less sensitive to high frequency
 
noise than o'ther QRS features. We are currently investigating several beat
 
classification algorithms which include consideration of TDIFF as a clustering
 
parameter, and expect to include TDIFF in our final revision of Cycle. 
Because Argus processes Aztec rather than raw sample data, we have modifiedI the calculation of TDIFF so that the least squares fit is done with Aztec data. 
I Additional Features--Preliminary investigation of several other features has begun. Although data on the various descriptors is at this time too 
sparse to draw any conclusions, promising results have been obtained with 
I an additional time-domain feature, percent below the baseline (PBBL), and with several frequency-domain features including the First Spectral Moment 
of the amplitude spectrum from 6-25 Hz, the phase of the maximal power com­
ponent in the same range, and the magnitude and location of the maximal 
I power component in the lower portion of the power spectrum (2-6 Hz) (G-6). 
I 
PBBL is a measure of the amount of QRS area above and below each beat's 
"baseline" and is thus an expansion of the concept of QRS offset. All 
frequency-domain features are calculated using a 512 msec FFT, thereby allowing 
for inclusion of the entire PQRST complex within the transform window. 
I Supraventricular Dysrhythmia Detection. Historically, the Argus system has not had the ability to generate data concerning the presence 
of supraventricular dysrhythmias (SD). However, with the start of the MILlS 
project (A-2l), efforts were made to develop algorithms for the automaticI detection of SDs o At present, a semiautomatic, interactive scheme has been developed and is in routine use. As the new version of Cycle is developed, 
portions of the interactive algorithm will become fully automated. 
I Following routine human editing of each tape, a computer search is 
made through the Cycle stream and all Normal beats preceded and followed 
by Normal complexes are analyzed. For each such beat, the ratio of theI forward to backward coupling intervals is calculated (FCI/BCI). A histogram 
I 
of these ratios is internally generated for each l5-minute epoch on the 
tape and each histogram is analyzed to determine the number of beats lying 
on either side of a threshold value (typically .5--1.5). In addition, the 
gross shape of the histogram is determined. A composite histogram for the 








the times of occurrence for the five earliest beats in each epoch (thereby 
allowing human verification and strip generation), and a shape-code letter Icorresponding to the dominate rhythm in each epoch (S--sinus rhythm, characterized 
by minimal deviation from the mode; A--sinus arrhythmia, characterized by 
significant deviation from the mode; F--atrial fibrillation, characterized 
by maximal deviation from the mode). I 
Before being implemented for routine processing, the algorithm was 
evaluated on 218 recordings of 12-24 hours in length. 79.4% of the known I
SDs were correctly identified with a false-positive rate of 20.6%. It should 
be noted that nearly half of the false-positive SDs represented PVCs missed 
by routine processingo The algorithm appears to be a reliable source of 
SD information and plans to have each machine-detected SD "edited" by a I 
human technician in a manner similar to that of PVC verification are currently 
underway. I 
(l)C. F. Pieper and L. J. Thomas, Jr., "QRS Detection for the SICD," BCL 
Monograph No. 222, February 1974. I 
(2)So Kuo and R. Dilman, "Computer Detection of Ventricular Fibrillation," 
Proceedings of the Conference on Computers in Cardiology, Stanford, California, I 
pp. 347-349, September 1978. 
I(3)D. E. Lovelace, S. B. Knoebel, and D. P. Zipes, "Recognition of Ventricular 
Extrasystoles in Sedentary Versus Ambulatory Populations," Proceedings of 





A-2. High-Speed ECG Processing: Hardware I 
Personnel:	 R. E. Hitchens, BCL 
J. A. Ritter, BCL I 
Support:	 RR 00396 
HV 72941 I 
The programmed input/output interprocessor link in the MILlS system 
(PR 14, A-2) has been replaced with a direct memory access link using DEC 
DAll-B/DRll-B hardware. The improved hardware considerably reduces the I 










A high performance digital convolution filter has also been addedI to the MILlS system. It is interfaced to the PDP-ll/34 through DEC DRll-L and DRll-M mod~les and is used for bandpass filtering of EGG data. 
I Additional hardware features are planned for the IBM System/7 in order to upgrade it to two-channel processing. A 160 megabyte disk system 
I 
is nearing completion (G-15). Also planned are: 1) addition of a cycle-steal 
analog-to-digital converter for ECG digitizing; 2) a cycle-steal tape interface 
to an 800/1600 bit per inch 75 inch per second tape drive; 3) upgrade of 
the Siemens chart recorder from two to four channels; and 4) a cycle-steal 
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Holter recordings are no longer analyzed by the single-channel Argus/H
 




tapes created by that system may still be reviewed. The special purpose
 
and expensive hardware used for the Argus/H system was severely limited
 
for efficient processing of the dual-channel recordings which emerged in
 




systems. New hardware (A-2) is being added to the Argus/H system so that
 
another Argus/2H-like system can serve the growing needs of Holter-processing
 




from the CPUs (DEC PDP-ll/34s) of the Argus/2H systems, the Argus/2H software
 
cannot be simply transferred, even though most of the peripherals are similar.
 
In addition, the System/7 software, although it served for seven years,
 
is not adequate for the changeover. A major software revision is planned,
 
and work is well underway to make the new system software much more user­

oriented than was the Argus/H software. Toward that end, the operating




which, when joined with the text editor and assembler, make the creation
 
and testing of new programs much simpler than was previously possible.
 
New controlling routines and utility programs will be added as new peripheral
 
devices are attached. The software for the ECG processing aspects of the 










Operational software for the Argus/2H systems reached a near steady­
state a year ago (PR 14, A-3) and most software efforts during the past Iyear were invested in algorithm development (A-I). The only major additions 
to the operational software have been (a) the printing of a special-purpose 
Holter recording summary for the MPIP study (A-19), (b) several additions 
to the edit program (PR 13, A-3; PR 14, A-3) , and (c) a post-edit interactive I 
routine which allows an editor to confirm or regroup machine-identified 
clusters as distinct PVC morphological groups. I
MPIP summary. The Multicenter Post-Infarction Program (MPIP) study 
(A-19), requires 44 variables for each Holter recording analyzed. The 44 
items appear on a 3-page computer-printout which is reviewed locally by Ia cardiologist and then mailed to the MPIP coordinating center where the 
data are entered into the study's database. A special-purpose summary program 
produces the required items: (a) name/date-of-birth code and study identifi­
cation number; (b) date of the recording, the length of recording in minutes, I 
and the amount of data loss in minutes; (c) mean and standard deviation 
of the normal QRS-to-normal QRS intervals; (d) number of PVCs, average and 
peak hourly PVC rates adjusted for data loss, the number of bigeminal PVCs I
and the number of PVCs in the longest run of bigeminy, and the number of 
PVC shapes; (e) the distribution of PVC couplets by PVC-to-PVC coupling-interval 
class; (f) the number of PVCs in the longest PVC run and the distribution 
of PVC runs by PVC-to-PVC coupling-interval class with respect to both minimum I 
and average PVC-to-PVC intervals; (g) a binary code for the absence/presence 
of the occurrence of a PVC within the T wave of the previous QRS which is 
not a PVC and the minimum ratio of the coupling interval of a PVC to the I 
coupling interval of the previous interval provided the two beats of that 
previous interval are not PVCs; (h) the average coupling interval of all 
PVCs preceded by nonPVCs and the distribution of nonPVC-to-PVC coupling Iintervals; and (i) 3-digit personnel codes of the editor/analyst and reviewing 
cardiologist. 
IEdit program additions. Following machine analysis of a Holter-recording 
(PR 14, A-3), a human editor verifies computer decisions via an "edit" program 
(PR 14, A-3; PR 13, A-3) with which PVCs are confirmed as true, false-positive 
PVCs are rejected, and example ECG strips are produced for documentation I
and subsequent review. After the routine edit session, the editor may elect 
options to search the disk-resident beat-by-beat data stream (called the 
Cycle data stream), which includes beat labels, times of occurrence, and Iediting decisions, for sequences of beats which suggest events of clinical 
interest and/or areas of questionable analysis. 
One option considers only PVCs for which the editor is shown the I 
longest and shortest coupling intervals of nonPVC-to-PVC and PVC-to-PVC, 
the shortest nonPVC-to-PVC interval as a function of local heart rate, the 
longest run, and the first episodes of bigeminy and trigeminy. A second I
option considers beats labeled "normal" for which the editor is shown areas 
of the fastest and slowest heart rates (each based on 5 consecutive normals) 
and the shortest and longest normal-to-normal intervals. These two options Ihelp discover possible missed beats, point out mismeasured onsets, and 
reveal such interesting clinical phenomena as PAT, heart block, pauses, and 
I 






supraventricular premature complexes. For any event displayed, the editor 
may elect to generate an appropriately annotated strip recording, disagree 
with the display and make any necessary changes, or simply advance to the 
next event. 
I Two other options allow the editor to look at areas where the data 
are questionable. The first such search looks for nonPVCs with long coupling 
intervals based on an absolute figure and local heart rate. Any couplingI interval over 1.5 times that .of a computed running average normal-normal 
I 
interval or over 2000 ms is flagged and shown to the editor. Striking selected 
keys, the editor may insert a K beat (chaotic signal) in the middle of the 
interval in areas of noise, advance to the next such event, backup to the 
I 
previous event or reenter the manual scan portion of the program. This 
has turned out to be especially useful in discovering low amplitude PVCs 
missed by Argus. The companion routine to the long-interval search is a 
routine that looks for normal beats with short coupling intervals. A normal 
beat is displayed if its R-R interval is less than some absolute value input 
I 
'" by the editor. When shown such an event, the editor may strike special 
keys to delete either or both beats comprising the short R-R, advance to 
the next event, backup to the previous event or reenter the manual scan 
I 
should the event require special consideration. This mode allows the editor 
to trim out some of the mismeasured normals and to catch APCs which may 
have gone undetected. 
I A fifth type of search shows areas of conduction defects based on 5 consecutive normal beats each with duration greater than 0.12 seconds for which appropriately annotated strip recordings may be generated. A 
sixth type of search, intended to expose any R-on-T phenomena, displays
I in sequence, the absolute shortest nonPVC-to-PVC coupling interval and the five shortest nonPVC-to-PVC intervals, each a function of local heart rate. 
The editor keys "yes" or "no" in response to each candidate R-on-T. The 
I decisions are machine-recorded for future reference and strip-recordings may be generated. 
Multiform PVC clusteringo In order to obtain quantitative informationI about multiform PVCs, a true-PVC cluster routine runs after each editing 
I 
session. This routine classifies true-PVCs by cluster center using morphological 
features similar to that of "machine edit" (PR 14, A-3). Each cluster center 
then undergoes human verification in order that all centers may be defined 
as unique. If two cluster centers appear to be of the same focus, they 
are reclassified as a single center. After all cluster centers have been 
I positively identified, a printout is obtained which lists all the centers, their family members, each family's average features, and the average normal 
features. Also printed is a coupling interval histogram depicting the backward 
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Holter tape	 processing facilities include 3 systems. The original Isystem, Argus/H, processed single-channel recordings for the natural history 
study of sudden death (A-7). New hardware (A-2) is being added to that 
system and the software (A-3) will undergo an extensive revision before 
the system will become similar to the two Argus/2H systems. One Argus/2H I 
system processed a number of dual-channel recordings from the sudden death 
study (A-7) and for a small-scale drug study of the efficacy of LB-46 (Prindolol), 
a cardio-selective beta adrenergic blocking agent (PR 14, A-4). The system Iis now used to process recordings for the Multicenter Post-Infarction Program 
(MPIP) (A-19), assist in the development of the American Heart Association 
database for automatic arrhythmia detector evaluation (A-8), and accomodate Ialgorithm development (A-I). The second Argus/2H system is used to process 
recordings for the Multicenter Investigation of Limitation of Infarct Size 
(MILlS) (A-2l). The MPIP (129 recordings) and MILlS (320 recordings) studies 
have predominated the Holter processing activities and their respective I 
processing protocols are briefly described here. The protocols are extensive 
and involve many activities which extend over many days; a data management 
system (DMS), also described here, assists in the proper execution of these Iprotocols. 
MILlS Holter processing. Dual-channel 24-hour recordings are received 
by mail from 5 clinical units. A tape is received along with a packing I 
slip and several ID labels. The ID labels are affixed to various forms 
and tapes used in routine processing. Information on the packing slip includes 
ID number, date and time of recording start and stop, lead placement drawing, I 
a signature strip obtained at the time of hook-up, and a description of 
any problems encountered. The ID, date of arrival, start and stop dates 
and times, and lead placement and problem codes are logged into the DMS. IBoth channels of the entire recording are digitized onto disk and onto magnetic 
tape. The disk-resident waveform is automatically analyzed, edited, and 
I 






sununarized (PR 14, A-3; A-3). The resultant beat-by-beat "Cycle data stream" 
is saved on magnetic tape along with the digitized waveform. The Cycle 
I 
data stream is saved also with other Cycle streams on magnetic tape for 
the subsequent extraction of 150 relevant variables for statistical analysis 
(PR 14, A-6) on a larger machine. The editor/analyst notes arrhythmic findings 
on a review sheet and records the date of analysis, the number of the digital 
tape containing the Cycle data stream destined for statistical analysis, 
I percent data loss and his initials. The ECG strips generated during editing, the printed summary produced after analysis, and the editor-completed review 
sheet are sent to a cardiologist as a quality control procedure. The cardiolo­
gist likewise notes on the review sheet any arrhythmic findings and the 
I
 number of PVC forms (0, 1, 2, 3 or more) evident in the strips provided.
 Dates of processing and review, arrhythmic findings, Cycle data stream tape 
number, data loss percentage, number of PVC forms, and initials of the editor 
I
 and cardiologist are entered into the DMS. The 150 variables extracted
 by the statistical analysis system and the arrhythmic findings noted by 
the cardiologist are distilled to 12 variables which are sent on tape to 
the MILlS data coordinating center at the Research Triangle Institute inI North Carolina. The 12 variables are: ID; date of processing; PVC rate 
I 
adjusted for data loss; number of couplets; number of runs; a flag to indicate 
the presence/absence of bigeminy; the number of PVC forms; the average normal­
to-PVC coupling interval; average heart rate; maximum and minimum 5-minute 
heart rates; and a flag to indicate the presence of any of four supraventricular 
phenomena: atrial fibrillation, atrial flutter, an APC rate of greater 
I
 than 5 per minute, or PAT at a rate of greater than 150 for 20 or more beats.
 A signature strip produced at the time of editing is affixed to the packing 
slip which accompanied the recording to BCL; presumably the waveform is 
similar to that on the strip produced by the clinical unit. The packing
I slip is signed, copied, and sent on to the data coordinating center. 
I 
All analog tapes are stored at BCL. Digital tapes containing waveform 
and Cycle data streams are saved until the 12 variables are sent to the 
I 
data coordinating center. A folder for each recording is filed in numerical 
ID order by clinical center; each folder contains ECG strips, printed sununaries, 
the editor-cardiologist review sheet, and a DMS-produced printed summary 
of all stages of processing. As a quality control/reproducibility measure, 
the data coordinating center selects some percentage of tapes to be reprocessed. 
In order to blind the BCL personnel, the requested analog tapes are returnedI to their originating clinical units, where new ID labels are affixed and the recordings remailed to BCL. 
I MPIP Holter processing o Dual-channel 24-hour recordings are received by mail from 9 clinical units. Half the study's Holter recordings are sent 
to BCL; the other half are sent to a similar processing system at Columbia 
University. A label is attached to each reel and specifies an ID number,I a name/date-of-birth code, and date and start time of the recording. Both 
I 
channels of the entire recording are digitized onto disk and onto magnetic 
tapeo The disk-resident waveform is automatically analyzed, edited, and 
summarized. The Cycle data stream is saved on magnetic tape along with 
the digitized waveform and also accumulated with other Cycle data streams 








a fashion similar to that of the sudden death study (PR 14, A-6), although 
neither plans nor funding presently exists for such analysis. In addition Ito the printed summaries generated for any Holter recordings, MPIP or not, 
a special MPIP printout (A-3) serves as both a cardiologist review sheet 
and a transmittal form to the MPIP data coordinating center. The information 
which is transmitted summarizes normal-to-normal coupling intervals and I 
ventricular ectopic activity. The cardiologist's review of ECG strips and 
printed summaries produced by the editor requires the acknowledgement of 
the presence of PVCs, bigeminy, number of PVC forms, couplets, runs, and IPVC R-on-T. These decisions are entered into the DMS. 
Each analog tape is returned to the data coordinating center when 
all steps in analysis and cardiologist review are complete. The data coordinating I 
center may then attach a new ID label and re-mail the recording to one of 
the Holter processing centers for a reprocessing quality control check if 
the tape is returned to the same Holter processing center, or for a parallel I 
quality control check of systems alignment if sent to the other processing 
center. IA digitized waveform is retained only until the analog tape is returned 
to the data coordinating center. A folder for each recording is filed in 
numerical ID order by clinical unit; each folder contains ECG strips, printed 
summaries, a copy of the special MPIP summary whose original cardiologist­ I 
signed record is mailed to the data coordinating center, and a DMS-produced 
printed summary of all stages of processing. I 
Data management system. The experience garnered with the Myocardial 
Infarction Patient Information (MIPI) system (D-2) suggested that similar 
data management techniques could be implemented to monitor Holter processing Iactivities for the MILlS and MPIP studies. That same experience permitted 
the rapid implementation of an activity-monitoring subsystem for each multicenter 
study, and these data management subsystems have now proven beneficial and 
even crucial to the daily conduct of the Holter processing protocols. All I 
data management subsystem routines are written in MUMPS on a time-shared 
terminal tied into the Washington University Medical Computing Facility. I
Each subsystem retains the date and start and stop times of the recording, 
the recording's arrival date at BCL, the date of analysis, the date of cardiolo­
gist review, and the date of completion of total processing. These dates Iare used to generate internal and external management reports on systems 
throughput and to expose unexpected bottlenecks. 
The subsystems also retain information concerning the arrhythmic I 
content of each recording as determined by automatic analysis, editing, 
and cardiologist review. Searches can be made on any set of variables. 
For example, these subsystems can easily provide lists of recording IDs Icontaining the more common arrhythmias; such lists may be generated for 












The MILlS subsystem has several unique aspects. Unlike the MPIPI study, for which only one recording is obtained per patient, the MILlS protocol 
I 
dictates 3 recordings per patient. As each MILlS patient enters the study, 
the BCL Holter Core Lab is notified of the entry date and can therefore 
determine when to expect the three recordings. The Core Lab is also notified 
I 
of patient termination. In that respect, work loads may be predetermined 
and clinical units can be contacted if recordings do not appear within some 
grace period of their expected dates. As each MILlS Cycle data stream is 
condensed into 150 variables by the statistical analysis system and several 
I 
of those variables are merged with cardiologist review data to produce the 
12 variables sent to the data coordinating center, the MILlS data management 
subsystem records the date of statistical,analysis and the date on which 
I 
the variables are approved for transmission to the data center. The MPIP 
subsystem, on the other hand, records the date on which the printed summary 
and analog tape are mailed to the MPIP data center. 
Although these management information subsystems are laudable in 
the tasks they perform, the crucial dimension to their success is the error­I checking logic built onto the routines for data acquisition and activity 
I 
monitoring. Nonsensical entries are disallowed and improbable entries are 
questioned. Various steps in processing and review may not proceed until 
previous steps have not only been completed but have produced meaningful 
results. The many details involved in paperwork, machine-processing, and 
internal and extramural personnel interactions are an excessive burden for 
I




A-5. A Low Cost System for Holter Tape Playback 
I Personnel: R. E. Hitchens, BCL 








developed for use as a 60-times-real-time computer input device where real­

time playback, chart recording, and other features of the full Avionics
 
scanner are not required. The playback unit is compatible with tapes recorded
 
on Avionics Model 425 and 445 recorders.
 
The Ampex Model ATR-700 audio recorder/reproducer was chosen as the




reliability and easy maintainability; 2) availability of 2-track heads;
 
3) direct-drive DC servo capstan for low wow/flutter and tape speed variations;
 
4) accurate elapsed time counter; 5) optional remote control; 6) ability
 
to operate on 120/240 volts, 50/60 Hz; and 7) low cost relative to the Avionics 
playback units. 
I 





Several modifications have been made to the tape deck. The reproduce 
equalize amplifier was modified in order to give flat response (+ 3 decibels) Ifrom 6 Hz to 6000 Hz (0.1 Hz to 100 Hz in real time) for constant tape flux. 
This was accomplished by modifying or removing the NAB frequency breakpoints. 
Additionally, an inverting variable-gain amplifier was added to increase 




A-6o Extended Analysis of Argus/H and Argus/2H Quantified VEA I 
Personnel:	 J o Po Miller, BCL 
K. W. Clark, BCL 
C. N. Mead,	 BCL I 
P. Hoore, BCL 
G. C. Oliver, M.D., Medicine 
J. M. Paine, B.A., Biostatistics IS. J. Potter, BCL 
M. A. Province, BCL 
L. J. Thomas, Jr., BCL I 
Support:	 RR 00396 
HL 18808 
HV 72941 I 
Sandoz-Wander, Inc. 
IFollowing the processing and editing of Holter tapes by Argus/H or 
Argus/2H (A-4) the beat-by-beat annotation of the 10- or 24-hour recordings 
(Cycle streams) are accumulated on industry-compatible tape and transported 
to the IBM System/360-370 for bulk processing of the Cycle streams in order I 
to extract salient features of the ventricular ectopic activity (VEA). 
Summary (PR 12, A-2), the PL/I program which runs on the System/360-370 I 
to reduce the Cycle streams to variables of interest continued to be utilized 
for routine processing of both Argus/H and Argus/2H processed tapes. A 
special version of Summary which produces for each PVC a record, which sum­ Imarizes features concerning the environment of that PVC, e.g o, its coupling 
interval, family number, Argus features, several averages of heart rate 
preceding the PVC, and the labels of the two beats preceding the PVC was 
utilized in order to more fully characterize the distribution of PVC coupling I 
intervals. The output of both versions of Summary are in turn utilized 
to construct a SAS database (D-lO) for further analysis and for merging 
with other record-keeping systems. I 
In en attempt to describe the form of the distribution of PVC coupling 
intervals, 1) a set of 12 Argus/2H Cycle streams were reprocessed using 
the modified version of Summary. For each of the 42,089 PVCs, a record I 










analysis. Since our previous attempts had been confounded by the grouping
I of all PVCs on the tape, those PVCs with similar morphology (based on the four Argus features) were grouped together into clusters utilizing algorithms 
developed for Argus processing (PR 14, A-3). 
I In order to investigate the relationship between heart rate and the 
PVC coupling interval (CI), PVCs within a cluster were grouped into quartiles 
I by the average heart rate (based on average N-N interval) just prior to their occurrence. The mean, standard deviation, skewness, and kurtosis 
of the CI was then compared across the four heart rate groups within each 
I 
cluster. The mean CI (in ms) increased monotonically as the heart rate 
slowed (average N-N interval increased). On the other hand, the mean of 
I 
the percent prematurity (i.e. CI divided by the running average of the N-N 
intervals) monotonically decreased with slowing heart rate, indicating that 
the PVC coupling interval increases with increasing N-N, but at a slow rate. 
Various indices created from the CI and the current average N-N interval 
were investigated in an attempt to find an index which would be characteristic 
of the particular morphology and independent of the heart rate at whichI it occurred. No single adjustment was found which yielded an index which was independent of heart rate for all clusters. 
I Within a cluster, the CI was usually not normally distributed, with most distributions being both positively skewed and leptokurtic. Utilizing 
I 
a procedure based on Johnson's systems of functions, (2) an attempt was made 
to find a transform of either CI or the CI adjusted for heart rate which 
was approximately normally distributed. Unfortunately, no single transformation 
was found which would yield nearly normal distributions for all clusters. 
I Of continuing interest is the relationship of complex VEA such as 
I 
runs (3 or more consecutive PVCs) to other features noted on the tape. On 
the basis of previous analyses of the results of Summary processing we have 
concluded that, contrary to conventional wisdom, runs are usually initiated 
by PVCs with longer coupling intervals (PR 12, A-6).(3) To understand better 
the characteristics which are associated with tapes with runs, we examined 
I 1486 10-hour tapes which had one or more PVC. The tapes were classified according to the presence or absence of couplets, bigeminy, and rate (per hour) of isolated PVCs (those PVCs not contained within either a couplet 




PVC Rate No Bigeminy Bigeminy 
(/hr) No Couplet Couplet No Couplet Couplet 
<10 5 (37/802) 8(8/106) 0(0/14) 17 (/16)I 10-100 2 (3/168) 16 (30/182) 4 (1/25) 33 (18/54)
 
I










Twenty percent of the tapes with a couplet also had a run while only 4%
 
of tapes without a couplet had a run. Five percent of the tapes with isolated
 
PVC rates under 10 per hour had runs whereas it was 12% for tapes with 10-100
 I
 
per hour and 29% for those with rat?s over 100 per hour. The corresponding 
figures for the percent of tapes with couplets is 12%, 55%, and 84%. Thus 
although there is a strong association between tapes with couplets and those I
 
with runs it may only be by virtue of their mutual association to PVC rate. 
The table shown above was analyzed with a multivariate logistic with the 
GSK approach for categorical models (D-ll). This analysis demonstrated I

that the probability of runs on the tape was associated significantly (P<.0005)
 
with both the presence of bigeminy and couplets but not to PVC rate (P>.15).
 
Thus support is demonstrated for the concept that the presence of complex
 




(l)M. A. Province, "A Comparison of PVC Coupling Interval Measures," M.A. 
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I The natural history study of sudden death (PR 14, A-7; PR 13, A-7; PR 12, A-I; PR 11, A-I; PR 10, A-I, PR 9, B-3; PR 8, B-4) has completed 
the clinical and demographic data collection activities on 2175 myocardial
I
 infarction patients who have been followed at least one year after infarction.
 The MUMPS-based Myocardial Patient Information System (MPIP) (D-2) was in­
strumental in guiding study personnel through a complex protocol to collect, 
I
 edit, and forward very detailed information to the study's database. The
 database is now being scrutinized to expose and correct lingering errors. 
A major substudy, the relationship of ventricular arrhythmias toI sudden death in survivors of myocardial infarction, has completed the arrhythmia 
I 
analysis of some 3200 Holter recordings obtained from 738 of those 2175 
infarction patients. Although the beat-by-beat (Cycle) data streams produced 
by automatic arrhythmia analysis have been distilled to 154 variables each 
I 
(PR 12, A-2), those Cycle data streams which exhibit clinically important 
ectopy (10 or more PVCs, multiformed PVCs, bigeminy, couplets, runs, or 
R-on-T) will be reprocessed to produce some 35-40 variables for each PVC. 
After the additional PVC information has been merged into the database 
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Detector Evaluation I 
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IThis project which has as its goal development of a database for 
the evaluation of automatic arrhythmia detectors (PR 14, A-8), began September 
30, 1977 and has proceeded at a rapid pace during the past year. Candidates Ifor database inclusion are 2-channe1, 24-hour ambulatory ECG recordings. 
To date seventeen contributing institutions have submitted 396 tapes for 
consideration. These contributors represent major research centers and 
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Following the processing of a 24-hour tape, results of the analysis 
are reviewed to identify a four-hour segment of the tape suitable for further 
I 
intensive analysis. If the tape is acceptable, it is assigned to one of 
eight arrhythmia classes. A digital record of this four-hour segment is 
then submitted to the Tape Selection Committee, which consists of four leading 
authorities on arrhythmias and arrhythmia detection. The committee members 
are: Dr. Robert C. Arzbaecher, University of Iowa; Dr. Nancy Flowers, Uni­
versity of Louisville; Dr. J. Thomas Bigger, Jr., Columbia University; andI Dr. Suzanne Knoebel, Indiana University. Individuals from this committee independently review the tape to select the three-hour portion of the tape 
which is to be considered for entry into the database. These three hour 
I segments are then submitted to the Tape Selection Committee as a whole for a group review. This is the final formal review of the tape. At this point 
the tape may be accepted, put on hold for later consideration, or rejected. 
I
 During the past year three of these group review sessions have been held.
 As a result of these meetings, the database arrhythmia classes have been filled as follows: 
I Tapes Arrhythmia Class Selected 
I No PVCs 14 Isolated Uniform PVCs 27 
Isolated Multiform PVCs 8 
Bigeminy 29I Couplets 26 
I 
R-on-T 3 
Ventricular Rhythms 12 















The tapes accepted represent 63 percent of the needed total. Tapes 
for the R-on-T class and Ventricular Fibrillation class have been very diffi­
cult to obtain. The other unfilled classes are expected to be completed 
very soon. With some additional special effort, including the use of the 
MECCA system installed at Jewish Hospital (A-9), the completion of the re­
I maining two classes should be feasible as well. The arrhythmia classes of Isolated Uniform PVCs, Bigeminy, and Couplets have been filled. 
I 
Currently, the last half hour of three-hour records in these classes 
are being annotated by the Committee of Expert Electrocardiographers. The 
I 
members of this distinguished committee are: Dr. Charles Fisch, Indiana 
University; Dr. Borys Surawicz, University of Kentucky; and Dr. Richard 
Langendorf, University of Chicago. The last half hour of each record is 
annotated on a beat-by-beat basis. The annotator must also note the noise 
content of the signal and the background rhythms in which the ventricular 
arrhythmias may be embedded. Annotated strips are then compared and reconciledI to create the final set of annotations for the database tape. 
I
 





During the next few months the final stages of database tape processing 
will begin. The analysis of 24-hour tapes will soon be completed. Major I
emphasis will then be placed on completing the processing of accepted tapes. 
The completion entails stripping, annotating, and reconciling of the last 
half hour of all accepted tapes. Major work yet to be done includes entering 
final annotations to the digital tape, microfilming of each record, and I 
documentation of each record. The anticipated completion date for the database 




A-9. MECCA System Development and Installation 
Personnel: R. E. Hermes, BCL I 
B. R. Hieb, M.D., Jewish Hospital 
S. R. Phillips, BCL 
K. L. Ripley, BCL IW. R. Roloff, BCL 
Support: RR 00396 IHV 72989 
Modification of the MECCA system (PR 13, A-14; PR 14, A-9) for use I 
for the American Heart Association Arrhythmia Database (AHA) (A-8) and changes 
for improved performance have been made. The system was converted from 
a single channel of ECG per patient to two channels per patient. The sampling I 
system and encoding software have been changed from a ten-bit system to 
a twelve-bit system. To facilitate these changes, nearly all existing data 
handling routines were rewritten. Enhancements of the display routines 
were made to display both channels of ECG simultaneously. With the addition I 
of a third interrupt level, sample buffering is now being done to enable 
the system to monitor eight channels of ECG instead of the original six 
channels. The disk storage structure was changed to allow for maintaining I 
a minimum of three hours of two channels of ECG for each of four patients 
connected to the system. ISignificant hardware changes were made to accommodate the requirements 
of the AHA database. Among these are the addition of hardware to sense 
the connection of a patient to the system, addition of control logic to 
sense alarm button presses and turn on indicator lamps in the event that I 
an important episode of ECG has been recorded, and expanding of the analog 
hardware to 32 channels with differential inputs. IAs part of the American Heart Association Arrhythmia Database project 
(A-8), the MECCA system was configured on a refurbished PC-1200 computer 
system and installed in the Jewish Hospital Medical Intensive Care Unit I(MICU). The PC-1200 and associated hardware was assembled into a compact 
and easily portable system which also allows for easy maintenance o 
I 







Installation of the system in the MICU was carried out in two phases.
 




rooms to a central computer room. A connection box with a special connector
 
and alarm button was installed at each patient bedside. During this phase,
 
the system was evaluated and its performance and signal quality were improved.
 
In addition to the computer installation, four two-channel Honeywell ECG
 
amplifiers on portable carts were prepared for patient monitoring. The
 
nursing staff of the MICU was trained in the connection of these ECG amplifiers




Following this test, training, and evaluation period, the MECCA system
 
was moved to a new MICU in the Jewish Hospital. This second phase required
 
the installation of cabling to seven patient rooms, installation of the 
computer in a new room, and a brief checkout period. The second phase has 
I
 been completed and routine patient monitoring is beginning.
 The system is capable of detecting when particular patients are con­

nected to the system and then automatically begins to record the data from
 
I that patient. Upon the occurrence of an important ventricular event, a
 button is pressed in the patient room to cause the computer to save the 
patient data permanently. These data are then removed from the MECCA system 
I on cartridge disk and transferred to magnetic tape into an Argus/2H system format	 for ECG analysis. 
I Future system improvements include additional data handling and display capabilities for greater versatility, more efficient software to increase processing speed, and improvements to the data-storage structure and Huffman 





A-lO.	 Assessment of Vascular Integrity of the Myocardium Following Ischemic 
InjuryI Personnel: R. Go Tilton, Ph.D., Pathology 
K. B. Larson, BCL 








The Kilo Diabetes and Vascular Research Foundation 
I 
I Although much progress has been made in elucidating the pathophysiology 
of ischemic injury to the heart, several fundamental aspects of the problem 
remain unresolved. Among these are: (i) identification of the determinant(s) 
of whether sustained injury is "irreversible" and will progress to cell 








cell function; (ii) the effects of ischemia on vasculature; and (iii) the 
role of compromised vascular integrity in the pathogenesis of myocardial Iinfarction. We have initiated a program of experimental studies intended 
to provide some insights to these issues. Our goal is to characterize the 
effects of ischemic injury on the temporal evolution of alterations of the 
integrity and of the permeability of membranes of the coronary vasculature I 
and musculature, and to assess the significance of observed changes in the 
pathogenesis of myocardial infarction. Additionally, we hope that our measure­
ments will allow us to determine the effectiveness of pharmacological agents I 
intended to modulate myocardial damage of the treatment of ischemic heart 
disease. IThe approach has been to use appropriate vascu1ar- and extrace11u1ar­
space markers labeled with gamma-ray emitting radioisotopes. By using external 
radiation detectors, the movements of these markers in living isolated heart 
preparations can be monitored following their injection into the arterial I 
inflow. Our method relies for its experimental design and for interpretation 
of the data on mathematical models based on established principles of tracer 
kinetics. (1-4) I 
We perform our experiments under constant-flow conditions using isolated 
rabbit hearts perfused with oxygenated Krebs-Hense1eit buffer. A blood-gas Ianalyzer is used to monitor arterial and venous ' and pH. RadioactivityP02 ' PC02 
is monitored using a lead-shielded sodium-iodide scintillation detector 
positioned to view the entire heart. Output signals from the detector are Iamplified and subjected to pulse-height analysis. Data acquisition, storage, 
and analysis are performed with a microprocessor. 
We have used 125I_1abe1ed albumin as a vascular marker and 131I-iodide I 
as a water-space marker. Measurements of the mean-transit time of the tracers 
enable us to compute volumes of distribution according to the central-volume 
principle. (1) Values of vascular volumes so obtained agree well with values I 
obtained by independent means in the same preparations. Our preliminary 
experimental determinations of the mean-transit time and the volume of distri­
bution for iodide anion suggests that this marker labels total water space Iand is not excluded from intracellular space, as previously thought by analogy 
with chloride ion. Our preliminary results with radio1abe1ed albumin suggest 
that ischemic injury brought about by interrupting perfusate flow for 30 
minutes is sufficient to disrupt both endothelial and sarcolemmal integrity. I 
(l)p. Meier and K. L. Zier1er, "On the Theory of the Indicator-Dilution I 
Method for Measurement of Blood Flow and Volume," Journal of Applied Physiology, 
vol. 6, pp. 731-744, 1954. I 
(2)K. L. Zier1er, "Equations for Measuring Blood Flow by External Monitoring 









I (3)D. G. Levitt, "Evaluation of the Early-Extraction Method of Determining Capillary Permeability by Theoretical Capillary and Organ Models," Circulation 
Research, vol. 27, pp. 81-95, 1975. 
I 
I (4)G. W. Roberts, K. B. Larson, and E. E. Spaeth, "The Interpretation of 
Mean-Transit Time Measurements for Multiphase Tissue Systems," Journal of 
Theoretical Biology, vol. 39, pp. 447-475, 1973. 
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A-II. Mathematical Models for Estimation of Infarct Size 
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I Although extension of infarction is well recognized clinically, its 
I 
frequency has not been elucidated definitively. Since morbidity and mortality 
associated with myocardial infarction are related in part to the amount 
of damage sustained by the heart, the contributions of recurrent episodes 
of infarction merit consideration. Objective assessment of measures designed 
I 
to prevent extension or recurrence of infarction requires delineation of 
the incidence, nature, and natural history of such episodes. Unfortunately, 
the biological significance of clinical criteria of extensions or recurrences 
I 
of infarction such as chest pain, electrocardiographic changes, arrhythmia 
or ventricular dysfunction is difficult to assess because these manifestations 
may reflect either recurrent ischemia, additional infarction or both. (1-8) 
In previous studies, we have evaluated the sensitivity and specificity 
of serial elevations of plasma MB CK activity as diagnostic marker of myocardialI infarction and as an index of the extent of infarction in experimental animals 
I 
and patients. (9) Release of MB CK into circulation was found to be a remarkably 
specific marker of irreversible, as opposed to reversible myocardial injury. 
Based on values from several hundred subjects, baseline MB CK values are 
I 
low and confined to a narrow range (2 ~ 1 (SE) IU/l). After infarction 
MB CK reaches peak levels within 12 to 14 hours and disappears rapidly from 
the circulation with values returning to baseline in 24 to 36 hours. With 
a log normal or gamma distribution function fitted to all the plasma MB CK 
values, it is possible to objectively characterize the plasma MB CK time 
activity curve associated with a discrete episode of infarction. The extentI of deviations from the curve fit to all values provides an index of atypicality, 
,I 
suggestive of an anomolous pattern of release of enzymes compatible with 








The present study is designed to detect and quantify apparent early 
and late extensions or recurrences of infarction based on serial changes Iin plasma MB CK activity and to assess the biological significance of the 
episodes recognized with the use of independent methods characterizing cardiac 
biochemical integrity and electrical stability, ventricular performance, 
myocardial metabolism, and the intensity of the inflammatory process in I 
the heart in vivo. In addition, the apparent impact of enZYmatically detected 
extensions on prognosis will be assessed. I 
Characterization of CK kinetics based on previous CK modeling studies 
will be utilized to evaluate procedures for estimating the extent of infarction 
associated with multiple episodes. In preliminary studies we have found Ithat a scaled gamma distribution function of the form: 
f (t) Atae-ct I 
where A, a, and c are adjustable parameters, fits CK curves adequately. 
A more general form, the gamma distribution function convolved with an ex­ I 
ponential, i.e.: 
kt rt -kt(t-s) -csf(t) = A(te-ct) * e- se ds, IA J~ e 
o 
I
where the * denotes convolution, has been used by us as well as other investi­
gators. Due to the large variation in plasma CK curves we will first analyze 
a large number of normal CK time activity curves to determine which equation 
is most suitable and to define potential limitations that may be required I 
on the values of the parameters. 
Initially, we will assume that CK curves associated with the initial I 
infarction and reinfarction events are of the same functional form as curves 
obtained after single, discrete episodes of infarction and that the initial 
and reinfarction events are independent with the exception that the removal Iof enzyme from the blood occurs at the same rate in both cases. The plasma 
CK time activity curves will then be treated as the sum of two or more curves, 
each curve associated with a single infarction event. I 
Non-linear least-squares approximation will be used to fit selected 
curve equations to the plasma CK curves by adjusting the value of the parameters. 
The resulting best-fit curves will then be analyzed statistically to determine I 
whether significant CK release occurs late in the time course of the curve, 
suggestive of one or more reinfarction events. Infarct size associated 
with each event will be calculated from the best-fit curve using the portion Iof the fitted equation which corresponds to each infarction event. 
Since secondary elevations of plasma MB CK activity may reflect accel­
erated or late "washout" from zones of infarction rather than new necrosis, I 
independent criteria, including concomitant release of myoglobin, electrocardio­
graphic changes, and clinical symptoms, will be used to determine whether 
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In previous	 studies in this project the influence of altered cardiac Ilymph flow on release of myocardial enzymes into the systemic blood circulation 
and hence upon enzymatic estimation of infarct size was characterized. The 
potential importance of qualitative or quantitative detection of regional 
cardiac lymph drainage in refining paramefers used in enzymatic estimation I 
of infarct size was therefore identified. 1) During the past year, a study 
was completed in which external detection of cardiac lymph flow was achieved 
with 99mTc-sulfur colloid injected intramurally into selected regions of Ithe heart in 17 dogs.(2) Serial images of the chest were obtained for 24 
hours with a scintillation camera after which the animals were sacrificed 
and the cardiac and other mediastinal nodes removed and assayed for radio­
activity. Analysis of the images and counts in vitro demonstrated a consistent I 
drainage pathway between the anterior left ventricular wall and the cardiac 
node. Other areas of the heart exhibited variable drainage patterns. After 
injection into the left ventricular wall in both open-chest and closed-chest I 
dogs via a percutaneous, subxiphoid approach with a specially designed collared 
needle, the cardiac node was visualized within two minutes. Activity in 
the cardiac node region peaked within 40 minutes and accumulated to levels Iexceeding 1,000 counts/min in 5 of 6 dogs before reaching a plateau. However, 
in dogs with cardiac lymphatic occlusion five days prior to anterior left 
ventricular wall injection of the tracer, appearance of radioactivity in 
the cardiac node was markedly delayed and maximum activity was far less I 
than that in controls. Thus, regional cardiac lymph flow from the anterior 
left ventricular wall can be assessed semi-quantitatively with a radionuclide 
imaging technique potentially useful in refining enzymatic estimates of Iinfarct size.(3,4) 
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Studies were performed in the Cardiac Care Unit at Barnes Hospital 
to assess the effect of selected pharmacological agents on infarct size, 
ventricular dysrhythmia and hemodynamics in patients with myocardial infarction. 
Infarct size was estimated from serial plasma creatine kinase (CK) changes 
during a 72	 hour interval and results in controls were compared to thatI observed in the treated group. All Holter tapes were digitized and processed by the Argus/H computer system. Hemodynamics including cardiac output were 
determined by Swan-Ganz thermodilution technique and the effect of the drug
I assessed by comparing hemodynamics before and after administration. In selected cases left ventricular fu?ctio) was assessed by radionuclide ventric­
ulograms before and after therapy. 1-13 
I	 Results of the study completed in 1976 assessing the effect of dobutamine 
in patients with acute myocardial infarction showed dobutamine to be a potent 
inotropic agent with minimal chronotropic effect. Dobutamine significantlyI increased cardiac output and decreased the wedge pressure without deleterious 
I 
effect on infarct size or ventricular arrhythmias. However, in order to 
obtain adequate data for prediction of infarct size, dobutamine was not 
administered until 12 hours after the onset of chest pain. Another study 
is now in progress assessing the effect of dobutamine in patients with myo­
cardial infarction when administered immediately upon admission to the Coronary(I 
I	 - 50 ­
I 
1 
Care Unito Results of dobutamine on infarct size and ventricular arrhythmias 
will be compared to that observed in concomitant controls. Eighty patients 1 
with acute myocardial infarction have been entered into the study and results 
so far are similar to those obtained in the previous study showing beneficial 
effect on hemodynamics without deleterious effects on heart rate, ventricular Iarrhythmias or infarct size. 
A randomized trial initiated in 1978 to assess the effect of intravenous I,nitroglycerin on chest pain, ventricular arrhythmias and infarct size in 
patients with acute myocardial infarction is progressing well. The intravenous 
I
Iinfusion of nitroglycerin is titrated so that the systolic blood pressure 
does not fall more than 20% and the heart rate does not increase by more 
than 20 beats per minute. The drug is initiated immediately after the patient 
is admitted to the Coronary Care Unit and results of infarct size and ventricular 
arrhythmias will be compared to that of the concomitant randomized controls. 
So far, 90 patients have been entered into the study. Patients have tolerated I 
the drug well without any significant side effects and in patients, particularly 
those with cardiac failure or pulmonary edema, marked improvement in hemodynamics 
has been observed without any significant increase in heart rate. It is I 
too early to determine the effect on infarct size but preliminary results 
on the first 69 patients are summarized below. INitroglycerin has been shown to be beneficial during experimental 
myocardial infarction. To determine the effects in man, 69 patients (Class 
I-II) were randomized to control (C) (n=30) or treated (T) (n=39). Nitroglycerin 
was started at 10 ~g/min and increased until a 10% decline in blood pressure, I 
a 10 beats/min increase in heart rate or 200 ~g/min was attained. ECGs 
were recorded continuously and analyzed by Argus/H computer. Frequency 
of PVCs in the first 12 hours was significantly higher in treated than controls I (178 + 44 (SE) vs 106 + 31, p < 0.05) but not ventricular tachycardia or 
coupl~ts (4.7 + 1.5 vs-2.8 + 1.0/12 hours). Infarct size index was similar 
(13 (T) vs 18 (C) CK-g-eq, NS). Severity of pain, reflected by the amount Iof morphine given was similar (12.4 (T) vs 13.8 (C) mg/24 hours). Slightly 
more lidocaine was required in the treated group averaging (1692 vs 1512 
mg/24 hours, NS). Radionuclide ventriculograms showed slight improvement 
in ejection fraction in the treated group (n=8) (46 vs 49%, p < 0.05) versus I 
controls (n=15, 34 vs 34%) but no change in wall motion abnormalities. 
Thus, nitroglycerin did not reduce analgesic requirements but increased 
ventricular ectopy despite absence of significant hypotension or tachycardia. I 
The role of digoxin in the treatment of cardiac failure associated 
with acute myocardial infarction is controversial. Accordingly, we compared Ithe hemodynamic effects of digoxin to those of dobutamine, an inotropic 
agent with rapid onset of action and clearance (t%=2.5 min) in 6 patients 
(Killip Class II-III) who were catheterized within 36 hours of acute myocardial 
infarction. Dobutamine (5-10 ~g/kg/min) was given intravenously for 30 I 
minutes and then discontinued until hemodynamics returned to baseline. 
Digoxin (0.0125 mg/kg) was then given intravenously and hemodynamics were 
recorded for 90 minutes. Dobutamine markedly decreased ventricular filling Ipressure (23.8 to 8.5 mm Hg, p < 0.05) and systemic vascular resistance 
(1624 to 1202 dyne·sec·cm- 5 , p < 0.05) and increased cardiac index (2.4 to 
3.2 L/min/M2, p < 0.001) and stroke work index (23.7 to 35.6 g.m/M2, p < 0.02) I 





without a change in heart rate or arterial pressure. In contrast, digoxin
I had no effect on filling pressure (19.0 to 18.8) or systemic vascular resistance
 and stroke work index (21 to 24, p < 0.05). Neither drug affected the inci­

I,
 dence of ventricular arrhythmias. Thus, dobutamine increased cardiac output,
 decreased filling pressure and after load as opposed to digoxin which did
 not affect filling pressure or afterload. 
I To initiate prompt and appropriate therapy in patients presenting with chest pain and to optimize utilization of Intensive Care facilities, 
I 
an early and specific diagnosis is required. To assess data on selective 
diagnostic techniques in relation to patient turnover in a large volume 
of patients, we established a MUMPS database in the IS-bed Barnes Hospital 
Coronary Care Unit. The primary goal of the present study was to determine 
on a routine basis the diagnostic specificity and sensitivity of 99~c-pyro­
I phosphate scintigrams and ECGs compared to plasma CK isoenzymes (ME CK) in the diagnosis of myocardial infarction. The study was performed on 1733 
patients with chest pain admitted to the CCU over a 2.5 year period. To 
collect and analyze the data we employed a MUMPS database which ran on aI time shared minicomputer system. The entry procedure for this database is interactive and answers are entered in standard medical codes. As the 
operator enters the data all entries are checked for validity and appropriate 
I ranges. If an error is made in data entry, the prompt for the question is repeated. Since the coded data entry is redisplayed in full context, 
errors are easily detected and corrected. Data in the database consist 
I of patient identification, admission date, admitting diagnosis, length of stay in the CCU and the CCU final diagnosis. Diagnostic techniques in the database consisted of serial l2-lead ECGs, pyrophosphate scintigrams and 
CK isoenzymes. 
I 
I Diagnosis of myocardial infarction was based on elevation of plasma 
ME CK activity. Out of a total of 733 patients, 674 had myocardial infarction. 
It is of note that in patients with myocardial infarction, only 66% developed 
new Q-waves. All of the patients had myocardial infarction and 90% of the 
patients without myocardial infarction exhibited some non-specific ST-T 
I wave changes. In patients with proven myocardial infarction, a positive pyrophosphate scan was observed in 86% of the patients, however in patients 
without infarction only 9% exhibited positive pyrophosphate scans. It is 
worthwhile to point out though that the incidence of positive scans is 89% inI patients with anterior infarction while it is only 78% in patients with inferior infarction. All of the scans were performed at 24-48 hours after onset 
of symptoms, the time at which myocardial uptake is maximum. Patients with 
I myocardial infarction stayed on an average of 6.3 days in the CCU, as opposed to only 3.4 days in those patients without infarction. Patients admitted 
to the CCU for exclusion of infarction, whose sole symptom was chest pain, 
averaged only 2 days. However, patients admitted with chest pain who alsoI had cardiac failure for causes other than acute myocardial infarction stayed 
I 
on an average of 4.9 days. In the present study, with the aid of a MUMPS 
database, we were able to analyze a large amount of data concerning patients 
admitted consecutively to the Coronary Care Unit for exclusion of myocardial 
infarction. Plasma MB CK analysis provides for a specific and rapid diagnosis 
of myocardial infarction. Its use is important in facilitating efficient 
,I 





CCU bed utilization and in proper utilization of highly trained personnel. 
The diagnostic specificity of pyrophosphate scintigrams compared to ME CK I 
was 0.89. The development of new Q-waves on ECG is highly specific, however 
it is relatively insensitive since only 66% exhibited Q-waves. An ongoing 
study is now in progress utilizing the MUMPS system to analyze ECGs taken Iin the Emergency Room with results compared to diagnostic studies and patient 
course in the Coronary Care Unit to determine whether additional information 
can be obtained from the ECG to improve screening of patients for the Coronary 
Care Unit. I 
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,I Activities associated with the maintenance and operation of the PETT IV 
tomographic system for cardiac imaging (PR 13, B-5) have required major 
efforts in both software and hardware during the past year. Thirty-sixI cardiac imaging studies have been performed, each study requiring several 
I 
hours for data collection, processing, and display. (1-4) Calibration procedures 
are perform~d daily to ensure that the 96 photomultiplier tubes are properly 
adjusted and the detectors are counting approximately the same number of 
photons in each coincidence line. 
I Preliminary studies with the PETT IV indicated that the resolution of the constructed images, 1.8 cm FWHM, was not adequate for imaging the 
moving heart. Additional lead septa were added to the system and the sampling 
rate was increased, resulting in a resolution of 1.4 cm FWHM in the reconstructedI images. These changes necessitated modifications in the data collection 
I 
and processing programs as well as the filter function used in the filtered 
back-projection. The effects of various filters on the reconstructed images 
were investigated with the use of phantoms, and a filter which did not signifi­
cantly degrade the resolution and produced images which were fairly smooth 







Considerable effort was expended in reducing execution time of the 
PETT software and improving ease of operation for clinical studies. The Idevelopment of several new modes of display has aided in the detection and 
quantitation of infarct size in myocardial infarction patient. Sagittal 
and coronal sections can be generated from the reconstructed transverse Islices and displayed via the Ramtek display system in either color or gray 
scale. Any of the slices can be plotted in gray tones on the Versatec 
printer/plotter with an overlaid grid. Images from different studies can 
be superimposed with the use of special color or gray scale schemes. Figure 1 I 
shows an example of a blood-pool image obtained from a patient following 
inhalation of llC-labeled carbon monoxide superimposed on a gray-scale image 















Figure 1. Superimpositions of two PETT IV transverse images obtained in a normal II
subject showing the distribution of llC-labeled palmitate in the myocardium 
(displayed in gray tones) and of llC-labeled red cells in the blood pool (dis­
played as a homogenous white region). I 
ICurrently, we are investigating alternative procedures for calculating 
correction factors which ~ompensate for the attenuation of the annihilation 
photons within the subject of study. Our present procedure of using the 
ratio of data obtained from two scans suffers from several defects including I 
the unavoidable fluctuation of data values due to the statistical properties 
of radioactive decay. As a first step, we will attempt to reduce the fluctua­
tions in the attenuation correction factors by smoothing the projection Idata used to compute these factors. 
I 
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During the past year, studies have continued regarding the correlation 
of e1ectrophysio1ogica1 derangements and biochemical factors underlyingI malignant dysrhythmia due to ischemia. In addition, the influence of the autonomic nervous system on e1ectrophysio1ogica1 and biochemical derangements 
during myocardial ischemia is a major focus of the laboratory. Many patients
I autopsied after sudden cardiac death do not show pathological evidence of 
I 
complete coronary occlusions, suggesting that vasospasm of normal or partially 
occluded coronary arteries, with phasic alteration in regional flow may 
be a major progenitor for malignant dysrhythmias associated with sudden 
death. Since both coronary occlusion and reperfusion initiate severe ventricular 
dysrhythmias in experimental animals, we have recently completed studies 




Iprocedures, the dysrhythmias induced by coronary occlusion alone were character­
ized by increased conduction time through ischemic regions, asynchronous 
depolarization, shortening of ischemic zone refractory periods, normal idio­
ventricular rates and exacerbation by high rate atrial pacing implicating I 
reentry within ischemic myocardium as a major progenitor. (1) In contrast, 
the dysrhythmias induced by coronary reperfusion were characterized by normali­
zation of conduction time through myocardial regions, synchronous depolarization, Inormalization of ischemic zone refractory periods, high idioventricular rates 
and consistent suppression by high atrial pacing, implicating enhanced ventricu­
lar automaticity as one possible progenitor for these malignant dysrhythmias 
associated with reperfusiono(l) Thus, two distinct mechanisms may underlie I 
these two types of dysrhythmias, and since both may be potentially important 
in the sudden death syndrome in man, each may require different therapeutic 
interventions. I 
As an extension of previous studies pertaining to the influence of 
the autonomic nervous system during myocardial ischemia, studies have recently Ibeen completed demonstrating a major electrophysiological role of a-adrenergic 
stimulation during both coronary occlusion and reperfusion.(3-7) Alpha-
compared to S-adrenergic contributions to dysrhythmias induced by left anterior 
descending (LAD) coronary occlusion and by reperfusion were assessed in I 
chloralase-anesthetized cats. Alpha-adrenergic receptor blockade with either 
phentolamine or prazosin significantly reduced the number of premature com­
plexes (PVCs) during coronary reperfusion (321 + 62 PVCs to 14 + 10, p < .001), I 
abolished early ventricular fibrillation (from 25% in controls to 0%) and 
prevented the increase in idioventricular rate (IVR) normally seen with 
coronary reperfusion. However, S-receptor blockade with propranolol was Iwithout effect. Ventricular dysrhythmias induced by coronary occlusion 
alone (without reperfusion) were attenuated markedly by a-receptor blockade 
under conditions in which perfusion (measured with radiolabeled microspheres) Ijwithin ischemic zones was not affected. Alternative sympatholytic interventions, 
including pretreatment with 6-hydroxydopamine to deplete myocardial norepinephrine 
from 8 0 8 + 1.4 ng/mg protein to 0.83 + 0.2 and to render the heart unresponsive 
to tyrami;e (120 ~g/kg) attenuated dysrhythmia induced by both coronary II 
occlusion and reperfusion in a fashion identical to that seen with a-receptor 
blockade. Although efferent sympathetic activation induced by left stellate 
nerve stimulation increased idioventricular rates from 66 + 6 beats/min 
to 144 ± 7 (p < .01) prior to coronary occlusion, this response was blocked II 
by propranolol but not phentolamine. In contrast, during reperfusion the 
increase in idioventricular rate induced by left stellate nerve stimulation 
(to 203 + 14 beats/min) was not inhibited by propranolol but was abolished I 
by phentolamine (71 + 10 beats/min). Likewise, intracoronary methoxamine 
(10-7M) in animals depleted of myocardial catecholamines by 6-hydroxydopamine 
pretreatment did not affect idioventricular rate prior to coronary occlusion. IHowever, early after coronary reperfusion, regional intracoronary infusion 
of methoxamine increased idioventricular rate from 33 ± 7 beats/min to 123 ± 12 
(p < .01). Thus, enhanced a-adrenergic responsiveness occurs during myocardial 
ischemia and appears to be a primary mediator of the electrophysiological I 
derangements and resulting malignant dysrhythmias induced by catecholamines 










Recently, studies have been initiated to evaluate the role of increased 
intracellular Ga++ in the rapid increase in idioventricular rate and dysrhythmia 
induced by reperfusion. Since reperfusion induces a two-fold increase in 
I, Ga++ within 90 sec, we are evaluating whether this increase is mediated through enhanced a-adrenergic activity and whether a-adrenergic blockade or enhancement affects accumulation of intracellular Ga++ in this setting. 
Recently, we have detected accumulation of lysophosphoglyceridesI in ischemic myocardium early after coronary occlusion as well as in effluents from isolated, perfused hearts under hypoxic conditions. As reported in 
PR 14, A-IS, comparable concentrations (.75 to 3.0 roM) of lysophosphoglycerides 
I bound to albumin markedly and reversibly altered action potentials of canine Purkinje fibers in vitro using an automated system for analysis of intracellular 
action potentials stored on analog tape. (8) Electrophysiological alterations 
induced by lysophosphoglycerfdes include decreases in resting membrane pot~~-lO)I tial, overshoot of phase 0, Vmax of phase 0 and action potential duration. ' 
In addition, these compounds induced fractionation of the action potential 
into several components, unresponsiveness to external stimulation and enhancedI automaticity at normal and reduced membrane potentials, all phenomena character­istic of ischemic tissue in vivo.(9) In addition, a rightward and downward 
shift in the membrane response curve (V vs membrane potential) resulting 
I in a 40-fold prolongation of conductionm~!me together with an increase in the ratio of effective refractory period to action potential duration such 
that the effective refractory period persisted be~ond action potential duration 
I resulting in post-repolarization refractoriness. ( ,10) Since all these alterations are peculiar to ischemic tissue in vivo, the accumulation of these metabolites may playa major role in the membrane alterations and 
resultant electrophysiological derangements and malignant dysrhythmia during
I ischemia. More recently, we have demonstrated that both lysophosphatidyl choline (LPG) and lysophosphatidyl ethanolamine (LPE) increase in ischemic 
tissue within three minutes, at the time of onset of ventricular dysrhythmia 
I
 and that a correlation exists between the number of premature ventricular
 complexes and the tissue lysophosphoglyceride content (r=.79, p < .01). 
In addition, one major study has involved the demonstration in vivo that 
lysophosphoglycerides appear in venous effluents from ischemic regions withinI 10 minutes after coronary occlusion and may explain the known arrhythmogenic effects of venous effluents from ischemic regions in vitro. 
I
 Additional studies have been performed to determine whether free
 L-palmitoyl (acyl)-carnitine induces alterations similar to LPG in canine 
Purkinje fibers! since this amphiphilic compound also accumulates in ischemic 
myocardium.(ll- 3) Both LPG and palmitoyl-carnitine (75 ~M) without albuminI induced significant decreases in maximum diastolic potential (tWP), Vmax 
of phase 0 and amplitude, changes identical to those induced by albumin-bound 
LPG (.75 roM) at ten-fold higher concentrations. (11) Thus, free LPG andI acyl-carnitine induce similar electrophysiological alterations suggesting potential cumulative arrhythmogenic effects of amphiphilic compounds accumulating 
in ischemic myocardium in vivo. 
I 
I To determine whether the electrophysiological alterations induced 
by LPG in vitro resulted in action potentials dependent exclusively on the 







fibers with inhibitors of fast (tetrodotoxin) and slow (verapamil or Mn++) 
channels. (14) Verapamil (1 mg/l) or Mn++ (10-6 M) triangularized action
. 
potentials without altering MDP or Vmax of phase O. Subse9uent superfusion I 
with 0.2 mM LPC decreased MDP from -92 ± 5 mV to -57 ± 3, V from 660max± 47 V/sec to 11 ± 1 and amplitude from 132 ± 2 mV to 34 ± 4 (all p < .01). 
Although at a MDP of -53 + 3 mV the fibers were inexcitable in the presence Iof both verapamil or Mn++-and LPC, increasing (Ca++) from .75 to 8.1 mM 
led to immediate initiation of action potentials witg slow upstroke velocity 
(26 + 8 V/sec) and low amplitude (48 + 3 mV) even though MDP remained unchanged 
(-54-+ 1 mV). Action potentials were-not affected by tetrodotoxin. Thus, I 
low concentrations of LPC induce action potentials dependent exclusively
 
on the slow inward current and suggest the possibility that these types
 
of action potentials may underlie in part the abnormal electrophysiological
 I 
behavior in ischemic myocardium. (14) 
Initial studies have begun to determine whether the apparent alteration Iin S- to a-adrenergic responsiveness during ischemia and reperfusion occurs
 
as a result of accumulation of amphiphilic metabolites. Using [3H]-dihydro­

alprenolol (DHA) as a specific S-receptor ligand, preliminary results revealed
 
that LPC induced a significant decrease in specific DHA binding in rat myo­
 I 
cardial membrane preparations (68.4 to 18.1 fmoles/mg protein) suggesting
 
a decrease in S-receptor number with no alteration in affinity for the re­

maining receptors (KD 5.05 to 4.92, n.s.). Although specific binding of I
 
a-adrenergic receptors has not yet been completed, these studies might explain
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I 
The goal of this project is the implementation of a system for ultrasonic 
reconstruction based on measurements of regional attenuation and backscatter 
of normal and ischemic myocardium and of normal and atherosclerotic vascular Itissue. Although initial experiments have been performed in transmission, 
the ultimate goal of imaging of tissue will incorporate the use of reflected 
ultrasound. The current research program is multidimensional in that experiments 
are designed for investigation of tissue properties utilizing three approaches: I 
(1) characterization of ultrasonic and biochemical properties of tissue 
in vitro, (2) development of a method for the measurement of quantitative 
backscatter by reflected ultrasound~n vivo, and (3) refinement of the data I 
acquisition system designed by Digisonics. Within these three approaches, 
specific accomplishments during the past year include characterization of 
the dependence of the ultrasonic backscatter and ultrasound upon the myocardial Icontent of collagen.(1-3) Specific interventions, including the use of 
collagenase for dissolution of collagen and variable osmolar concentrations 
of buffer for alteration of water content of tissue, were employed in experiments 
utilizing isolated, perfused rabbit hearts. Both canine and rabbit hearts I 
have been employed in studies addressing the use of quantitative backscatter, 
an ultrasonic parameter measurable with the use of reflected rather than 
transmitted ultrasound. In these studies, we have demonstrated detectable I
alterations of ultrasonic backscatter from ischemic regions of canine hearts 
compared to nonischemic regions within two hours of coronary occlusion. 
Further refinements of the Digisonics DigiscanR data collection system include 
the use of alternative methods for data analysis and display. Accordingly, I 
manipulation of parameters utilized in data processing has improved definition 
of myocardial dimensional and structural characteristics. I 
(l)J. W. Mimbs, M. O'Donnell, J. G. Miller, and B. E. Sobel, "Changes in 
Ultrasonic Attenuation Indicative of Early Myocardial Ischemic Injury," I 
American Journal of Physiology, vol. 236, p. H340, 1979. 
I(2)D. Bauwens, M. O'Donnell, J. G. Miller, B. E. Sobel, and J. W. Mimbs, 
"Quantitative Alterations in Ultrasonic Backscatter in Ischemic Myocardium 
Induced with Collagenase," Clinical Research, vol. 27, p. l52A, 1979. I 
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I, The digital echocardiograph designed and built for this project combined 
I 
burst-analog sampling circuitry usin~serial analog memory and a dual Motorola 
6800 microprocessor network (PR 14, A-17). It can send 256, 8-bit samples 
taken every 5 ms to a TI-980 computer for storage on disk in real time. 
This acquisition and analysis system was used to study depth compensation 
functions (gain applied to the ultrasonic echoes) and to develop methods 
for quantitatively evaluating the resolution of clinical imaging systems. 
I 
I We compared conventional depth compensation techniques, automatic 
analog gain control methods, and digital gain control algorithms. Digital 
control of gain has two important advantages over the other two methods. 
I 
Like automatic analog gain, the dynamic range of echo signals can be increased 
compared to conventional ramp functions. The response of digitally controlled 
gain functions, however, can be much sharper than analog AGC because it 
has memory of the received signal from previous echo periods. For example, 
the automatic digital gain function brought out about twice as many echoes 
in a gelatin target with a nearly uniform distribution of air bubbles as 
I either the conventional or analog AGC methods. Similar results were obtained when imaging cardiac structures. 
I The digital echo cardiograph is now being used to evaluate the quality of ultrasonic images. The primary limitations come from the transducer 
and initial stages of signal processing. We scanned the American Institute 
of Ultrasonics in Medicine 100-mm test object with a typical adult transducerI (2.25 MHz, unfocused) using both conventional and digital AGC depth compensation 
I 
functions. From digital records of both the echoes and the gain functions, 
the original echo strength was reconstructed to quantify the dynamic range 
attained with each depth compensation technique. In addition with these 
I 
data we can investigate transformations from echo to display which give 
maximum resolution in the optical image. Effects of deconvolution filters 
used to sharpen the image beyond the defraction limits of the transducer 







Other transducer effects which limit image quality have been examined. 
Models were implemented on the TI-980 to calculate the conversion of an Ielectrical excitation pulse into an acoustic force on the face of the transducer 
and to compute the pressure patterns throughout the region insonified by 
circular and rectangular piston transducers given the force across the trans­
ducer face. These models will be used to simulate image generation to deter­ I 
mine resolution limits of existing scanners, as well as appropriate design 
constraints for new echocardiographs. I 
In order to determine ultrasonic resolution in tissue, we built several 
gelatin models with attenuations and propagation velocities similar to those 
of tissue. Attenuation measured with the CUTAR scanner (PR 13, B-3) at Ifrequencies from 4.0 to 7.5 MHz ranged from 0.3 to 1.3 db/cm/MHz. Velocities 
measured with the digital echocardiograph varied from 1540 to 1650 m/sec. 
We plan to image the test object and other known structures through well­
characterized tissue models to measure the effects of tissue on resolution I 
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IA microprocessor-based (Intel 8080) acquisition system was previously 
developed to study the signal quality of 3-lead electrocardiograms stored 
on FM analog tape (PR 14, A-18). This system was used to evaluate both 
the quality of 708 pediatric vectorcardiograms and the performance of algorithms I 
tailored to	 test interactively for technical problems, primarily baseline 
shift and excessive high-frequency noise. (1) The implementation for the 
FM tape study had no high-gain ECG amplifiers and no mass storage. It used Ia CRT for interactive displays. A number of modifications have been made 
to convert the acquisition system to an ECG cart. 
IThe circuitry has been put into a portable cabinet. A l6-character 
self-scan display and a 3-channel strip-chart recorder have replaced the 
CRT. A floppy disk drive was installed for mass storage, however, the con­
troller is not operational yet. The major change was in the addition of I
analog amplifiers and control circuitry for direct ECG measurement. 
Design of the analog section incorporated the following features: Iisolated patient connections, performance exceeding American Heart Association 
recommendations, fixed gain, and automatic calibration and reset. Buffered 
I 






isolation amplifiers with a gain of 10 have a common-mode-rejection ratio 
of more than 86 db. A driven right-leg reference further reduces the common­
I, 
mode signal. After an overall gain of 2000, ECGs are coupled to a l2-bit 
analog-to-digital converter with a + 10 volt range. These values yield 
an input range of ~ 5 mv with a resolution of 2.4 ~V. Both the calibration 
procedure and baseline restoration for signals that are out of range are 
under the control of the microprocessor which sets the measurement protocol. 
I The number of ECG channels was increased from three to eight, so 
I 
that either the standard l2-1ead or the Frank lead signals could be taken 
simultaneously. The equivalent leads are calculated by the microprocessor, 
thus eliminating any resistor networks. The system senses which cable set 
is attached and processes the signals accordingly. A clinical trial of 
the cart is being planned. 
I 
I 
(l)R. M. Arthur, "Assessment of Electrocardiographic Signal Quality During 
Acquisition," Proceedings of the IEEE Conference on Computers in Cardiology, 
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St. Luke's Hospital East 
I The Multicenter Post-Infarction Program (MPIP) is a study of myocardial infarction patients in diverse geographical settings. Organized in 1978 








of sudden death from clinical and demographic information collected during 
the acute phase prior to hospital discharge along with telephone follow-up Iinformation. Special procedures include, for each patient, a Holter recording, 
ejection fraction determined by radionuclide angiography, and a low-level 
activity evaluation. I 
The various enrolling centers are located in four cities: New York 
City (Columbia University College of Physicians and Surgeons, Roosevelt 
Hospital, St. Luke's Hospital Center); Rochester, New York (Highland Hospital); ISt. Louis (Jewish Hospital, St. Luke's Hospital East); and Tucson (St. Joseph's 
Hospital, Tucson Medical Center, University of Arizona). The data coordinating 
center and project administrators are located at the University of Rochester 
School of Medicine, Rochester, New York. I 
One half the Holter recordings are processed by the Biomedical Computer 
Laboratory (A-4) and the other half by Columbia University. After analysis, I 
the analog recordings are sent to the data coordinating center for storage. 
As an alignment cheCk of the two processing systems, some recordings are 
sent to the processing center where they were not previously processed. IAs well, some recordings are sent to the same processing center to assess 
processing consistency. 
Several local logistical problems have surfaced at Jewish Hospital. I 
First, radionuclide angiographic equipment has been ordered but not delivered; 
patients consenting to the study's procedure must be transported to and 
from Barnes Hospital for the test. Secondly, some private physicians have I 
been reluctant to have their patients undergo the low-level exercise test 
so soon after infarction. Nonetheless, of 89 patients eligible to participate 
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The Division of Cardiovascular Diseases is interested in the noninvasive 
measurement of myocardial perfusion and metabolism evaluated with positron 
emitting tracers. Studies are conducted in isolated rabbit hearts which 
allow for the precise control of many factors that modify myocardial perfusion 
and metabolism. 
I 
I Traditionally, isolated perfused hearts (perfused retrograde via 
the aorta) are perfused with buffered salt solutions. Since oxygen solubility 
is low in these solutions, hearts require high flow rates in order to maintain 
adequate oxygenation. Since high flow rates decrease the transit time of 
an injected tracer, and may thus induce artificiality to monitored time 




for adequate oxygenation of the hearts at physiological flow conditions.
 
Furthermore hearts perfused in this fashion exhibit metabolic and ventricular
 




The development of quantitative noninvasive measurement of myocardial
 
metabolism in patients is dependent on adequate modeling of fatty-acid flux
 
in the isolated heart. Currently we are injecting llC-palmitate as well
 
as a vascular tracer (68gallium-transferrin). In addition to monitoring 




manner we hope to be able to analyze llC-palmitate washout curves in a quanti­

tative manner and correlate back extrapolation of the monoexponential tail
 




The use of the erythrocyte-enhanced perfusion media has enabled us
 
to evaluate certain tracers that are currently proposed as perfusion indicators,
 
but which have not been tested in rigorously controlled systems. In a recent
 
study l3NH3 , a positron-emitting tracer that has been used as a flow indicator,
 
was evaluated in the isolated heart system. By comparing the results of
 
I washout curves in hearts perfused with the erythrocyte-enhanced buffer with
 hearts perfused with buffered salt solutions alone, and with the use of
 









for the incorporation of ammonia into glutamine, we demonstrated that the 
accumulation of l3N via the myocardium after a bolus injection of l3m1 
is not, as conventionally thought, due to myocardial flow per se, but ~ue I 
to a large extent to the metabolic status of the myocardial cell.(2) 
External assessment of perfusion has been limited in part by the I 
dependence of tracer extraction on metabolism, lack of regional specificity, 
and high radiation burden. To overcome these difficulties we have been 
developing an approach potentially useful in the quantitative external measure­ Iment of myocardial flow. A diffusable tracer (we are currently using H2l50) 
is infused exponentially into the inflow of isolated hearts and time activity 
curves are analyzed for a parameter that approaches a constant value as 
a function of tracer delivery and decay while cardiac radioactivity increases. I 
With this approach we have been able to estimate myocardial flow based on 
this derived steady-state function and correlate it with measured flow. 
We are currently pursuing this approach in the "blood" perfused isolated Iheart (to simulate physiological flow) and using llC-butanol, a tracer which 
has a lipid:water partition coefficient of approximately 1 and which should 
prove particularly useful as a diffusable tracer in this context. (3,4) I 
(l)S. R. Bergmann, R. E. Clark, and B. E. Sobel, "An Improved Isolated Heart IPrepara tion for the External Assessment of Myocardial Metabolism," American 
Journal of Physiology, vol. 236, p. H644, 1979. 
(2) IS. R. Bergmann, S. Hack, T. J. Tewson, M. J. Welch, and B. E. Sobel, 
"The Dependence of Accumulation of l3NH3 by Myocardium on Metabolic Factors 
and Its Implication for Quantitative Assessment of Perfusion," Circulation, 
in press. I 
(3)B. E. Sobel, "Non-Invasive Regional Assessment of Myocardium with Positron­
Emitting Radionuclides," in Advances in Cardiology, vol. 26, J. H. K. Vogel, I 
ed., S. Karger, Basel, Switzerland, pp. 15-29, 1979. 
I(4)M. S. Klein, R. A. Goldstein, M. J. Welch, and B. E. Sobel, "External 
Assessment of Myocardial Metabolism with lIe-Palmitate in Rabbit Hearts," 
American Journal of Physiology: Heart Circulation Physiology, vol. 6, 









A-2L Multicenter Investigation of Limitation of Infarct Size 
Personnel: R. Roberts, M.D., Medicine 
(MILlS) 
H. D. 
I D. R. K. W. 
E. M. 
R. E.I A. S. K. A. 
C. N. 
I J. P. J. W. 
B. A. 
I B. E. L. J. L. L.
, Support: RR 
Ambos, BCL 
Biello, M.D., Radiology 
Clark, BCL 
Gel tman , M.D., Medicine 
Hitchens, BCL 




Mimbs, M.D., Medicine 
Siegel, M.D., Radiology 
Sobel, M.D., Medicine 
Thomas, Jr., BCL 








On August 1, 1978 Washington University, in collaboration with four 
other centers implemented phase II of the collaborative clinical trial of 
therapy to protect ischemic myocardium. The overall goals of the project 
I 
include objective evaluation of the efficacy of administration of hyaluronidase 
and of propranolol in limiting the extent of infarction among patients with 
acute myocardial infarction and in modifying prognosis. Data will be acquired 
I 
from five clinical centers, including Washington University, Massachusetts 
General Hospital, The Medical Center Hospital of Vermont, Parkland Hospital 
in Dallas, and the Peter Bent Brigham Hospital in Boston. Each of the clinical 
units plans to enroll patients during a three-year interval to provide an 




I In addition to the five clinical units participating in the study,
 
a series of core laboratories will be utilized so that objective analysis
 




core facilities include a CK Reference Laboratory (at Washington University),
 
a Holter Recording Analysis Reference Laboratory (also at Washington University),
 
an Electrocardiographic Reference Laboratory (at the Peter Bent Brigham
 
Hospital), a Myocardial Infarct Scintigraphy Laboratory (at Parkland Memorial
 
Hospital in Dallas), a Radionuclide Ventricular Function Laboratory (at
 
the Massachusetts General Hospital), and a Pathology Core (at Duke University).




with the necessary analytical biochemical and computer equipment (PR 14,
 
A-2; A-2). In addition, personnel were trained in procedures needed for
 




of the study. Data from each core laboratory is forwarded to the Data Coordi­

nating Center (Research Triangle Park, North Carolina) so that objectivity
 








The Washington University components of this project comprise the 
Clinical Investigation Unit, directed by the Clinical Unit Coordinator, 
Dr. Allan S. Jaffe, the CK Reference Laboratory, directed by Dr. Robert I 
Roberts, and the Holter Reference Laboratory, at the Biomedical Computer 
Laboratory, directed by Dr. Lewis J. Thomas, Jr. During phase I, biochemical 
analytical techniques were verified with samples obtained from other institutions I 
and software for the Holter Reference Laboratory developed. 
The final protocol, developed after 18 months of planning, defines I
studies among patients with suspected myocardial infarction identified as 
early as possible after arrival at each clinical unit and specifically within 
18 hours of the onset of acute symptoms leading to admission. The diagnosis 
of infarction is based on electrocardiographic criteria, clinical indices, I 
and confirmed with the use of isoenzymatic criteria. Patients to be excluded 
are those with cardiogenic shock, 75 years or more, and those with other 
significant illnesses or conditions that may effect their response to therapy. I 
Therapy includes administration of placebo, propranolol, or hyaluronidase 
in a randomized fashion. For purposes of randomization patients are initially 
divided into two groups based on the presence or absence of possible contrain­ Idications to propranolol. Management of patients participating in the study 
is standardized by a regimen developed during the planning phases, designed 
to provide maximum safety to the patient and to avoid potentially conflicting 
effects of other unnecessary medications. Medical management of each patient I 
remains the responsibility of his own personal physician, and adjunctive 
emergency measures will, of course, be instituted whenever indicated. I 
Several endpoints are being utilized to assess the effects of therapy 
on the extent of infarction and on prognosis. These include enzymatic esti­
mation of infarct size based on analysis of serial changes in plasma creatine 
kinase activity, the extent of infarction assessed in plasma creatine kinase I 
activity, the extent of infarction assessed from the number of electrocardiographic 
leads in which initial ST-segment elevation is followed by development of 
criteria of transmural infarction, the distribution and extent of impairment I 
of ventricular function assessed from radionuclide ventriculograms, the 
severity and persistence of dysrhythmia assessed from Holter recordings, 
and the distribution of infarction assessed from 99mtechnetium pyrophosphate I
scintigrams. Additional endpoints include exercise tolerance tests six 
months after the episode of infarction, as well as clinical follow-up recorded 
on standardized forms developed during the planning phases of the project. IRadioventriculograrns are obtained three months after infarction, along with 
a 24-hour Holter recording. Six months after infarction myocardial infarct 
scintigrams are obtained, along with a repeat 35-lead precordial electrographic 
map and 24-hour Holter recording. A Pathology Core Lab will perform studies I 
among patients who expire during the acute or follow-up phases of the study 
for whom autopsy permission can be obtained. ISince August 1, 1978 forty-two patients have been entered into the 
study by the Clinical Investigation Unit at Barnes Hospital. All studies 
during the acute phase and in follow-up have been completed according to 
protocol. A recent visit by the Policy Board, the Clinical Coordinating I 










Clinical Unit, CK Laboratory and the Holter Laboratory as superb. A totalI of 192 patients have been enrolled by the five centers. The operation of the clinical centers and the core laboratories after initial problems has 
been extremely successful. Data bank analysis studies have been approved






















B. Tomography (Ultrasound and PETT) IAlthough ultrasound has proven to be a useful source of diagnostic 
information, results of examinations based on current ultrasonic methods 
are primarily qualitative and pictorial. To provide quantitative information 
in addition to a picture, a collaborative effort with the Physics Department I 
has been undertaken to develop ultrasonic tomography to measure regional 
parameters of tissue. To this end, a multiple frequency-attenuation and 
time-of-flight transmission tomographic reconstruction system has been imple­ I 
mented, and the physical limitations of ultrasonic transmission tomography 
have been assessed. The results are being used to derive physical and al­
gorithmic corrections to improve reconstructions. The past year has been Ispent improving the actual scanning system and completing the first phase 
of an extensive ultrasonic-measurement simulation effort. Time-of-flight 
measurements can now be made simultaneously with the amplitude measurements 
allowing reconstructions from both velocity and attenuation-related parameters. I 
In order to provide realistic test specimens without the expense of animal 
studies, ultrasonic tissue phantoms have been constructed. Simulation of 
ultrasonic propagation models and algorithms are being evaluated using these Iphantoms with known, easily controlled properties and geometries. 
Ultrasonic measurement, modeling, and simulation has proceeded in 
two parallel efforts. The problem of signal degradation by phase cancellation I 
effects in piezoelectric receiving transducers is discussed in Section B-1. 
An analytic model based on a Fourier series expansion of the incident ultrasonic 
field has been developed and experimentally verified. A geometrical ray-tracing I 
model based on a local solution of the eikonal equation has been developed 
and is discussed in Section B-2. IStimulated by the clinical impact of the EMI transmission tomographic 
scanner in 1973, experimental studies were initiated in collaboration with 
the Division of Radiation Sciences to evaluate the positron coincidence­
detection as a method for emission reconstruction tomography. This collab­ I 
orative activity resulted in a prototype scanner called PETT (Positron-Emission 
Transaxial Tomograph). A back projection algorithm, based on a convolution 
approach, was implemented in a mini-computer to effect reconstruction of I
radioisotope activity from coincidence detections. Extensive studies in 
patients and animals were conducted subsequently with the PETT III scanner 
in collaboration with the divisions of Neurology and Cardiology. A subsequent Iscanner, PETT IV, utilized concepts developed with its predecessor but in­
corporated a novel technique for the simultaneous collection of four tomographic 
slices from a single set of detectors. PETT IV is now located in the Cardiac 
Care Unit for use in the SCOR project for the quantification of regions of I 
myocardial ischemia and infarction in vivo in experimental animals and patients 
(B-3, B-4). Over the last year PETT V has been developed for rapid, high­
resolution head scans. This is described in Section B-S. I 
Theoretical studies of various aspects of tomography systems have 
been pursued in the Resource since the initial projects in 1973. The most 
recent advances have been in the area of fan-beam algorithms and architectures I 
for high-speed processing and in fully three-dimensional tomography algorithms. 
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I A. Time-of-Flight Tomography: Biomation 8100 
I 
A Biomation 8100 fast-transient recorder was interfaced to the PC-12, 
and a library of FORTRAN-callable subroutines was produced (G-20). Digitization 
with 8-bit resolution at programmable rates up to 100 MHz provides new flexibility 
for this research. 
I The Biomation 8100 was incorporated into the CUTAR scanner and CUTARSYS software (PR 14, B-1) with leading-edge waveform recognition algorithms 
providing 10 ns time-of-flight measurement resolution. Time-of-flight measure­
I ments are made simultaneously with amplitude measurements during the standard CUTAR scan. Time-of-flight analysis and reconstruction software is also 
used for concurrent development in tomographic simulation (B-2). 
I In addition to time-of-flight tomography, the Biomation 8100 provides
 a means for improved received signal analysis. The effects of refraction,
 
pulse width, pulse gating envelope shape, and intervening attenuating media
 
I
 on measurements made using piezoelectric and acoustoelectric receiving trans­
ducers can be studied with the aid of computer analysis of the associated 
digitized waveforms. This capability is exploited in the validation of the 
I
 ultrasonic simulation studies.
 B. Ultrasonic Tissue Phantoms 
I Madsen(l) describes the use of laboratory gelatins for ultrasonic 
I 
tissue phantoms. Both the ultrasonic attenuation and acoustic velocity 
can be adjusted, predictably, over the range of values encountered in actual 
tissue by the addition of varying amounts of powdered graphite and n-propanol 
to the gelatin solution prior to cooling. Samples of gelatin mixtures have 
been scanned, and the attenuation and speed of sound values reconstructed 















Figure 1. Time-of-F1ight Tomography. A typical reconstructed time-of-f1ight 
image of a cylindrically shaped laboratory-gelatin tissue phantom with two 
cylindrical regions removed from the interior. I 
The precisely formed gelatin phantoms are providing a new means for I 
evaluating the CUTAR scanner performance. Resolution, limitations of dynamic 
range, refraction effects, and effects of finite beam width may all be system­
atically studied. Because of the controllability of the acoustic properties Iof these phantoms, a quantitative measure of reconstruction degradation due 
to these various limitations can be made. 
IComparison of measurements made using these tissue phantoms with 
computer simulations based on geometrical ray tracing allows verification 
of the accuracy of the simulations before corrective algorithm development 
proceeds. I 
C. Dynamic Range Enhancement IThe overall dynamic range of the imaging system has been improved 
by greater than 10dB over the entire range of frequencies from 2 to 8 MHz 
with as much as 20 dB improvement at some frequencies. Maximum dynamic range 
with an acoustoe1ectric receiver is now in excess of 50 dB at 5 MHz. Practically I 
speaking, the dynamic range enhancement permits more attenuating objects 
to be imaged without degrading the measurement signa1-to-noise. The improvement 
in dynamic range resulted from a combination of changes in instrumentation I
and improvement in ultrasonic transducers. 
Increased efficiency has been achieved in both ultrasonic transmission 
and reception. Low insertion loss broadband piezoelectric transducers have I 
been acquired from Precision Acoustic Devices for use as ultrasonic transmitters. 
I 






 These transducers have a 5dB minimum one way insertion loss as compared to




used. The tradeoff is a reduction of the overall usable bandwidth; however,
 
the kidney image (PR 14, B-1) derived from the slope of the ultrasonic attenuation
 




for such images. Since these Lransducers have an approximate 50% bandwidth,
 





An acoustoelectric receiving transducer(2) has been constructed out of 
a single crystal of CdS expressly for use in the scanner. An improved quarter­
wave matching layer has increased the receiver sensitivity by 3dB. A tungsten 
doped epoxy backing material provides better matching to the CdS crystal, 
reducing the reflected wave in the crystal. This allows the use of a longerI pulse to improve sensitivity, and permits received pulse integration instead of simple peak detection. Improvements in the low pass filtering of the 
I 
acoustoelectric signal has enhanced the receiver dynamic range through an 
improvrnent in signal to noise. 
I 
Several changes in instrumentation have resulted in the improvement 
of dynamic range. A new Wavetek Model 165 function generator replaced an 
HP8690A sweeper/oscillator as the master signal source. A voltage controlled 
oscillator provides the programmable frequency function of its predecessor 
while the gated mode allows generation of an integral number-of-cycles tone 
I




distortion at high signal levels, from the system. A gated swept frequency (3)
 
capability may also be useful in experiments with chirp signal transmission.
 
A modification of the programmable (auto-ranging) gain module, coupled with
 
the elimination of the gating mixers permits a wider dynamic range of trans­

mitter drive levels without added distortion. 
I D. In Vitro Cardiac Tissue Studies 
I 
Canine hearts were chosen as an animal study model for ultrasonic 
tomography since the ultrasonic properties of dog myocardium were documented 
previously by other members of the Laboratory for Ultrasonics in the Physics 
I 
Department. Representative results are shown in Figure 2, a series of four 
cross-sections of the same heart spanning the basal to apical regions of 
the heart. Qualitatively, these images are substantially improved over 
previously reported work; (4) however, quantitative results were compromised 
by insufficient dynamic range. The dynamic range enhancement detailed inI Section C and mechanical scanner improvements detailed in Section E were 
I 
made after this series of measurements. After evaluation of the scanner 
improvements using the tissue phantoms described in B, further cardiac tissue 





































Figure 2. Reconstructed Attenuation in Canine Heart. Consecutive cross 











I E. Mechanical Scanner Improvements The transducer mounting fixtures in the scanner were modified to 
provide a more flexible arrangement of both transmitter and receiver. TheI transmitter to receiver distance as well as the center of scan rotation-to­transducer distances are now adjustable to accommodate the focal length of 
each transducer and the size of the specimen to be imaged. Simulations and 
I experiments have demonstrated that the receiving transducer should be located as close as possible to the object to be imaged to reduce refraction error. 
F. Phase Cancellation: Analytical Model and Experimental Verification 
I 
I One of the primary problems with computed ultrasonic attenuation 
tomography is the limitation of dynamic range. It has been shown(2) that 
ultrasonic amplitude measurements made with piezoelectric transducers are 
I 
substantially degraded by phase cancellation effects; thus, the phase insensitive 
acoustoelectric transducer has been used in our effort with an accompanying 
reduction in the dynamic range of the imaging system. Although significant 
improvements have been made in dynamic range with the acoustoelectric transducer 
and efforts to further improve its characteristics are being carried out 
in the Laboratory for Ultrasonics, (5) analytical modeling of phase cancellationI was pursued with the objective of identifying a method for deconvolving the
 phase cancellation to provide accurate attenuation measurements. Such a
 






We first considered the simple case of a plane wave perturbed har­
monically in space in a direction perpendicular to the direction of propagation. 
Analytic solutions for this case were derived for receiving transducers of 
rectangular and circular aperture. An approximate form of these solutions 
exists that is independent of the size and shape of the receiving transducerI in many experimental situations. Under such conditions, a generalized solution for arbitrarily shaped wavefronts was derived based on a two-dimensional 
Fourier series expansion of the wavefronts. 
I An experimental verification of one of the major predictions of this 
I 
theory is presented in Figure 3. Results of substitution-technique experiments 
in a water bath performed on acrylic plexiglass samples with machined surface 
corrugations are reported. To determine the magnitude of phase cancellation 
I 
that occurs in measurements with piezoelectric receivers, such measurements 
are compared with measurements made on the same samples with a phase insensitive 
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Figure 3. Phase Cancellation Measures i~ Transmission. Comparison ot the 
excess signal loss measured with a piezoelectric receiving transducer (~) 
to the theoretical prediction of the magnitude of phase cancellation (-). IPlane ultrasonic waves were transmitted through an acrylic plexiglass sample
 




(l)E. L. Madsen, R. A. Zagzebski, R. A. Banjavie, and R. E. Jutila, "Tissue 
Mimicking Materials for Ultrasound Phantoms," Medical Physics, vol. 5, no. 5, I 
pp. 391-394, September/October 1978. 
I(2)L. J. Busse, J. G. Miller, D. E. Yuhas, J. W. Mimbs, A. N. Weiss, and 
B. E. Sobel, "Phase Cancellation Effects: A Source of Attenuation Artifact 
Elimination by a CdS Acoustoelectric Receiver," in Ultrasound in Medicine, 
vol. 3B, D. White and R. E. Brown, eds., Plenum Press, New York, pp. 1519­ I 
1535, 1976. 
(3)Interim Progress Report, NSF Grant APR77-09776, January 1, 1979. I 
(4)J. R. Klepper, G. H. Brandenburger, L. J. Busse, and J. G. Miller, "Phase 
Cancellation, Reflection, and Refraction Effects in Quantitative Ultrasonic I 
Attenuation Tomography," Proceedings of the IEEE Ultrasonics Symposium, no. 
77CH1264-ISU, 1977. I 
(5)L. J. Busse and J. G. Miller, "Broadband Acoustoelectric Receivers that 
Eliminate Phase Cancellation Effects," Third International Symposium on 
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As demonstrated in earlier ultrasonic tomography experiments (PR 14, 
B-1) the imaging limitations stemming primarily from acoustic velocity inhomo­
geneity can be severe. Imaging limitations, in the context of transmission 
tomography, are manifest in two general categories: 
a)	 Instrumentation-related errors such as phase cancellation in 
piezoelectric receiving transducers, or dynamic range limitations. 
b)	 Deviations from the assumptions underlying tomographic reconstruction 
algorithms, including: 
1) deviation from straight line transmission due to refraction; 
2) deviation from strict 1ine-integra1-derived measurements, 
for example, reflections at acoustic impedance discontinuities; 
3) complicated geometry of the finite-width transmitted beams. 
The initial thrusE of this effort has been to gain a clearer understanding 
of the above limitations through development of models and simulation algorithms. 
Besides establishing practical ultrasonic imaging performance limitations, 
a goal of this research is the development of error correction algorithms. 
A refraction-correction tomographic reconstruction algorithm based on samp1ed­
beam ray tracing has been developed. This algorithm will be tested as soon 
as results from the simulation algorithms are validated. 
During this year, a set of algorithms to simulate acoustic beam trans­
mission were developed in conjunction with geometrical ray-tracing algorithms. 
The algorithms permit transmission attenuation and time-of-f1ight measurement 
simulation for finite width (focused or unfocused) beams traversing inhomogeneous 
objects by appropriately summing the amplitude and phase of the traced rays. 
Propagation through elliptically bounded regions can be simulated. The super­I imposed-ellipse geometries are also easily fabricated as laboratory gelatin phantoms (B-1) and laboratory validation of the algorithms is underway. 
I
 Simulations include: 1) ultrasonic propagation effects such as:
 
I 
a) Refraction (ray path error and beam distortion); 
b) Reflection (non-unity transmission coefficients and total internal 
reflection); 









and 2) instrumental effects such as: I
a) Piezoelectric receiving transducer phase cancellation errors;
 




The simulation algorithms are an integral part of the CUTARSYS software 
on the PC-12. Simulated tomographic scan data files are generated as though 
they had been acquired by the CUTAR scanner. Simulated data may be subject I 
to the identical processing used on actual scan data. Intermediate simulation 
stages can be output or subject to analysis as needed. Software generation 
for refraction correcting tomographic reconstruction, an outgrowth of the Isimulation, has already begun as part of CUTARSYS. 
Figure 1 graphically illustrates the development of the simulation 
methode To simulate transmission acoustic imaging measurements, algorithms I 
were developed based on an "iso-index" region model. Inhomogeneous objects 
were modelled as superpositions of regions, each described by unique acoustic 
velocity, attenuation, and density. Algorithms trace rays through the object I 
to be imaged from transmitter to receiver keeping track of signal loss, 
refractive bending or total internal reflection, and lapsed time (or phase). 
Ray-summing algorithms were employed to accumulate the signals from bundles Iof rays simulating the finite-width transmitted beam (Figure 1B, 1C). Trans­
mitted beam geometry, such as focusing, was simulated by appropriate amplitude, 
phase, and launch angle from the transmitting transducer (Figure 1D). Piezo­
electric receiving transducers of finite width and particular aperture (circular I 
or rectangular) were modelled by appropriate phase cognizant processing (Figure 2) 















































































A: Infinitesimal-width acoustic beam, non-refracting object 
B: Finite-width collimated beam, non-refracting object 
c: Finite-width collimated beam, refractive index: 1.05 
D: Focused beam, refractive index: 1.05 
- 80 ­
:~. 
A:	 Reconstructed attenuation from infinitesimal-width beam simulated scan 
of non-refracting'heart. 
B:	 Graphic illustration of the effect of the refracting medium (refractive I
 
index: 1.05). 
C:	 Simulated example of phase cancellation in a piezoelectric receiver; 
Dashed line: Desired phase-insensitive received signal. I
Solid line: Actual phase-sensitive received signal suffering pulse­
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I A	 B 
I	 Figure 3. Simulated Heart: Reconstructions of Refracting Object. 
Reconstructions from collimated beam data assuming refractive index of 1.05.I A: Time-of-flight reconstruction. 
B.	 Reconstructed attenuation slope with respect to frequency simulating 
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The overall goal of this project is to define and quantify regional 
myocardial metabolic rates and zones of impaired biochemical integrity by 
external detection of positron-emitting radionuclides. A subsidiary goal I 
is to assess regional perfusion quantitatively with appropriately selected 
tracers. (l,Z) Previously we demonstrated that administration of llC-palmitate 
to isolate perfused hearts led to a characteristic time-activity curve which Ipermitted estimation of extraction fraction of tracer and global metabolic 
rate of oxidation of fatty acid initially incorporated into lipids. Results 
were compared to rates of l4COZ production from prelabeled myocardial lipid 
stores and to arteriovenous differences of fatty acid concentration. In I 
addition, we found that reduction of perfusion to such preparations led to 
impaired uptake, trapping, and accumulation of exogenous labeled fatty acid 
with retained fractions diminishing from approximately 40% to 3%. These I 
observations were extended to intact dogs in which the accumulation of intra­
venously administered llC-labeled palmitate was quantified externally with 
a positron-emission transaxial tomograph (PETT III). Zones of prolonged Iischemia were delineated in animals subjected to occlusion of the left anterior 
descending coronary artery 48 hours prior to administration of llC-palmitate 
and were found to correlate closely with zones of infarction detected at 
necropsy by enzymatic analysis of the myocardium, morphometric determination I 
of the extent and distribution of the infarction, and concomitant changes 
in the myocardial content of l4C-palmitate administered intravenously in 
the same animals prior to sacrifice. In a preliminary previous study, we I 
demonstrated with PETT IV that zones of infarction could be identified in 
patients as well. IDuring the past year several studies have been completed in conjunction 
with this project. An improved isolated heart preparation was devised and 
validated to permit characterization of regional myocardial metabolism under 
conditions in which bulk flow was comparable to that in vivo. Generally, I 
isolated perfused heart preparations incorporate a hemoglobin-free perfusion 
I 






medium. Hence, flow must be several fold greater than physiological flow 
in vivo in order to provide adequate oxygenation of the tissue. To facilitate 
characterization of myocardial metabolism with the use of positron-emitting 
tracers, we developed an isolated heart preparation designed to simulate 
I physiological levels of flow in substrate extraction. Isovolumically beating hearts were perfused retrograde and without recirculation at 60 mm Hg with Krebs-Henseleit solution enriched to hematocrit of 25 or 40% with washed 
sheep red cells (for which the oxyhemoglobin dissociation is independentI of DPG concentration). Under conditions in which coronary perfusion was comparable	 to that in vivo, the preparation was stable for several hours 
with left ventricular systolic pressure averaging 98 when the hematocrit 
I
 was maintained at 40 and with left ventricular dP/dt, pressure-time index,
 and directly measured oxygen consumption being comparable to values in vivo. 
I 
Fatty acid extraction was several fold higher in hearts perfused with red 
cell-enhanced media compared to those perfused with buffer alone even under 
conditions in which the buffer-perfused hearts were well oxygenated. This 
preparation avoids intrinsic limitations encountered with buffer-perfused 
hearts in studies in which radiolabeled tracers are employed to characterizeI	 metabolism and in which time-activity curves must be evaluated under conditions of flow comparable to those likely to be encountered in vivo. (3) 
I With this preparation, studies were undertaken to characterize the relationship between flow and retention of l3NH since this tracer has been3 , 
used in vivo as an indicator of perfusion. The study was performed because 
of our concern that metabolic factors might markedly influence the relationshipsI between retention of ammonia an~ flow and that accordingly, quantitative 
I 
delineation of perfusion with 1 N-labeled ammonia would not be possible even 
if the detection system employed permitted quantitative delineation of the 
distribution of the radionuclide. The residual fraction of l3N-labeled ammonia 
was evaluated in isolated perfused rabbit hearts under conditions in which 
I 
flow and cardiac metabolism were selectively and independently controlled. 
In 13 hearts perfused with buffer alone, the residual fraction of l3N counts 
was not altered significantly when flow was decreased by 75% from the control 
rate of 4.2 ml/g/min (residual fraction = 17.9 + 2.7, mean + S.E. (%) under 
control conditions to 18.4 ± 1.2 under conditio~s of low fl~). In 12 heartsI perfused with red-ceIl-enhanced media, residual fraction was not altered despite marked ischemia when flow was diminished by 75% from control values 
of i.4 (residual fraction = 54.6 + 2.4% under control conditions and 58 01 
I + 404 in the face of ischemia). In hearts perfused with red-ceIl-enhanced media containing methionine sulfoxamine, a glutamine synthetase inhibitor, 
I 
myocardial retention of l3N counts was reduced by more than 60% despite constant 
flow. The results obtained indicate that retention of l3N activity by myocardium 
is markedly influenced by the metabolic state of the tissue and that accordingly, 
I 
relationships between extraction and retention of tracer and flow per se 
are complex and preclude direct estimation of perfusion from the amount of 
tracer sequestered by the myocardium. 
I 
In view of these limitations of conventionally used perfusion indicators, 
studies were undertaken to determine whether perfusion could be assessed 
quantitatively in such preparations with the use of programmed exponential 








isolated perfused rabbit hearts with Krebs-Henseleit buffer alone or Krebs­
Henseleit enriched with red cells to a hematocrit of 40%. With flow varied I 
from 1.2 to 5 ml/g/min actual and estimated flow correlated cloRely (r = .95, 
n = 52 determinations). The method employed permits quantification of flow 
by exponential infusion of a diffusible tracer and analysis of a parameter Ithat approaches a constant value rapidly as a function of tracer delivery 
rate and decay constants while tissue radioactivity increases monotonically. 
Since time-activity curves with tracers such as llC-palmitate in isolated 
perfused hearts presage regional changes detected by positron tomography I 
in vivo, the results with exponential infusions of tracers suggest that such 
approaches will permit regional quantification of myocardial perfusion in 
vivo as well. I 
In additional studies the applicability of quantitative delineation 
of regional metabolism with IlC-palmitate was assessed in rabbits in vivo. IThe animals were given intra-atrial injections of IlC-palmitate (100 ~Ci) 
and cardiac time-activity curves monitored with two NaI(Tl) crystals with 
a field of view encompassing the heart. In the same animal under constant 
physiological conditions, the rate of decline of cardiac llC-palmitate counts I 
remained constant (.009 + .002 SE In counts/min, n = 4). In contrast, mono­
exponential clearance, reflecting oxidation varied directly with tension 
time index (range = 1,000 to 2,850 rom Hg·sec, r = .96) and peak dP/dt (1,000 Ito 5~550 rom H~/sec, r = .84) among different animals. Simultaneous injection 
of 1 C- and 1 C-palmitate led to a prompt decline of counts from blood in 
contrast to the heart. Thus, persistent, circulating tracer did not distort 
results. These results indicate that external detection of cardiac IlC_ I 
palmitate metabolism quantitatively reflects myocardial oxygen requirements 
in vivo and may permit a~sessment of regional metabolism in man with disappearance 
of tracer monitored by positron emission transaxial tomography. I 
An additional study was performed to characterize the distribution 
of labeled palmitate in lipid extracts from control and ischemic isolated Ihearts and to determine whether the nature and extent of labeled fatty acid 
uptake within minutes after its administration would impair accurate delineation 
of infarction by positron emission tomography. Perfused hearts were exposed 
to l4C-palmitate complexed to defatted albumin in conditions of high (20 I 
ml/min) or low (5 ml/min) flow -- conditions providing adequate and impaired 
oxygenation respectively. After 5 minutes of perfusion with tracer, hearts 
were removed quickly and flushed with perfusate free from tracer to clear I 
the vascular space of residual 14C- pal mitate. For subsequent radiochemical 
analyses, myocardial samples were taken from the interventricular septum 
in order to avoid inclusion of epicardial fat, frozen in liquid nitrogen, Iand stored at -70 0 Lipid extracts were prepared in methanol:chloroform,• 
and radioactivity in short-chain fatty acid metabolites (in the upper phase) 
assayed by liquid scintillation spectrometry. Radioactivity in long-chain 
fatty acids and acyl CoA and other neutral and phospholipids was assayed I 
by evaporation of the lower phase to near dryness, dilution with chloroform, 
and chromatography on silicic acid column~. Additional aliquots were evaluated 
by two-dimensional thin-layer chromatography on silica gel plates. Results Iindicated that the percentage of radioactivity in neutral lipids was higher 
in ischemic than in control hearts (75 ± 3.3 versus 41 + 3.3%) but that the 
I 





percentages of radioactivity in polar lipids were similar. Counts recoveredI in the upper phase represented 40% of total extractable radioactivity in 
I 
control hearts but only 6% in ischemic hearts. This reflects the lack of 
degradation of long-chain acyl groups to short-chain, aqueous soluble metabolites 
of oxidation in the ischemic hearts. Although the percentage of tissue radio­
activity in trig1ycerides was higher in ischemic than in control hearts (36 
I 
± 2.3% versus 20 ± 1.5%), the total amount of radioactivity per gram of 
tissue was significantly less in the ischemic than in the control hearts 
(19,150 + 5,922 dpm/g compared to 38,048 + 5,891). These results indicate 
I 
that despite the altered metabolism of fatty acid evident in ischemic tissue 
with preferential deposition in neutral lipids, net accumulation of radiolabeled 
exogenous fatty acid decreases in ischemic myocardium. Accordingly, the 
relative increase in deposition of fatty acid in neutral lipids does not 
obscure detection of metabolic consequences of ischemia based on diminished 
I uptake of labeled fatty acid. As described in (B-4), application of some of these approaches to studies of myocardial infarction in man with regional 
radioactivity detected by positron emission tomography has been accomplished. 
I (l)B. E. Sobel, "Non-invasive Regional Assessment of Myocardium with Positron­

Emitting Radionuc1ides," Advances in Cardiology, vol. 26, J. H. K. Vogel,
I edo, S. Karger, Basel, SWitzerland, pp. 15-29, 1979.
 
I
 (2)M. S. Klein and B. E. Sobel, "Fatty Acid Uptake and 'Metabolic Imaging'
 of the Heart," Cardiovascular Clinics, A. N. Brest, ed., F. A. Davis Company,
 Philadelphia, pp. 165-176, 1979. 
I (3)S. R. Bergmann, R. E. Clark, and B. E. Sobel, "An Improved Isolated Heart 
Preparation for 
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This project is designed to determine whether positron emission transaxial 
tomography (PETT) permits delineation of regional myocardial metabolism in I 
vivo with particular emphasis on delineation of zones of jeopardized ischemic 
myocardium and infarction. Its overall objective is to provide a diagnostic 
modality of superior quality to conventional procedures and to provide an I 
investigative tool that will permit objective assessment of the efficacy 
of potentially therapeutic interventions in diminishing the progress of ischemic 
injury to myocardial necrosis. Previously (B-3) we have demonstrated that I 
llC-palmitate is a particularly useful radionuclide for assessment of myocardial 
metabolism externally. Fatty acid is the preferred substrate of the heart 
for a variety of reasons, including the high cytoplasmic ratios of carnitine 
to CoA which leads to conversion of activated fatty acids to species that I 
can ingress into the mitochondria where oxidation takes place. In our previous 
studies we demonstrated, using isolated perfused hearts, that the reduction 
of llC-palmitate accumulation detectable externally correlated closely with I 
hypoxia and its metabolic sequelae despite the maintenance of constant flow. 
In addition, we found that the distribution and extent of myocardial infarction 
detectable tomographically with llC-palmitate administered intravenously I 
into intact dogs correlated closely with myocardial infarction quantified 
morphometrically at necropsy and delineated with the use of enzyme assays 
applied to contiguous cross sections of the heart. A series of studies has 
defined the consistency of li1id pools in heart muscle, the relationships I 
between altered retention of lC-palmitate and metabolic integrity reflected 
by generation of CO 2 , and physiological determinants of myocardial oxygen 
requirements in relation to oxidative rates of llC-palmitate detected exter- I 
nally.(1-4) 
In this project, the feasibility of tomographic delineation of myocardial 
infarction was demonstrate~ initially with PETT III in patients with remote I 
myocardial infarction. (1-3 In the initial study it was demonstrated that 
the distribution of llC-palmitate in cross sections of the heart from normal 
subjects was homogeneous but that zones of diminished uptake characteristically I 
occurred in patients with pre-existing myocardial infarctions in locations 
corresponding to the electrocardiographic loci of infarction. In a study 
completed very recently, PETT IV was used to image myocardium after intravenous I 





injection of lIe-palmitate to delineate zones of jeopardized or irreversiblyI injured tissue and after inhalation of lleo to image the cardiac blood pool 
I 
with llCO-hemoglobin. Twenty-eight patients with suspected myocardial infarction 
were studied (21 with electrocardiographically documented transmural infarcts 
and 7 in whom the diagnosis of infarction was ultimately excluded based on 
I 
enzymatic and electrocardiographic criteria). To assess reproducibility, 
4 patients were studied on two occasions one month apart. Inferior and apical 
infarcts were readily localized with sagittal and coronal reconstructions 
as opposed to transaxial reconstructions. Complete electrocardiographic 
and tomographic concordance was observed for the loci of all transmural infarcts. 
Reproducibility of tomographic estimates was within 10%. Tomographic estimationI of the extent of infarction with llC-palmitate in a subset of patients in 
I 
whom right ventricular contributions to overall enzyme release could be excluded 
was facilitated by delineation of the endocardial border wiih llCO-hemoglobin 
cardiac blood pool images in each of the planes for which 1 C-palmitate images 
I 
of myocardium were obtained. The correlation between enzymatic (serial plasma 
MB CK method) and tomographic estimates was close (r = .92). Thus, as has 
been demonstrated previously in experimental animals, positron emission 
tomography with llC-palmitate permits quantification and localization of 
myocardial infarcts in patients. Future directions in this project include 
the anticipated use of rapid scan instruments that will permit detectionI of regional metabolic rates of oxidation of initially incorporated llC-palmitate 
I 
based on serial analyses of selected tomographic regions of interest within 
the left ventricle. In preliminary experiments in animals, we have demonstrated 
that the rates of decline of llC-palmitate activity within regions of the 
I 
left ventricle are virtually identical in hearts from normal animals, and 
that the rates of decline are markedly increased when metabolic demand of 
the heart is increased by acceleration of heart rate after administration 
of atropine. Accordingly, it appears highly likely in patients that homogeneity 
I 
of metabolism of llC-palmitate will be characteristic in normal hearts, that 
variation in regional metabolic rate will be a manifestation of differential 
nutrition and oxygenation, such as that occurring in association with coronary 
I 
artery disease, and that evaluation of regional metabolism will provide a 
sensitive index of occult coronary artery disease in patients studied at 
rest or during physiological stress. An additional future direction involves 
clinical application of procedures, developed in our studies of ischemic 
myocardium in experimental animals (B-3), for quantification of regional 
perfusion based on exponential infusion of positron-emitting radionuclides.I Again, rapid scan instrumentation will be required, gating of the tomographic system to the cardiac cycle, and an interpretation of results will depend 
on verification with other biological sequelae of regional ischemia. 
I 
I 
(l)B. E. Sobel, E. S. Weiss, M. J. Welch, B. A. Siegel, and M. M. Ter-Pogossian, 
"Detection of Remote Myocardial Infarction in Patients with Positron Emission 
Transaxial Tomography and Intravenous llC-Palmitate," Circulation, vol. 55, 
pp. 853-857, 1977. 
I
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PETT v(1,2) is a high sensitivity, seven slice positron emission tomograph I
designed for the imaging of the human brain. The design concepts incorporated 
in PETT V, such as maximum circumferential detection efficiency, flexible 
linear and angular sampling, high and low resolution, and minimum data acqui­
sition times of one second, enable it to be used in a low resolution dynamic I
 
mode or a high resolution static imaging mode. The detector system of PETT V
 
consists of a circular array of 48 NaI(Tl) scintillation detectors, each
 
fitted with two photomultiplier tubes, with one dimensional positioning capa­
 I
bility. Angular sampling is achieved by the rotation of the circular array 
of detectors and the linear sampling is obtained by a unique wobbling m9tion 
of the detectors. A detailed description of PETT V has been published. ,1,2) 
PETT V has been built and tested and has been used in both animal and patient I
 
studies. Work is still in progress in improving the performance of PETT V
 
with the aid of phantom studies and new software.
 I
 
(l)M. M. Ter-Pogossian, N. A. MUllani, J. T. Hood, C. S. Higgins, and D. C. 
Ficke, "Design Considerations for a Positron Emission Transverse Tomograph I
 
(PETT V) for Imaging of the Brain," Journal of Computer Assisted Tomography,
 
vol. 2, pp. 539-544, 1978.
 I
 
(2)N. A. Mullani, M. M. Ter-Pogossian, C. S. Higgins, J. T. Hood, and D. 
C. Ficke, "Engineering Aspects of PETT V," IEEE Transactions on Nuclear Science, 
vol. NS-26, no. 2, pp. 2703-2706, April 1979. I
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I As reported last year (PR 14, B-3), we have derived a fan beam re­
construction algorithm for a geometry in which the detector rotates with the 
source. This algorithm can be implemented by adaptive transversal-filterI technology to achieve a very high processing speed. The relationship between 
I 
the number of source angles, number of taps in the transversal filter, number 
of detectors, image resolution, and the reconstruction time has now been 
established. We have also derived a fan beam algorithm for a geometry in 
which a ring of fixed detectors surrounds the object. 
For the rotating detector geometry (PR 14, B-3), we have establishedI the following relationship: N z N ' where N is the number of source angles,a S aand NS is the number of detectors in the fan. In the case where the image 
pixels are distributed ~r apart on concentric circles with ~r radical incre­
I
 ment, the total reconstruction time T is given by:
 
I T = 41T (~)2
 f ~r '
 B 
or alternatively by:I 2N
aT ~, 
I B 
where L is the radius of the object, and f is the bandwidth of transversalBfilter. The number of taps in the transversal filter, Nt, is given by:I 
L 
I Nt 41T ~r 
I 
The fan beam reconstruction algorithm 
a weighted sum of filtered detector outputs. 
independently but the filter function is the 
algorithm is based on the relation that if: 




I - 90 ­
for a fixed detector geometry is 
Each detector output is filtered 










-1 j r sin (28-~)/2 - r cos ~/2} ~ = tan tR sin ~/2 - r cos (28-~)/2 I 
2 2 -1 W(r,8.~) = [R + r + 2 r R sin (8-~)] I 
a source angle,
 
~ = origin-detector angle.
 
8 total fan angle,
 I m
 




R origin to source distance,
 I 
g (0) = filter response used in the parallel beam algorithm,
 
m(a,O data at source angle a, origin-detector angle ~,
 





B-7. Algorithms for Three-Dimensional Tomography I 
Personnel: D. L. Snyder, BCL 
N. C. Cheng, BCL I 
Support: RR 00396 
ILet a(~) be the density of a three dimensional object to be recon­
structed from projection data; here ~ is a point in the three dimensional 
object space. Let e be a unit vector of arbitrary orientation. A projection 
of a(o) on the line-t~ is defined by: I 
m(t~) = .£ a(~)ds, IP (t~-L) 
where P(te-L) is a plane perpendicular to ~ and at a translation distance t 
from the origin, and where ds is a differential area in this plane. The I 
three dimensional reconstruction problem is to determine a(~) for all ~ 
in terms of m(t~) for all t and e. If e in polar coordinates is denoted 
by (1,8,~), we find that: I 
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 G(f,8,cj» = fex> g(t,8,cj» exp(-j2TTft)dt If I~(f~)
 -ex> 
I and where 
M(f~).= fex>	 m(t~) exp(-j2TTft)dtI	 _ex> 
I is the one dimensional Fourier transform of mete). This equation can be interpreted as a "filtered back projection" that generalizes the usual parallel 
beam back projection in two dimensions by using projection data mete) resulting 
from integration over planes P(teL) rather than lines, employing a ~ne dimen­I	 sional filter with an Ifl 2 respo;se rather than an If I response, and by back projecting as a constant over planes ~T~ = constant rather than lines. 
I In an emission tomography system having detectors distributed on a cylinder, mete) is obtained by appropriately summing all detection events 
I 
occurring in detectors intersected by the plane P(te~). With this algorithm, 
there appears to be a potential for rigorously accommodating data that are 
obtained in	 planes other than those perpendicular to the cylindrical axis of 
the system;	 such "cross plane" data 








are presently ignored or treated in an 






C. Clinical Pathophysiology and Patient Monitoring 
BCL activities addressing clinical pathophysiology and patient mon­ Iitoring began in 1970. In 1973 a minicomputer-based patient monitoring 
system was installed in the Cardiothoracic Surgical Intensive Care Unit 
(SICU) at Barnes Hospital. After nearly seven years of continuous use, Ithis highly regarded system will be replaced by a commercial monitoring 
system that incorporates several of the novel features found useful in the 
existing SICU patient monitoring system. The presence of the SICU system 
has heightened the awareness of clinical investigators to the value of on­ I 
line digital signal processing in their research. In general, the computer 
is now seen as an important tool in a continually increasing number of 
biomedical research activities. These demands for digital computing have I
stimulated us to develop more flexible and enduring solutions to better 
satisfy pathophysiologic research needs. The Clinical Physiologic Research 
System (CPRS) offers a generalized approach to meeting a significant class 
of such needs with modular system elements and distributed processing. I 
In addition to providing a methodology for implementing instrumentation 
systems in a local environment, the CPRS concept may provide a convenient 
means for interfacing instrumentation systems to more global networks where I 
expanded computational and data storage capacity reside. 
During the past year, several research activities have dealt with Ithe development of new and enhanced instrumentation and measurement techniques 
needed to make important clinical measurements. Included in these activities 
is the development of a system for acquiring serial left-ventricular angiograms 
that are subsequently analyzed to evaluate and improve ventricular boundary I 
extraction algorithms. The objectives of the ultrasonic flowmeter and cardiac 
output studies are to enhance the clinical measurement of respiratory gas 
flow and cardiac output respectively. Instrumentation systems which have I 
the promise of providing information that will contribute to a better understanding 
of glaucoma have been implemented in collaboration with the Department of 
Ophthalmology. I 
Research activities have applied mathematical methods in the statistical 
analysis of factors contributing to the risk of visual-field loss associated 
with glaucoma. The detection of high risk individuals is essential for I 
the early institution of appropriate therapy. A multiple logistic function 
was used to assess the relative contribution to risk of multiple factors 
acting in concert. Another activity seeks to refine the mathematical model I 
of fluid and exhaust mechanisms via the canal of Schlemm by measuring the 
temporal response of intraocular pressures following sudden displacements 
of the fluid. I 
Pathophysiologic research activities which initially focus on new 
instrumentation techniques or employ mathematical methods to answer important 
biomedical questions through modeling and statistical analysis have clinical I 
application as an ultimate objective. The prototype SICU monitoring system 
has contributed to the clinical application of physiologic patient data 
and the SICU signal processing algorithms have been translated for use in I
clinical applications of the CPRS. 
I 





C-l. Clinical Physiologic Research System 
I Personnel: R. W. Hagen, BCL 
H. D. Ambos, BCL 
G. J. Blaine, BCLI M. W. Browder, BCL W. R. Roloff, BCL 
L. J. Thomas, Jr., BCL 
I Support: RR 00396 
I The Clinical Physiologic Research System, CPRS, results from a search for a reasonable and systematic approach to the application of microcomputers 
in meeting biomedical instrumentation needs. The CPRS demonstrates a practicalI methodology for integrating commercial instruments with distributed modular elements of local design in order to make facile responses to changing 
instrumentation needs in medical research laboratories and clinical environments. 
I 
I The changing needs that characterize clinical research instrumentation 
systems are not unique. This dynamic situation prevails in most active 
research environments where biomedical instrumentation is employed. Our 
experience indicates that these systems evolve in such a way that new needs 
are determined by the outcomes of current experiments making it impossible 
to predict long-range requirements satisfactorily. In the past, a degree
I of flexibility was gained through the introduction of minicomputers into medical research activities. Since the beginning of the "microprocessor 
revolution," the microcomputer has been applied either as a less expensive 
I and less powerful substitute for an instrumentation system's centralized minicomputer or as an inaccessible component embedded within a particular 
instrument. Through experience in applying microcomputers, another role 
I
 for this new tool has emerged. The CPRS concept embodies this new role
 in that it depends on a distributed set of programmable microcomputers 
I
 
packaged in function-specific modules which communicate over a standard
 
digital bus. Through this approach, the implementation of biomedical instru­

mentation systems can be effectively addressed.
 
I 
The scheme adopted for the CPRS is general enough to enable the 
addition of both experimental and established measurements to previously 
configured systems. While the required transduction techniques and control 
devices may differ from application to application, many research applications 
have common underlying needs for signal acquisition, feature extraction,I information display, information storage and control. The processing power that can be economically focused on these common needs continues to increase 
as the offerings of electronic component manufacturers improve almost daily. 
I However, the low-cost virtue of microprocessors cannot be realized until a substantial investment has been made in support equipment, support personnel 
and an implementation procedure. 
I The CPRS design focuses on a modular approach which spans hardware, 
software and packaging as reported in PR 14, C-2. This enables instrumentation 
I 





systems to be configured appropriately for each particular application 
while maintaining the flexibility necessary to change with needs. Each 
hardware module is tailored to provide a specific function. Although each I 
module is functionally different and operates independently in time, they 
are coupled to one another through a standard communications pathway. Because 
the functional portion of each module is isolated from the common pathway, Ithe design of new modules is not constrained, allowing the designer of 
new modules to take advantage of current hardware and software offerings, 
while remaining compatible with previously designed modules. Software 
modularity is achieved through the use of a microprocessor-development I 
system. It contains a growing library of subprograms written in assembly 
language. The application program for a particular functional module is 
constructed by linking together the appropriate subprograms using the development I 
system described in G-l. 
During the past year the CPRS has been used in a pulsatile perfusion Istudy (C-2), a data acquisition system (C-3), and a patient monitoring 
application. To date, five different module designs have been packaged 
in Tektronix TM sao blank plug-in kits. In order to expedite module 
construction, a wire wrap panel with an on-board switching regulator was I 
designed to substitute for the kit's circuit board. Plans call for the 
extension of the existing wirelist program (G-14) to accomodate this wire­
wrap panel. General software modules have been written to provide the Ilistener, talker, and controller capabilities for the IEEE standard 488 
bus using the M6800 microcomputer chip set. The physiologic signal processing 
algorithms, long employed in the Surgical Intensive Care Unit (PR 14, C-l), Iwere translated into M6800 assembly language and reside as software modules 
in the microprocessor development system for use in CPRS applications. 
Two commercial devices compatible with the IEEE standard 488 bus have been 
readily incorporated into CPRS implementations during the past year. In I 
order to expand intermodule communication capabilities, new hardware offerings 
are being surveyed. Of particular interest are offerings which will permit 
the efficient transfer of bus control from module to module. Direct memory I 
access and dual-ported memories need to be examined as means for reducing 
bus transaction times and task coupling. It is expected that the CPRS 
will provide the flexibility necessary to adapt to changing instrumentation 
requirements in the existing applications as well as general enough to I 
be appropriate for use in new applications such as the intraocular-pressure 










C-2. Pulsatile Perfusion System 
I Personnel: M. W. I. Y. 
R. E.I R. W. W. R. 
Browder, BCL 
Christlieb, M.D., Cardiothoracic Surgery 




 Support: RR 00396
 
I
 BCL, in collaboration with the Division of Cardiothoracic Surgery,




Using the Clinical Physiologic Research System (C-l) modular approach,
 
a new pulsatile perfusion system has been implemented. A block diagram
 




as well as several standard software modules. A user interface module
 
is used for parameter input to control the pumping cycle and volume to
 
be pumped, a controller module is used for communication control between
 
modules, and a signal processing module is used to detect QRS complexes
 
from the ECG and to control the occlusive-roller pump operation by providing
 
the QRS-synchronized signals required by the motor driver. A standard




routines. The use of the CPRS modular approach greatly enhanced our ability
 
to implement a new pulsatile perfusion system, requiring the construction
 
of three standard hardware modules and the incorporation of the software
 
necessary to control user input and pump operation. 
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C-3. Data Acquisition System for Extracellular Cardiac Potentials 







R. W. Hagen, BCL 
B. R. Hieb, M.D., Jewish Hospital 
S. R. Phillips, BCL 
R. Ruffy, M.D., Jewish Hospital 
S. M. Shatz, BCL 
B. F. Spenner, BCL 
B. H. Tanaka, BCL 
RR 00396 
American Heart Association, Missouri Affiliate, Inc. 
Buder Peters Scholar Award 
Changes in left-ventricular myocardial activation are known to correlate 
I 
with the development of ventricular tachycardia and/or ventricular fibrillation 
(VT/VF) during acute myocardial ischemia, but little quantitative information 
is available regarding the electrophysiologic precursors of VT/VF. The 
study of the time course of the changes in several characteristics of multiple 
left-ventricular epicardial and endocardial electrograms induced by acuteI coronary artery occlusion in the dog necessitates multichannel acquisition of high-bandwidth analog data. 
I A system has been designed to address the signal-acquisition requirements 
I 
of these electrophysiology experiments. A modular approach, based on our 
CPRS development activities (C-l), provides the high-speed sampling, digitization, 
storage and display capabilities commensurate with the requirements of a flexible 
experimental protocol, laboratory space and economic constraints. The data 
collected using the acquisition system are to be transported via flexible 
diskette to a minicomputer system for feature extraction and analysis. 
1
 
I A 4-channel analog burst-sampling module (ASM), a control/display
 
module (CDM) and a data-storage module have been defined. The IEEE-488
 
bus provides the modular interconnection which facilitates system expansion.
 




(10 Hz to 20 kHz), delay after trigger (1 to 200 msec) and sampling window
 
(1 to 100 msec). The ASM contains 8K bytes of local memory to store the
 




A small computer system, of the "personal" computer class, the "PET"
 




The capability to program in BASIC, the video graphics for prompting protocol
 
specification, a pseudo-IEEE-488 interface port and low cost allow many
 
of the CDM needs to be easily addressed. Resolution of the PET graphics
 
is inadequate for display of digitized/reconstructed waveforms. Plans now
 
include a separate display module for sampled-waveform review. 








The prototype DSM has been constructed and preliminary testing has been 
completed. System level routines to allow ASM acquisition and transfer 
to the DSM have been written and testing is in progress. I 
The prototype configuration consisting of a single ASM (4 channels), I 
the PET and a Tektronix storage oscilloscope to address the CDM requirements, 
and the floppy-disk-based DSM is to be evaluated under experimental conditions 
in the electrophysiology laboratory before construction of those modules I 
required to	 support sixteen-channel experiments. 
I 
C-4. Intraocular Pressure Measurement 
Personnel:	 R. J. Arnzen, BCL IW. J. Grodzki, Jr., D.D.S., Ophthalmology 
R. W. Hagen, BCL 
R. A. Moses, Ophthalmology IL. J. Thomas, Jr., BCL 
Support:	 RR 00396 
EY 00256 I 
Supporting effort has continued in collaboration with researchers Iin the Ophthalmology Department of Barnes Hospital for measurement of the 
temporal response of the intraocular pressure following a sudden displacement 
of fluid. Study of this behavior will assist in the refinement of physiological 
models of the fluid-generation and exhaust mechanisms via the canal of Schlemm I 
which play a central role in the development of glaucoma. 
Hardware preparation to carry out these experiments has been completed. I 
The system consists of a chart-recorder pen motor coupled to an LVDT tonometer. 
The footplate of the tonometer is placed against the cornea and the pressure 
within the cornea is measured. Current, flowing through the pen motor, Ican be accurately monitored and used as a direct measure of the torque produced 
by the motor. The tonometer, driven by the pen motor arm gently pushes 
against the cornea causing a volume of fluid to be displaced as flattening 
occurs. By continuously measuring pressure and total force, the area of I 
flattening can be maintained constant. This procedure will be carried out 
automatically with a TI-980 computer which will have direct control over 
the current supplied to the pen motor. I 
Through the course of the experiment a Universal Storage Device (G-3) 
will collect pressure and force data that will be subsequently used in the Idevelopment of a physiological model. Furthermore, the USD will act as 
a means to bootstrap the applications program into the TI-980 computer that 










Currently, all hardware needs for this system have been completed 
and verified; and a FORTRAN program for monitoring and controlling the ex­
periment is under development. Results from this experiment should contribute 
to the verification and refinement of algorithms which will ultimately be 
I,
 written for CPRS modules (C-l). These modules will be employed in the clinical
 environment where their discreteness will be needed for routine diagnostic 
work with glaucoma patients. 
I 
I C-S. A Microprocessor-Based Data-Acquisition System for the Goldmann Perimeter Personnel: R. K. Hartz, BCL 
G. J. Blaine, BCL 
I W. M. Hart, Jr., M.D., Ph.D., Ophthalmology 
I 
Support: RR 00396 
EY 00336 
EY 02044 
I A prototype microprocessor-based system has been developed to obtain
 computer-readable visual-field data at the time of patient examination (PR 13,
 
1-2; PR 14, C-12). This system permits the use of existing examination
 
I
 techniques and is designed to allow easy attachment to a Goldmann perimeter.
 The instrument contains five major peripherals: 1) a keyboard with an alpha­
numeric display, 2) point-location and stimulus-setting transducers, 3) 
I an oscilloscope display, 4) a floppy-disk drive, and 5) a serial-communication link to a host minicomputer. Operation centers about a menu that permits 
push-button selection of all major functions: 
I A. Calibrate the location transducer,
 B. Start a new examinat~on,
 
C. Edit the textual data,
 
I
 D. Edit the field data,
 E. Display the field for each eye as a set of closed contours, 
F. Save the data on the floppy diskette, 
I
 G. Obtain an index of the examination,
 H. Retrieve an examination from the diskette, and 
1. Communicate with a central computer. 
I The mechanical attachments to th~ perimeter have been refined and 
I 
the system has been packaged as a portable desk-unit. The serial communication 
protocol has been modified to be compatible with a PDP-ll/34 using RSX-llM. 
In addition, this protocol has been improved so that the user is only responsible 
for understanding the acquisition system. The user is given the option 
of transfering the entire contents of the diskette or paging through the 
I










A calibration procedure has been formalized and added to the menu. 
The instrument has been moved to a clinical environment and a perimetrist 
has been trained in its use. A user's manual is being prepared and will I 
soon be released as a monograph. A number of patient studies using the 
instrument are planned (C-6). I 
C-6. Visual Fields and Ocular Hypertension I 
Personnel:	 W. M. Hart, Jr., M.D., Ph.D., Ophthalmology 
G. J. Blaine, BCL I
R. K. Hartz, BCL 
R. E. Hitchens, BeL 
L. J. Thomas, Jr., BCL I 
Support:	 RR 00396 
EY 00336 
EY 02044 I 
Work has continued on the quantitative evaluation of visual field Idata obtained from patients with known or suspected glaucoma. (1) Prior 
work, using retrospectively obtained data recorded with a PC-1200, established 
the presence of quantitative though "nonspecific" pressure related changes Iin the visual field prior to the onset of typical glaucomatous visual-field 
defects. During the past year the visual-field programs have been transferred 
to a dedicated mini-computer (PDP 11/34A) located in the Department of 
Ophthalmology. Data are recorded by two methods. In the first, visual I 
field charts are traced directly using a magnetic graphics tablet (Tektronix 
4953). The second method employs a microprocessor-controlled recording 
device for the Goldmann perimeter (C-5). All programs have been modified Ito be compatible with the new operating system (RSX 11M), and the necessary 
software has been written to permit graphic output to both display terminals 
(Tektronix 4010) and a matrix printer-plotter (Versatec l200-A). I 
Data are stored on disk in patient-specific files, permitting real­
time retrieval of all data at the display terminals. In addition, graphic 
records can be obtained in a condensed hard-copy form for inclusion in I 
physical charts (see Figure 1). 
Automated pattern analysis techniques have been developed for the Idetection of specific topographic features characteristic of glaucomatous 
visual field defects. (2) Detection strategies employ isopter and sector­
area computations, angular orientation of connecting line segments, changes 
in orientation at each point of an isopter contour, and a generalized shape I 
feature (P2/A) that quantifies any deviation from a generally circular 
contour. Thus, enlargement of the physiologic blind spot, the presence 
of central or paracentral scotomata, significant constriction of central I 
or peripheral isopters, altitudinal patterns of field loss, and "nasal 
steps" may all be detected and quantified for any of a large number of I 
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visual-field records. It is intended that this will permit cross sectional 
studies on large numbers of subjects in the Glaucoma Center, using objective 
criteria for the description of visual-field defects. I 
Additional work reported this year involved the statistical analysis 
of factors contributing t~ Jhe risk of visual-field loss among subjects Iwith ocular hypertension. 3 The detection of individuals felt to be at 
high risk prior to the actual development of visual loss is essential for 
the early institution of appropriate therapy. A multiple logistic function 
was used to assess the relative contribution to risk of multiple factors I 
acting in concert. Those factors found to have the greatest predictive 
value included mean intraocular pressure, age, cupping of the optic disk 
and a positive family history of glaucoma. I 
During the coming year attention will be given to correlation of 
quantitative visual field changes with electrophysiologic testing (visual Ievoked response) being carried out in parallel studies on the Glaucoma 
Center population. The automated feature-detection algorithms will be 
refined, and two-dimensional surfaces will be used to improve appreciation 
of complex topographical features in pathological visual fields. I 
(l)W. M. Hart, "Computer Applications to Visual Fields," Computers in I 
Ophthalmology 1979, St. Louis, Missouri, April 5-6, 1979, in press. 
I(2)W. M. Hart, R. K. Hartz, G. J. Blaine, and L. J. Thomas, "Automated 
Pattern Analysis of Visual Fields," presented before the Association for 
Research in Vision and Ophthalmology, Sarasota, Florida, May 1, 1979. I 
(3)W. M. Hart, M. Yablonski, M. A. Kass, and B. Becker, "Multivariate 
Analysis of the Risk of Glaucomatous Visual Field Loss," Archives of 












C-7. Ventricular Boundary Extraction 
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G. C. Oliver, M.D., Medicine 
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I The closed-circuit TV (CCTV) video-image acquisition hardware/software 
I 
system (IMSYS) (PR 14, C-9) was completed and used to digitize and store 
several left ventricular (LV) serial angiograms from a video tape recorder 
(VTR). While VTR instability complicated the digitization procedure, a 
number of digitized LV images were produced for a~tomated boundary detection 
algorithm performance evaluation. 
I The performance evaluation of the LV image acquisition system (lAS) revealed t~I)VTR as the largest source of signal degradation within the 
lAS chain. The peak-to-peak signal noise ratio (SNRpp / pp ) achieved 
from VTR images was 18 dB, equivalent to 3-bit image grey-level quantization. 
I 
I In addition, the VTR noise levels dominated the 23 dB SNRpp / pp noise levels 
inherent in the X-ray fluoroscopy system (XFS). The video digitizer system 
(VDS) noise measurements indicated the SNRpp / pp of 47 dB, or 8-bit quantization 
reliability. Hence elimination of the VTR from the lAS chain would result 
in the digitized LV image noise being solely dictated by the XFS noise 
levels and the inherent biological noise. In addition to high levels ofI noise, the VTR contributes significantly to the non-linearity of the lAS
 transfer characteristic. The full-scale non-linearity of the VTR was deter­

mined to be about ± 1% as compared to + 0.3% for the VDS. Finally, measurements
 
I
 identified the VTR to be the greatest source of image-edge position jitter.
 As fractions of the horizontal and vertical image-sampling periods, the 
jitters were determined to be ± 11% and + 33%, respectively. The horizontal 
and vertical jitters for the VDS were determined to be ± 17% and negligible,I respectively. 
To assess the implications of the digitized LV image noise on the 
I performance of LV boundary extraction algorithms the noise was characterized as a random process. (1) The digitized noise levels were observed to be 
independent of the digitized signal levels, indicating additive noise. 
I Flat-field grey-level scatter diagrams showed the noise samples to be highly uncorrelated, thus indicating the noise spectral density approximation 








grey-level histogram distributions were strong indications that the noise 
was a Gaussian random process. I 
The performance analysis of a digitized-image edge extractor was 
accomplished by modeling a one-dimensional edge profile as a known deterministic 
function corrupted by an additive, Gaussian, white-noise random process. IA non-linear, single-parameter estimation procedure resulted in deriving 
a matched filter followed by a maximum-value detector as an optimum edge­
position estimator. The estimator performance was assessed by a theoretical 
lower bound (minimum value) for an expected root-mean-square (rms) error. I 
The lower bound was inversely proportional to the ratio of the peak edge 
signal to rms noise (SNRp/ rms ), the constant of proportionality being dependent 
on the selected edge-transition model. I 
For 1eft-ventricu~a5 edge recognition, both the Latte5-Day-saints 
Hospital (LDS) algorithm 2 and the algorithm of Modestino(3 were investigated Iin great detail and comparisons were made between these approaches. Although 
radically different, both use a comparable number of empirical constants. 
The LDS algorithm was chosen for the initial implementation, and the requisite 
software is 50% completed. Plans have been made for future implementations I 
and performance comparisons with the Modestino and other possible algorithms. 
For algorithm experimentation, the LV image data acquired by IMSYS will 
be used. To be able to study the differences between image row and column Iboundary search directions, a fast row-column matrix-transposition a1gorithm(4) 
has been implemented. 
IThe new BDOS file access routines (G-2) have substantially simplified 
the software to process the vast (approximately 105 words) image-sequence 
files. The graphic tablet for manual LV boundary tracing has been built 
and can now be used in conjunction with the boundary extraction algorithm I 
development. 
I 
(l)B. Zvo1anek, "Video Digitizer System for Acquisition of Cardiac Left­
Ventricular Images: Design, Implementation, and Performance Evaluation," BCL 
Monograph No. 365, May 1979. I 
(2)p. D. Clayton, L. D. Harris, S. R. Rummel, and H. R. Warner, "Left 
Ventricular Videometry," Computers and Biomedical Research, vol. 7, I 
pp. 369-379, 1974. 
(3)G. P. Ashkav, and J. W. Modestino, "The Contour Extraction Problem with I 
Biomedical Applications," Computer Graphics and Image Processing, vol. 7, 
pp. 331-355, 1978. I 
(4)J. o. Ek1undh, "A Fast Computer Method for Matrix Transposing," IEEE 









C-8. Ultrasonic Gas-Flow Instrumentation 
I Personnel: R. W. Hagen, BCL 
R. D. Livengood, B.S., Electrical Engineering 






I Our interest in ultrasonic gas-flow instrumentation began several years ago during the development of a physiologic monitoring system which 
was implemented to assist clinical personnel in caring for post cardiothoracic 
surgical patients (PR 14, C-l). Since these patients are usually supportedI by mechanical ventilation, an objective was to provide reliable, long-term monitoring of respiratory flow in the patient-ventilator circuit. In 
measuring this flow, ultrasonics offered several potential advantages over 
I alternative methods. Commercial ultrasonic flowmeters were evaluated and found to be unsuitable. An effort to design an ultrasonic flowmeter was (1) 
initiated and resulted in a prototype instrument described in PR 14, C-6. 
I The discrepancies which exist between the theoretical models of sound-flow interaction within this transducer and experimental results limit the under­
I 
standing of transducer design trade-offs and component specifications. 
The mathematical modeling of sound-flow interaction has been given considerable 
attention during the past year and should lead to a better understanding 
of transducer behavior. (2) 
I In addition to developing an improved theoretical model of the transducer, plans include an evaluation of polyvinylidene fluoride (PVDF) 
films as a piezoelectric transceiver element. Poled and stabilized PVDF 
I is reported to possess several ch(r~cteristics which may be useful in gas-flow transducer applications. 3 These characteristics include a very broad-band frequency response and flexible fabrication into different 
geometries.
I 
(l)R. W. Hagen, L. J. Thomas, Jr., and M. L. McCartney, "An UltrasonicI Ventilometer," Proceedings of the 31st Annual Conference on Engineering in Medicine and Biology, Atlanta, Georgia, vol. 20, p. 232, October 21-25, 
1978. 
I 
I (2)R. D. Livengood, "Mathematical Modeling of the Sound/Flow Interaction of 
an Ultrasonic Flowmeter," Master of Science thesis, Department of Electrical 
Engineering, Washington University, St. Louis, Missouri, August 1979. 
I 
(3)p. E. Bloomfield, R. A. Ferren, P. F. Radice, H. Stefanou, and O. S. Sprout, 
"Piezo- and Pyroelectricity in Poly (Vinylidene Fluoride)," Naval Research 
Reviewo, pp. 1-15, May 1978. 
I 
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Personnel: R. W. Hagen, BCL I 
I. Y. Christlieb, M.D., Cardiothoracic Surgery 
R. E. Clark, M.D., Cardiothoracic Surgery 
G. H. Hays, BCL IJ. Markham, BCL 
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ISupport: RR 00396 
Thermal dilution studies during the past year have focused on signal I 
processing strategies for evaluating cardiac output in anesthetized dogs. 
In earlier.experiments, reported in PR 14, C-7, it was observed that the 
constant infusion of room temperature saline solution into the right ventricle 
produces changes in an animal's pulmonary artery blood temperature, Tpa ' I 
which may be described by a function of the following form: 
I 
T (t) = T 1· + B(l-e-at ) + -2C [t-tl +
It-t l I] (1)pa base 1ne 
IThese experiments suggested that temperature effects due to recirculation 
are significant but can be expressed as a linear function with slope C, 
beginning at time tl, as shown in the last term of the preceding equation. 
The first term in this equation is the average baseline blood temperature I 
prior to indicator infusion. The middle term describes the transient ex­
ponential change in Tpa resulting from the constant infusion of thermal 
indicator. I 
Data were collected during animal experiments using the Universal 
Storage Device (G-3). Equation 1 was fit to the temperature data collected Ifrom the pulmonary artery by varying the four parameters B, a, c and tl 
to obtain a best fit according to least-squares criterion. An iterative 
procedure based on a method developed by Marquardt(l) was used to minimize 
the least-squares problem. Figure 1 shows a typical Tpa curve with the fit I 
curve superimposed. 
The steady-state temperature change in the pulmonary artery when I 
a constant infusion of thermal indicator is added to the blood returning 
to the right atrium is expressed as parameter B. Once B is determined 
by the curve fitting procedure, the cardiac output may be estimated using Ian equation based on conservation of thermal energy (PR 14, C-7). During 
the experiments, an independent measurement of cardiac output was obtained 
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Figure 1. Time course of pulmonary artery temperature (Tpa) during constant 
infusion of thermal indicator. 
I The results indicate that the described procedure consistently under­estimates parameter- B, producing overestimates of cardiac output. Limiting 
I 
the ranges of the curve fitting parameters needs to be evaluated as a means 
for improving the accuracy of parameter B estimates. In addition, the 
validity of the assumed model must be verified. The underestimated value 
I 
of parameter B, may result from the exchange of thermal energy between 
the blood/indicator mixture and the walls of the right atrium and ventricle 
through which the mixture passes prior to reaching the Tpa measurement 
site. This assumption, crucial to the viability of all thermal indicator 
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During the past year BCL has continued to address the patient monitoring 
needs in Barnes Hospital's West Pavilion through staff appointment to the Ihospital's Patient-Monitoring Committee. The anticipated monitoring needs 
in the West Pavilion were documented in a request for proposals (RFP) as 
reported in PR 14, C-5. Five vendors developed proposals in response to 
the RFP. These proposals were evaluated in order to determine the degree I 
to which each satisfied the monitoring needs. A survey of each vendor's 
installed systems provided additional information regarding the performance 
of the proposed monitoring systems. Selected components were tested by I 
Barnes Hospital's engineering staff. Proposed systems which satisfied 
the need and performance criterion were then evaluated with respect to 
cost. This procedure resulted in the selection of patient monitoring system Isuppliers in the fall of 1978. 
The first patient care area to be opened this fall in the West Pavilion 
will be a new cardiothoracic surgery facility. This new facility will I 
replace and expand the existing surgical intensive care unit (SlCU) and 
the patient monitoring system in the SlCU will be retired after 6.75 years 
of successful operation (PR 14, C-l). The commercially available monitoring I 
system in the new cardiothoracic surgery facility incorporates many of 












I D. Databases for Disease Management and Research The need for database facilities in several BCL projects became com­
pelling in the early 1970s. The quantity and diversity of data for theseI projects had grown unmanageable by manual methods. Prior experience underscored the desirability of interactive data entry in order to assure adequate quality 
and to provide easy access to up-to-date information. Primarily through 
I external funding a minicomputer-based system (MUMPS) capable of supporting database activities was imported, rewritten for the PC-1200, and applied 
in radiation oncology. This application has developed into an installation, 
I the Oncology Data Center, (ODC) , located within the Mallinckrodt Institute of Radiology. A fee-for-service installation, the Medical Computing Facilities (MCF) , was organized within the Medical School to provide MUMPS service 
to those who do not desire to operate their own installations. BCL, itself,
I operated a MUMPS facility for training purposes and investigation into database 
I 
characteristics until 1978. By that time the applications still operating 
on the system were deemed mature enough to migrate to either the MCF or 
ODC installations. 
Current activity of the lab includes the development and operation 
of several information systems for the support of ongoing research projectsI and routine clinical practice. Almost all of these databases concentrate on chronic diseases b.ecause of the importance of a long-term database to 
clinical investigators studying long-standing illnesses. Our enthusiasm 
I for MUMPS has continued and efforts over the past few years have been in 
I 
support of the MUMPS Users' Group's (MUG) objective to become self-sufficient. 
Concurrent with the termination of the major governmental funding, the office 
of the national MUMPS Users' Group (MUG) executive secretary was moved from 
BCL to the MITRE Corporation. The standardization of MUMPS and the subsequent 
commitment of major vendors to the support of that standard has provided 
promising opportunities for application program transfer and has given addedI impetus to research in new methods for the development of medical applications packages. 
I Following a long-standing tradition of the laboratory, an increasing emphasis has been placed on allocating the appropriate computer resource 
to each information processing task. As the databases which are described 
I
 in this section mature their analyses become of increasing importance.
 Because of the richness of the software development and because of the overall 
suitability of a general-purpose large-scale computer for analysis tasks, 
they have been performed largely on the University's IBM System/360-370.
I SAS, a popular statistical-analysis/data-management package, has provided the primary vehicle for the analyses of databases managed on other computing 
systems. 
I Experiences with disparate applications and with the instrumentation 
of conventional information systems continue to benefit design activities. 
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In 1974 investigators in the Glaucoma Center initiated automation I 
of their records to facilitate clinical research. From BCL's interest in 
characterizing clinical databases and their usage,(l) a collaborative effort 
emerged. Rather than design a new information system, MISAR(2) was imported I(PR 12, D-15). Since then the registries have grown and their supporting 
programs have been improved. The registries have facilitated both clinical 
and database research. (3-6) Approximately 1900 of the Glaucoma Center's 
estimated 2400 charts have been completely entered into and kept current I 
in the computerized registry. These data are represented in approximately 
three million bytes (March 1979) and utilize a total of 13.1 million bytes 
including registry data, auxilliary data, pointers, programs, and overhead. I 
The three million bytes represents a growth of one million bytes over the 
approximately two million bytes stored in May 1978. IThe emphasis of this project over the last year continues toward 
database growth, better quality control and organization of Glaucoma Center 
data, and clinical utilization of the computer stored information. Only 
modest changes, improvements, and additions to the MUMPS programs themselves ·1 
have been madeo 
Improvements to the database included the addition of a ZIP code Idirectory, and creation of a registry of approximately 200 referring MDs 
and ODso Both changes increased data quality and reduced storage requirements. 
Reminder slips which are created using the computer database and inserted Iinto the subject charts, prompt the physician to update historical data, 
such as family history of glaucoma and diabetes, and to perform tests that 
the subject has not recently had. This reminder system has greatly improved 
the completeness of both the written chart and the computerized summary. I 
The second major statistical study using data from the glaucoma registry 
was initiated. In April approximately 880,000 bytes of data (30 fields 
·1from 248 subject records) were transferred to the IBM System/360-370 computer 
on the Hill Campus for statistical analysis of diurnal variations of intraocular 
pressure. The data were successfully transferred via magnetic tapes, SAS 











The Glaucoma database has been supported by MUMPS-based computer
I services available through the Oncology Data Center (ODC), Mallinckrodt 
I 
Institute of Radiology. System availability forced a reevaluation of our 
needs, resulting in a selection of the MUMPS-based computer services provided 
by the Medical Computing Facilities (MCF). The programs to store and access 
the Glaucoma registries are currently being rewritten for the new environment. 
I (l)R. H. Greenfield, "Characteristics of Clinical Data Bases and Their Usage," 
D.Sc Dissertation, Sever Institute, Washington University, St. Louis, Missouri,o 
I
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During the past year the MUMPS-based MIPI system (PR 12, A-I; PR 13, 
D-2; PR 14, D-2) has supported the activities of the Sudden Death Study Iin three areas: 1) the gathering of data and the passage of coded data 
to a SAS database (D-lO) for statistical analysis, 2) the notification of 
patients and physicians concerning Holter recordings, the termination of 
the study, and the study's progress, and 3) the definition and performance I 
of "cleanup" tasks which are needed to convert free-text responses to coded 
format. Unless further tasks for the database are defined, it will cease 
to function in the corning year since all data will have been sent to the ISAS database or archived on tape. 
The gathering and management of data for the study can be classified Iinto three categories: 1) the recording of CCU admissions for Barnes and 
Jewish Hospital patients (10/27/75 - 03/31/78) and the gathering of relevant 
clinical data for all myocardial infarction (MI) cases, 2) the scheduling 
of Holter recordings and the acquisition of related data elements, and 3) I 
the follow-up done on all surviving MI patients. 
All patients admitted to the Barnes CCU or Jewish MICU were initiated Iin a system via a registry enrollment form, and then depending upon the 
admitting and final diagnoses, the system controlled the entry of data relevant 
to the in-hospital phase of the study. The major emphasis of the data collection 
process was on patients diagnosed as definite MIs. The CCU stays of these I 
patients were documented and an attempt was made to recruit those surviving 
their CCU stay into the Holter monitoring program. I 





I For patients recruited into the Holter monitoring program two recordings were made, the first 10-14 days post-MI and another 2-3 months post-MI, 
and then, for qualifying patients the recordings were continued at three 
month intervals for a minimum of one year. The MIPI system noted patientsI to be scheduled and generated applicable correspondence. The diverse sources of data for each recording included: 1) forms completed at the time of 
recording, 2) the digitization and Argus/H edit of the tape (A-4), 3) the 
I cardiologic review of the Argus/H edit results, 4) serial reading of the l2-lead ECG taken at the time of the Holter recording, 5) successful passage 
of Cycle-save data to the IBM System/360-370 and subsequent recycling of 
I
 digital tapes, and 6) data collected for a special lipid research project.
 As with the in-hospital phase of the system, tracking records controlled 
the entry of data, related the status of any file, and allowed the generation 
of work lists and management reports. 
I 
I All surviving MI patients were followed at six-month intervals to 
document their post-MI status. Presently a last follow-up effort is underway 
to determine each patient's status as of March 1, 1979. Final results are 
still needed for 25 Study I and 9 Study II patients. The MIPI system aids 
I 
the follow-up process. A periodic computer listing of patients to be contacted 
is made o Since the previous source of contact is included the nurse conducting 
the follow-up can decide upon one of several methods of contact: 1) a computer 
I, 
generated letter to the private physician which contains data specific to 
the particular patient, 2) a computer-generated letter to the patient or 
some other contact, or 3) a telephone conversation with the patient or some 
other contact. A computer generated log containing appropriate names, phone 
numbers, and addresses is used to keep track of attempts to contact by phone. 
I
 For patients who have expired, a blinded summary of the circumstances sur­
rounding death is prepared and coded. 
Data from all three phases of the project are transferred to theI project's SAS database via tape in a multi-step process. Data are transferred 
I 
according to the form on which they appear. Qualifying forms are rechecked 
since edits have been updated as the study progressed. Data from error-free 
forms are reformatted into records suitable for SAS using table-driven routines. 
Errors are corrected by rekeying data or by running one of several automatic 
conversion programs. When the data have been recorded in the SAS database, 
I forms which contain no free-text items and/or items needed to make future decisions about a patient are removed from the MIPI database. 
All data relating to the in-hospital phase of the study have been




of these data to SAS was delayed until the protocol under which the CK measure­

ments were made was carefully defined. Since the task has been accomplished
 
these data are being entered into the Ml~S database and will be sent to
 
the SAS database soon. 
I Data collected concerning the Holter monitoring phase of the study have also been passed to SAS with the exception of the l2-lead ECG form. When comparisons were made between various responses on these forms, some 
discrepancies were noted. The pertinent ECG's are being reviewed. After 
I








The latest version of the follow-up data are sent when they are needed 
for a particular analysis. When the follow-up phase of the project is com­
the latest version of the data will be sent to SAS. At that time Iplete,
 
patient identification data will be saved on tape and
 
no longer be needed.
 
The data collected for the Sudden Death Study 
follows: 
Barnes 
Patients Admitted 2734 
Diagnosis of Definite MI 610 
In-Hospital Data Forms Entered 17963 
Holtered Patients 235 
Holter Recordings 592 
The main uses of 
of data and its passage 
collected in free-text 
more interesting areas 
the MIPI system should 
I 





the MIPI system over the past year were the "cleanup"
 
to SAS. The system has generated lists of data
 Iso coding schemes could be developed. Some of the 
include diagnoses, concurrent problems in CCU, death 
complications, exercise, and l2-lead ECG features. All free-text data have 
been converted using special update procedures. A great deal of effort I 
was devoted to the development of an editing scheme for drug prescriptions. 
Codes were assigned to drugs by their generic name and reason for prescription. 
Common brand names, dosages, and schedules were included in an online medication Itable. All drugs recorded in the system were checked using these criteria 
and any problems were corrected. IThe MIPI system has aided project personnel both in the collection 
of data and its conversion to codes. Because the system guides the user 
through the entry procedure and flags errors immediately the number of errors 
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I The MUMPS-based PIM system (PR 13, D-3; PR 14, D-3) coordinates the double-blind propranolol intervention study for the reduction of infarct 
size run by St. Louis University and two collaborating institutions, St.I John's Mercy Medical Center and Veteran's Administration Hospital. Since the enrollment of patients in this study was terminated March 31, 1979 the 
system has been serving a dual role. In addition to monitoring the continued 
I collection of data, it has also aided the coding of data and its passage to the statistical database. All in-hospital data concerning study patients 
have been entered into the system and verified. It is estimated that in­
I
 hospital data for all patients will be entered and verified as of August 1,
 1979. Based on this assumption all of these data will be coded and sent to the SAS database by September 1, 1979. The system will continue to receive 
follow-up data and send it to the statistical database until all follow-up
I
 visits have been completed.
 
I 
The data collection protocol for this study is complex. Data are 
collected concerning the hospital and especially the CCU stay of any patient 
admitted to one of the three participating CCU's to rule out an MI. The 
forms completed documenting the patient's stay are determined by classifying 
the patient's case into one of four categories: 1) recruited for study,I 2) eligible but not recruited, 3) not eligible but MI was diagnosed, or 4) not eligible and no diagnosis of MI. 
I The major thrust of the system revolves around recruited patients for whom a minimum of sixty-five forms are completed. Besides data similar 
to that obtained by the MIPI system (D-2) hemodynamic measurements are made 
I for 72 hours, metabolic measurements for 4 days, propranolol blood levels for 10 days, and CK measurements for a maximum of 126 hours. Thallium, pyrophosphate, and HSA scans are made at various scheduled intervals during 
the hospital stay and 6 Holter recordings are taken. All medications admin­I istered during the first 14 days of the hospital stay are recorded with 
I 
a code number indicating reason for administration and the dosage. Any 
significant events occurring during that time are noted by time of occurrence 
and a numerical code. All in-hospital data, except scan data which are 
keypunched, are entered into the system upon receipt, verified, coded where 
needed, and then sent to the statistical database for analysis. 
I 





Recruited patients are scheduled for follow-up visits at 3, 6, and 
12 months post-MI, at which time five procedures are done (stress test, 
HSA scan, ECG, Holter recording, and chest x-ray) and a follow-up form is I 
completed. All data except data relating to HSA scans are entered and, 
as with the in-hospital data, when a file is completed the results are printed 
for review by the study's investigators and then formatted for passage to I 
SAS (D-10). 
As in the MIPI system the PIM system manages and controls the entry I
of data forms once the patient is initiated in the system via tracking records. 
These tracking records are used to produce ad hoc lists of "things-to-do" 
and weekly management reports which are distributed in order to encourage 
the prompt completion of incomplete files. Of particular importance is I 
a recently produced report which documented incomplete files and the number 
of days the system has awaited their completion. One improvement to the 
information system has been the development of a series of programs which I 
perform time-consuming edits and tracking of data not done when data are 
entered. Responses on various forms can then be cross-matched. Any files 
requiring attention are saved until time is available for inspection by Ithe data entry clerk or research nurse. 
Most software development during the previous year has centered around 
further edits of the data, the coding of free-text data, and the passage I 
of all data to the statistical database. Although data had been passed 
to the SAS database for analysis, no data were removed from the MUMPS database 
since free-text items had not been coded and some data items required further I 
clarifications. In support of this "cleanup" effort routines were written 
to print and/or change data items based on user-specified parameters. This 
listing capability was especially advantageous for the conversion of free­
text items and the display of questionable data items. The proper codings I 
of free-text items were marked on these listings by a research nurse and 
then keyed by the data entry clerk. All of the entered codings were verified 
by concurrently displaying the free-text and coded data on either the terminal I 
or printer This conversion effort has run smoothly since list generationso 
and changes to the data are all handled by table-driven routines. The medi­
cation edits and code lists developed for the MIPI system were used to handle I 
some of the data conversion problems. However because of the variety of 
free-text items in this study new coding schemes were also developed. IAt this time most of the data specific to the in-hospital stays of 
the study patients have been passed to the SAS database. The follow-up 
data are being coding so permanent versions of these data can replace the 
temporary SAS files. After these data are sent to SAS, data relating to I 
the registry of all patients will be sent. 
There are 2983 patients registered in the PIM system. Of these, I743 are documented MI's and 132 met the entrance criteria for the propranolol 
intervention study. Ninety-seven patients were recruited into the study. 
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I The SCaR database currently contains information on 543 patients. The discrete variables contained therein describe the patients' cardiovascular 
history, in-hospital physical condition, and long-term progress as assessedI through follow-up interviews and examinations. The data records are entered 
I 
onto disk with the use of the Interdata computer and then written onto magnetic 
tape. Tapes are transported to the IBM System/360-370 and maintained as 
a permanent SAS database o The database has been used in several studies 
concerned primarily with the relationship between infarct size and long-term 
survival after myocardial infarction. 
I A subset of 173 patients who had no evidence of prior myocardial infarction, who survived acute infarction for at least 24 hours, and who 
were 65 years of age or less was studied.(l) Mean infarct size index (lSI)
I of those who succumbed was significantly larger than that of survivors (46.5 
I 
+ 5.8 (SE) vs 21.1 + 1.4 CK-g-eq, P < .01). Overall survival was significantly 
better after small (lSI < 15) or moderate infarcts (15 < lSI < 30) than 
after large infarcts (lSI ~ 30) (p < .05). Regardless of the-locus of in­
farction, patients with small infarcts had a significantly lower long term 
mortality rate and fewer premature ventricular contractions evaluated with 
follow-up Holter recordings than those with large infarcts (P < .05). LateI mortality was comparable after transmural and subendocardial infarction 
I 
but higher after anterior than inferior infarction. Of the 10 clinical 
and hemodynamic variables investigated, the most important predictors of 
mortality were lSI and congestive heart failure present at the time of hospital 
admission. 
I Based on data from 356 patients (256 with initial and 100 with repeat infarction), the prognostic import of lSI in patients with prior infarction 
was investigated. (2) lSI was less with repeat compared to initial infarction 
(15 + 1 vs 22 + 1). Nevertheless, those with prior infarction had a significantlyI lower (P < .01) 1 year survival rate (64%) than those without prior infarct (77%). In contrast to the case with patients with initial infarction, mortality 
in patients with repeat infarction was not closely related to lSI, probably 
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I 
From June, 1975 to June, 1977 a MUMPS-based system was developed 
which allowed for the rapid entry and searching of data documenting admissions 
(identification information, maternal history, perinatal history, immediate 
post-delivery data, and initial admission evaluation) of babies to the 
Neonatal Intensive Care Unit (NICU) at St. Louis Children's Hospital. This 
I database, which was developed on the Artronix PC-1200 system at the Oncology Data Center (ODC) , Mallinckrodt Institute of Radiology, was designed around 
three basic criteria: 
I 1) patient files could be quickly searched for user-specified criteria, 
2) physicians would perform the searches rather than programmers, 
3) the system would be for research and not for patient management.I Over an 18 month period admission data were collected on over 800 patients 
and the coding structure for admission data was improved and stabilized. 
I At the same time methods were developed which allowed for the consistent coding of free-text in-hospital data by neonatologists. 
I The system for collection of admission data was then transferred to the ODC Artronix MODULEX system and software was developed to support 
the collection and manipulation of in-hospital data. The same design criteria 
were followed for the in-hospital phase of the system. Admission and in­I hospital data were recorded in this new system for patients admitted to 
I 
the NICU after July 31, 1977. Patient data stored on the PC-1200 was not 
transferred. In addition to these two data types, lab data could be -entered 
on patients where desired. 
I 
The entry of a patient's entire file into the system is a multi-step 
process. The hospital's daily census sheet is checked for any NICU admissions 
by the data-entry clerk and all new NICU patients are registered into the 
I 
system. Thereafter, the system ensures the computer entry of all required 
data o Admission data are collected and coded by an LPN, reviewed by the 
neonatologist, which serves as a quality control, and then entered o Data 






After the entered data are verified and approved they are added to the inverted 
file and can be searched. When the census sheet is checked for admissions, Ihospital discharges are also noted, so the system can generate lists of 
charts to be reviewed by the neonatologists during their periodic coding 
sessions. Final disposition and in-hospital data are coded by the neonatolo­
gists with a problem/concurrent event/complication approach. Each date I 
of onset is noted and in some cases termination dates are also recordedo 
The in-hospital data are recorded according to 17 major classifications, 
1) pulmonary, 2) infectious disease, 3) cardiovascular, 4) G.I. disorders, I5) endocrine, 6) hematology, 7) tumors, 8) metabolic, 9) neurology, 10) 
fluids and electrolytes, 11) immune disorders, 12) renal -- G.U., 13) skin, 
14) orthopedics, 15) ophthalmology, 16) diagnostic procedures, and 17) events 
of interest. All data which are entered into the system are reviewed by I 
the data-entry clerk and then printed out and checked by other personnel 
for typing errors. A copy of the in-hospital data is printed after this 
review and placed in each patient's chart and the data are added to the I 
inverted file for searching. 
All patient data collected for this system are stored in both a master Ifile and an inverted file. Data are stored in this manner so the database 
can be rapidly searched by physicians using criteria they have specified. 
In addition to searches of the database, the inverted files can be used 
to produce histograms and cross-reference tables. An automatic report gener­ I 
ator which tallies according to user criteria either year-to-date or six­
month data also utilizes the inverted files. Data are stored in the master 
file so that printouts of patients' files or subsets of patients' files I 
can be produced easily. 
If desired laboratory data can be entered and then printed via tabular Idisplays, plots over time, or X-Y plots. Various simple statistics on the 
data can be done. In the future these data will be "searchable" and can 
be displayed in conjunction with certain in-hospital occurrences. I 
Operational problems with the ODe MODULEX system resulted in a decision 
to transfer the entire database, which contains data on 953 patients, to 
the TANDEM system operated by the Pathology Department of St. Louis University IMedical School. The goals of the new system are the same as those previously 
stated. Because bit functions do not exist in the version of MUMPS being 
utilized, the development of an alternative method to quickly search the 
database is being developed. A system will be coded in MUMPS which will I 
allow fairly rapid searches. It will then be evaluated to see if part of 
the system must be developed in a different language. The current transfer 
effort offers the opportunity to extend the system to include the ability I 
to search the in-hospital data for complications which occurred according 
to certain rules of precedence and/or time constraints, and to allow the 
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The feasibility of computerization of cardiology reports was demonstrated 
as a pilot project (PR 13, D-6) and currently is in the process of being 
implemented on a production basis at the Washington University Medical Computing 
Facility (PR 14, D-6). The system was designed to meet the following goals: 
1) provide accurate data regarding all interactions of individual patientsI with the Cardiology Division, 2) reduce the professional and secretarial time required to generate clinical reports, 3) establish a database in a 
computer readable form to facilitate data management and clinical research,
I and 4) be economically viable as a clinical tool, paying for itself from savings in secretarial and professional time as well as reduced copying 
costs for the multiple reports. It was designed to be operated by the divi­
I sional secretaries rather than a specialized computer technician. All of the routine cardiology reports are planned to be implemented through this project. Implementation of the stress test report generation was completed 
June 1977 (PR 14, D-6). Echocardiographic reports were implemented MarchI 1979, and catherization-coronary angiography reports were implemented in June 1979. Details of the latter two reports are as follows. The echocardio­
gram reports are entered from a check-off sheet by the fellow and checked 
I by the supervisor. Individual comments are entered in code and expanded into full sentences by the computer for the report. Diagnosis and comments 
I 
are entered both in code and free text to permit ultimate flexibility of 
expression. Final diagnosis and indications for study are stored "on line." 
Simple searches on staged diagnosis can utilize MUMPS programs. The complete 
report will	 be transferred to tape in a form readable by SAS (D-lO). Extensive 
searches for all details of the program as well as statistical analysisI	 will be possible "off line" utilizing SAS on the IBM System/360-370. 
I 
The basic coronary angiography and cardiac catheterization reports 
have been implemented and are presently functioning. The report consists 
of sections entitled Demographic Information, Clinical Summary, Procedure, 
I
 
Hemodynamics, Coronary Vessel Description, Description of Angiography, Findings,
 
and Recommendations. The Procedure section can be entered as a) "standard
 




can be entered with a single code, b) "coded procedures" where individual
 
codes are expanded into complete sentences describing the procedure in chrono­

logical order and also any comments which can be stereotyped, and lastly,
 
c) free text which allows for unusual situations. Both the Findings and 








retrieval as well as free-text entries for maximum expressive flexibility. 
The Coronary Vessel Description is entered separately and permits the generation 
of sentences describing the name of the vessel, its size, the location of I 
the lesion in the vessel or vessel segment, (origin, proximal or distal 
section), the type of lesion, (focal or diffuse) and its severity. Each 
part of these descriptive sentences can be entered by a code. In addition, I
the presence or absence of collaterals and their source is easily specified 
by a short mnemonic code. There is provision for free text description 
as well. Any number of vessels or vessel segments can be coded. In addition, Iuncoded vessels can also be described with the same format. Description 
of Angiography is also entered separately. The details of the left ventricu­
logram ane entered in short codes and translated into sentences. Free text 
description is also available. Each of these three sections of the completed I 
report can be entered separately at different times if convenient Theyo 
are then combined by the program into one report. A special feature of 
the entire system is the flexibility of adding new coding. Codes consist I
of eight letter alpha-numeric entries which can be entered directly. New 
codes can be assigned or the text changed easily by the physician to permit 
ample opportunity for full expressiveness. Correction of errors is facilitated Iby provisions for addressing directly those responses which are incorrect 
and changing them. This part of the report has been operational since June 
1979. The system is still being phased in so that full benefits cannot 
yet be evaluated, but comprehensive and detailed reports which are searchable I 
have already been produced. Additional parts to the cath report are being 
implemented. A standard letter, including the findings from the report 
as well as recommendations will be generated. The letter will utilize files I
of the addresses of referring physicians for automatic addressing which 
should greatly minimize time spent addressing letters. In addition, we 
currently send photographs of the coronary angiogram to referring physicians. 
The computer can generate descriptive sentences which are placed on the I 
sheet to refer to these pictures enhancing their value as a teaching aid o 
Presently there are plans to generate computerized reports of cross-sectional 
echocardiogram and Holter monitors, and it is expected that these will be I 
working within the year. It is also anticipated that the SAS search programs 
will be operational by June 1980. Overall the acceptance of the computerized 
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K.	 F. Wong, M.S., Computer Science 
Support:	 RR 00396 
Washington University 
A modest experiment was defined to study the feasibility of a proposed 
high-performance information system configuration. (1) The experimental 
implementation consists of four physically distinct processing units and 
a Z x Z crosspoint interconnect implemented with restructured macromodu1es 
(RMMs). The processing units (Z-LSI-11, Z-PDP-11/34) utilize RMM compatible 
controllers to support a speed-independent, delay-insensitive communication 
discipline. Two of the processing units (PDP-11/34 based) are equipped 
with 80 Mbyte disk storage units to support database storage. 
The configuration has been utilized as a facility for time/space 
cost evaluations of the multitasking system software developments and system 
instrumentation. As a result of the evaluations, a design modification 
was made to the RMM controllers to improve processor efficiency by eliminating 
the need for message assembly into a continuous block before transmission. 
Review of system power and reset criteria established the need for independent 
AC power for the processing unit and the RMM controller and separation of 
the power-on reset. This change allows a processing unit to power on/off 
without requiring a system-wide reset. 
Preliminary studies were conducted to establish feasibility of expansion 
beyond the 2 x 2 configuration. The speed-independent delay-insensitive 
discipline can be preserved using a very-local interconnect based on the 
bus within the RMM crate. The RMM bus allows ready expansion to 31 processing 
units. An equivalent interconnect bandwidth of approximately 50 megabits/second 
should be achievable. A CATV-like coaxial cable approach(2) is being explored 
to provide a local-area interconnect which permits assimilation of processing 
units geographically distributed within the Medical Center. 
(l)J. R. Cox, Jr., "Development of a Technology for High-Performance Information 
Systems," Information Systems Group, Working Paper No.1, 1976. 
(2)N. B. Meisner, D. G. Willard, G. T. Hopkins, "Time Division Digital Bus 
Techniques Implemented on Coaxial Cable," Proceedings of Computer Networking 
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IPersonnel: J. Zimmerman, BCL 
J. Rothmeier, Ph.D., University of Massachusetts }1edical Center 
R. K. Stimac, B.S., Mitchell Humphrey and Co. 
R. E. Zapolin, M.S., The MITRE Corporation I 
Support:	 RR 00396 
The MITRE Corporation I 
Support by The MITRE Corporation of the MUMPS Users' Group (MUG) 
continued from the previous year (PR 14, D-9). MUG's activities were coordi­ I 
nated by Chairman Jeffrey Rothmeier and Executive Director Richard Zapolin. 
Joan Zimmerman became Chairwoman of MUG's Education Committee (EC). The 
major EC projects during the year were: I 
1.	 MUMPS programmer certification. Collaboration of MUG with the 
Institute for the Certification of Computer Professionals (ICCP) Iis possible, with MUG developing a specialty exam in MUMPS that 
would be taken in conjuction with the ICCP's core exam on pro­
gramming technique. I 
2.	 Curriculum development. The EC is collaborating with the ACM 
and other groups to define curricula for (a) an advanced degree 
in medical informatics and (b) informal training for clinical I
chemists and pathologists. 
3.	 MUMPS tutorials. Programming tutorials were arranged for the 
annual MUG meeting and other conferences. I 
4.	 The "Introduction to Standard MUMPS" (a document intended as 
a complet~ and clear first book about programming in MUMPS) I 
was	 drafted. 
A follow-up	 study was made of the 27 recipients of QUEST, DOC, and Ithe Standard MUMPS teaching program (PR 14, D-IO). Of the 22 contactable 
recipients, 16 (73%) had completed the transfer successfully. Problems 
had been experienced by 6 (38% of 16), mostly concerning needs for data 
reformatting. QUEST had been used by 4 (25% of the 16), DOC by 5 (31%), I 
and the teaching program by 11 (69%). Experiences of the 22 contacted re­
cipients have been reported. (1) Use of the teaching program by novice pro­
grammers shows considerable variation in the speed and skill of learning Ibut also indicates that the students do remember much of what they learn 
from the program because they were able to perform better on repeating the 
material some days later.(2) I 
(l)J. Zimmerman and R. K. Stimac, "Follow-up Study on Transfer of Applications, 
Particularly Those Developed for the MUG Application Library," Proceedings Iof the 1979 MUMPS Users' Group Meeting, Atlanta, Georgia, June 6-8, 1979, 
in press o 
I 





I (2)J. Zinnnerman, "Use of an Interactive Teaching Program to Teach Medical Workers About MUMPS Progrannning," Journal of Medical Informatics, in press. 
I
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R. K. Stimac, B.S., Mitchell Humphrey and Co. 
I D. K. Tao, D.Sc., Shared Medical Systems 
I 
Support: RR 00396 
HS 02760 
Our studies of procedures for specifying and building primary-careI medical records arose from concerns about (1) difficulties and problems 
I 
experienced by primary-care physicians and their administrative staff in 
defining and using automated record systems, (2) high costs of record-system 
development, and (3) difficulties in transferring medical applications between 
institutions. To address these problems, we: 
I
 1. Surveyed existing primary-care automated medical records.
 2. Synthesized these data in state-of-the-art reports. (1,2) 
I 3. Tested the COSTAR automated record system. (3) 
I 
4. Reviewed the potentials and problems of microcomputers in primary 
care. (4) 
I 
5. Designed and began the implementation of a computer-based Multi­
Environment Scheme (MESCH) that could guide representatives 
of the primary-care practice through the analysis of their present 
and future needs and the selection of suitable features of an 
automated medical-record system.(5)I 
(1)J. Zinnnerrnan, R. S. Gordon, Do K. Tao, and S. B. Boxerrnan, "The AcceptabilityI of Computer Applications to Group Practices," Journal of Medical Systems, vol. 2, no. 1, pp. 15-24, 1978. 








(3)J. Zimmerman, "Report on Oxford Work: 17 May 1978 to 15 July 1978," 
BCL Monograph No. 354, December 1978. I 
(4)J. Zimmerman, S. B. Boxerman, and A. L. Rector, "Personal Computing ­
Appropriate for Your Practice?", Journal of the American Medical Association, I 
in press. 
I(5)J. Zinnnerman, "Specification and Building of Ambulatory-Care Records: 
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 IWashington University 
IThe utilization of minicomputers under MUMPS as an environment for 
the interactive data acquisition and management of the information gathering 
process has been quite successful for a number of projects involving the 
study of chronic diseases (A-2l, D-l, D-2, D-3, D-4). However for analytic I 
tasks requiring the processing of large sets of patient data, the application 
of more computationally burdensome statistical procedures, or the production 
of large reports, the general-purpose IBM System/360-370 environment operated Iby the Washington University Computing Facilities (WUCF) has provided a 
more hospitable environment. 
Because of its strong data management components SAS(l) has continued I 
to be the chief tool for the analyses of databases gathered with these other 
computer systems (PR 14, D-12). By providing the necessary tools for the 
listing, creation and deletion of data sets within a SAS database, SAS removes I 
the user from much of the administrative burden associated with database 









has significantly augmented these facilities and has added facilities forI other utility functions so that many users need to only use SAS for their IBM System/360-370 data management. Indeed, several othe) studies utilize 
SAS exclusively for their data management requirements, (2 and SAS tape
I datasets were chosen as the medium of data exchanged for the results of Holter tape processing for the MILlS study (A-2l). 
I Industry-compatible tape has continued to be the primary mode for interfacing the SAS system to the data collection computers, including the 
MCF machine (D-2, D-3), the SCaR computer system (A-14, D-4) and the ODC 
MODULEX (D-l). Other studies utilizing similar approaches include the DiabetesI Education and Training Center's Patient Registry, and a study of the familial transmission of alcoholism and related disorders as part of the Alcohol 
I 
Research Center. The interface between DATA3, a MUMPS-based table-driven 
interactive data-entry and management system, and SAS has facilitated several 
of these studies. It provides a three-stage semi-automatic process which 
I 
utilizes the same tables as those used to drive the data-entry/retrieval 
operations. (3) 
I 
Work during the past year has been concentrated on the final transfer 
of information for studies already completed (D-2, D-3) and on data for 
the analysis of an ongoing patient registry (D-l). As the coding of items 
originally entered as free text is completed, checks are performed in MUMPS 
for each form Additional checks are made, especially those requiring exten­
sive cross-form criteria after the forms are transferred to SAS.I 
o 
During the last year the WUCF has installed MUSIC, (4) an interactive
 
system operating on one of the IBM System/370s. MUSIC has allowed the simpli­
I fication of interactive JCL generation for the submission of SAS jobs, thereby
 reducing the necessary training needed to utilize SAS efficiently in the
 






 (l)J. T. Helwigh and K. A. Council, eds., SAS User's Guide, 1979 Edition,
 SAS Institute, Raleigh, North Carolina, 1979. 
I (2)J. P. Miller, "The Role of SAS in the Support of Clinical Studies in 
I
 
Medicine," in Proceedings of the Fourth Annual Conference of the SAS Users'
 





(3)J. Achtenberg and J. P. Miller, "Interfacing a MUMPS-based Data Entry 
System to SAS," in Proceedings of the Third Annual Conference on the SAS 











(4)McGill University, MUSIC: McGill University System for Interactive Computing, 
McGill University, Montreal, Canada, 1978. I 
(5)D. A. Glenn and I. H. Cockrell, "Conversational Instruction in the Statistical 
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A frequent problem in the analysis of data obtained on chronic diseases 
is to select a mathematical function which will allow the estimation of I 
the probability of some future event, such as death, given a set of data 
for a patient. Alternative formulations of the problem deal with the estimation 
of the expected survival distribution for a group. Generally data are available I 
on a vector of observations and the subsequent presence (and its time of 
occurrence) or absence of the predicted event for a group of patients. IRisk function analysis may be performed for several distinct, but 
overlapping, purposes. First is the empirical identification of individuals 
with increased risk of morbidity or mortality. Treatments or observations 
with significant monetary cost or potential for adverse reactions may be I 
justified only for high-risk patients. High-risk patient participation 
may provide for more efficient evaluations of interventions. Secondly, 
by identifying which variables contribute to the ability to predict a future I
event it may be possible to more clearly elucidate the potential mechanisms 
of the subsequent event, thus providing clues for potential intervention 
strategies. Finally, risk function analysis should allow the evaluation 
of the independence of a risk marker or of an observed intervention in pre­ I 











Efforts during the past year have been directed towards implementing 
software to evaluate several statistical models for risk function analysis 
(PR 13, D-18; PR 14, D-13) that are being applied to the database accumulated 
I 
for the study on the natural history of sudden death (A-7). SAS procedures 
for the solution of the Cox model for the-multivariate analysis of survival 
distributions were obtained from the Mayo Clinic(l) and Duke University. (2) 
SAS 79 contains a program (PROC FUNCAT) for the analysis of multivariate 
categorical data utilizing the GSK(3) approach. While the GSK approachI is asymptotically equivalent to the log-linear models (PR 14, D-13) it is a more natural technique for risk function analysis in that it is formulated 
in terms of the relationships between a dependent variable (e.g. death) 
I and a set of independent variables (e.g. risk variables) utilizing techniques which are analogous to those utilized for analysis of variance 0 
I We utilized a log-linear model in order to clarify the relationship between nontransmural myocardial infarction and in-hospital prognosis. (4) Previous reports had attributed both a more favorable and an equivalent 
prognosis to patients with nontransmural MI. Since several authors hadI commented on the relationships between nontransmural MI and serum enzyme elevations (which are thought to reflect the amount of myocardial damage) 
it appeared that the observed more favorable prognosis of nontransmural 
I
 MI might be simply a reflection of the better prognosis of patients with
 less myocardial damage. Log-linear models were fit predicting a number 
I 
of endpoints (death, cardiomegaly, congestive heart failure, cardiogenic 
shock, and presence of PVCs). In each case the peak serum SGOT level was 
significantly related to the endpoint (P < .001) and type of MI (transmural 




(l)T. M. Therneau, "Procedures for the Analysis of Survival Data," in Proceedings
 
of the Fourth Annual SAS Users' Group International Conference, SAS Institute,
 
Raleigh, North Carolina, pp. 116-120, 1979.
 
(2)F. E. Harrell, Jr., "The PHGLM Procedure," Division of Epidemiology andI Biostatistics, Duke University Medical Center, Durham, North Carolina, 1979. 
(3) J. E. Grizzle, C. F. Starmer, and G. C. Koch, "Analysis of CategoricalI Data by Linear Models," Biometrics, vol. 25, pp. 489-504, 1969. 










E. Speech and Hearing I 
Early collaboration with Central Institute for the Deaf was the develop­
ment of digital instrumentation suited to speech-and-hearing research. 
The first systems that were developed, a Random-Access, Programmable (RAP-I) Idigital recorder, a computer system for processing sampled speech, and a 
RAP-II system that is interfaced to the LINC computer in the physiology 
laboratory, continue to be used in a variety of research applications, in­
cluding the analysis of sampled speech sounds and glottal source waveforms I 
and the synthesis and tailoring of speech sounds for psychoacoustic experiments 
with human and animal subjects. IThe RAP-I system has been invaluable in the study of speech waveforms, 
the evaluation of hearing aids, and the study of speech perception with 
infants, adults, hearing-impaired subjects, and animals. The RAP-II system 
has greatly enhanced the LINC facility with the addition of quickly accessible I 
mass storage for physiological data and program overlays and a high-quality 
analog subsystem for playback and recording of arbitrary auditory stimuli. I 
The proven usefulness of these first systems has led to the development 
of newer RAP systems that can be programmed to accommodate a variety of 
psychoacoustic experiments and a central computer system with increased Isampled data capability. This work is finished and laboratories at Central 
Institute for the Deaf presently are undergoing renovation to accommodate 
these new systems. I 
More recently a major emphasis has been directed towards certain 
basic questions related to hearing and deafness, that require the digital 
instrumentation available through the collaboration. These areas of study I 
include the following: 
1) Measurements of psychophysical characteristics of electrocutaneous Istimulation to determine if this ~ensory modality can serve as a substitute 
input for speech for profoundly deaf patients. 
2) The measurement of glottal source characteristics of normal and I 
deaf talkers. This study has involved developing glottal tube instrumentation 
and supporting computer programs. Additional work in this area of interest 
includes a study of the acoustic transmission properties of the throat wall I 
near the glottis, the development of a physically-based model of the throat 
wall, and the study of the human vocal tract using an input-output procedure. I3) Psychoacoustic studies related to questions of speech perception. 
Simplified speech-like sounds and exemplary speech sounds have been generated 
and used for testing human adults and infants and chinchillas. A major 
focus of these studies is to understand the acoustic and neural transformations I 
that are important in speech perception that occur in the cochlea and other 
parts of the auditory system. I4) The development of methods for generating rapidly changing visual 
displays that can be used in lipreading studies. This work was started 
in an attempt to delineate the facial cues that are important in lipreading. I 
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 Checkout of the third free-standing satellite computer has been com­
pleted. These RAP-III systems are part of a laboratory renovation at Central 
Institute for the Deaf that has been described in PR 13 and 14. 
I This last system is to be installed in the Psychoacoustic Laboratory 
and will be used for general applications of sound recording and editing 
and for stimulus generation, experimental control, and data collection inI a variety of psychoacoustic experiments. 
I 
The second RAP system has been installed in the Comparative Psycho­
acoustics Laboratory for use in studies of auditory learning and perception 
by animals. 
I Four subject stations have been added to the Eclipse central system. Each station consists of a videa display, keyboard, and earphones. Each display can be independently controlled to provide instructions and response 
feedback to the subjects. 
I 
I The stereo earphones are driven from the two analog channels of the 
system. Cue lights are included at each station that can be programmed 
to indicate the beginning of a trial or a response interval. 
Other work that has been completed includes: 1) the addition of 











E-2 Speech Microscopeo I 
Personnel:	 N. R. Vemula, M.S., Central Institute for the Deaf 
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J. L. Lauter, M.S., Central Institute for the Deaf IR. B. Monsen, Ph.D., Central Institute for the Deaf 
Support:	 RR 00396 
NS 03856 I 
Our interests in the study of speech production and perception have I
recently led us to need a means of precise measurements and analysis of 
acoustic details of the speech waveform. Our research has required accurate 
information about spectral, temporal and amplitude parameters of speech 
for steady state as well as dynamic portions. Examples of such information I 
are the measurements of formant transitions, fundamental frequency of vowels, 
and power spectra of vowels, stop consonants and voiceless fricatives. 
Such measurements require a computer based system for efficiency, flexibility I 
and ease of operation. The system should also have a high speed (analysis 
in seconds, not minutes) and should be easy to use by researchers not necessarily 
familiar with computer programming. I 
"Speech Microscope" is such a sY~fym developed over the past year, 
and presently in use at the laboratory. It is a software system, written 
in FORTRAN language, for the PC-1200 based Speech and Hearing computer system. I 
The system is designed to conveniently record, store, display, playback 
and analyze speech signals. It can be considered as an expanded version 
of the "Interactive Speech Wave Examiner System" (PR 10, G-5). The speech I 
microscope system is highly interactive, allowing a variety of controls 
by the user through a keyboard and a storage display scope. Because of 
the small memory size of the machine (16K), the system is divided into about I50 overlays. About 75 subprograms, in addition to the standard ones provided 
with the operating system have been written to make the system convenient 
to use. The system has three main parts: the display window, the analysis 
window, and the utility programs. I 
The display window can bring the waveform of a recorded sound onto 
the scope with a variable window width (from a fraction of a millisecond I 
to 1000 msec) and a variable amplitude scale, both under the keyboard control. 
The window provides a number of controls, enabling the user to essentially 
"walk through" the sound, and examine its successive segments. The window Iacts as a "temporal microscope" showing the whole syllable at a time, or 
a fraction of it. Pressing a single key can cause the waveform to be viewed 
on the scope in successive segments, allowing the user to sequentially scan 
the whole sound, forward or backward; this can be done automatically, or I 
under frame-by-frame, manual control. Once a portion of the sound is selected 
for closer attention, the user can adjust the display time and amplitude 
parameters and "zoom in" on the waveform with the help of knob-controlled I 
cursors, much as one can increase a microscope's "viewing field." The display 
window can also playback the cursor-selected segment of the sound on the 









I The analysis window performs spectral or Linear Predictor (LP) analysis on a selected segment of the waveform. The "zoom in" capacity is still 
available in the analysis window, allowing detailed examination to help 
I 
decide exactly which portion will be analyzed. The window offers an option 
to select the cursors at the zero crossings of the waveform. This option 
I 
is useful, for example in selecting a period of the wave for analysis. 
A rectangular, Kaiser-Bessel or cosine pedestal window can be applied to 
the signal before analysis. Once the analysis key is pressed, the system 
quickly performs the analysis, and the results are displayed on the scope. 
The available display frames are: (1) waveform and linear frequency DFT, 
(2) waveform and log frequency DFT, (3) waveform and phase spectrum, (4)I waveform and interpolated, smoothed spectrum obtained by evaluating the z-transform of the signal along the unit circle in the z-plane, (5) phase 
spectrum and linear frequency DFT, (6) locations of the poles of the LP 
I




bandwidths and the signal energy levels at the formant frequencies, (7)
 
waveform and LP magnitude transfer function, (8) an approximation to the
 
tract shape, (9) waveform, log frequency DFT, and LP magnitude transfer
 
function superimposed on the DFT, and finally, (10) waveform and a display 
of the energy levels in the 1/3 octave filter bands. The system also prints 
out the values of the DFT components, tract model sectional areas, and theI energy levels in the 1/3 octave filter bands. 
I 
The utility programs have options to record the samples of a sound, 
up to 1 sec, through a 12 bit A/D converter at a 20 kHz sampling rate, to 
I 
playback the recorded sound repeatedly until a key is struck, to save the 
sound on RAP disk (PR 11, G-l), to display the stored signals, to playback 
RAP tracks, and to read stored data from the disk for analysis. 
We are currently using the system for the following purposes: study 
of voice source characteristics (E-4), spectral analysis of noises of differentI durations for research on the psychoacoustics of sound sequence identification, 
I 
duration measurements for components of consonants for a study on identification 
of sub-phonetic speech sounds, and description of acoustic char.acteristics 
of English consonants as a basis for synthesis of a continuum of approximations 
to speech. The goals of speech microscope and its methods are not original, 
but its modular programming design, applicability to the study of a wide 
variety of acoustic signals, flexibility and ease of use have made it aI basic tool for our research on complex sounds. 
I (l)N. R. Vemula, A. M. Engebretson, R. B. Monsen, and J. L. Lauter, "A Speech Microscope," ASA 50 Speech Communication Preprint Experiments, Cambridge, 











E-3.	 Models for the Human Throat-Wall and a Study of the Vocal Tract from 
Input/Output Measurements I 
Personnel:	 N. R. Vemula, M.S., Central Institute for the Deaf 
A. M. Engebretson, BCL and Central Institute for the Deaf ID. L. Elliott, Ph.D., Systems Science and Mathematics 
Support:	 RR 00396 
NS 03856 I 
Work is continuing on the study of the throat-wall and the vocal I 
tract from input/output measurements. A lumped-parameter mechanical model 
for the throat-wall has been developed based upon the physiology of the 
larynx, anatomical data for the larynx, and existing data on the characteristics Iof the laryngeal muscles and ligaments. The elements in the model have 
a one-to-one correspondence with the laryngeal cartilages, muscles and liga­
ments. Each cartilage is represented as a mass element, and muscle or ligament 
as a pair of compliance and viscous loss elements. The soft tissue on the I 
inside and outside surfaces of the wall are represented as mass-compliance­
viscous loss elements based on the work done by Ishizaka et. al.(l) The 
transfer function of the model seems to agree well with the passive acoustic Itransfer function characteristic of the wall, measured experimentally by 
giving an external force with a vibrator and measuring the inside wall volume 
velocity while the subject has held the glottis closed articulating a neutral 
vowel without phonation. The inside response is measured with a reflectionless I 
terminator tube at the lips. 
The throat-wall, during phonation, is modeled as a 3-port network I 
with an "acoustic port" corresponding to the supraglottal pressure excitation 
of the wall, a "mechanical port ll representing the excitation due to the 
net dynamic force exerted by the vibrating vocal folds on the posterior Isurface of the thyroid cartilage, and an "output port" where the external 
transducer is affixed on the wall to measure the wall vibration. It is 
assumed that the wall is reciprocal, looking from these ports. Therefore, 
the 3x3 network matrix relating the port variables becomes symmetrical, I 
leaving only 6 unknown elements. One of these corresponds to the above 
measured passive acoustic transfer function characteristic. A second element, 
corresponding to the input impedance at the output port, is experimentally Idetermined by giving an external force on the wall and measuring the velocity 
of the outside surface. The remaining 4 elements are evaluated from a computer 
simulation of the above lumped-parameter physiological model, because of Ithe inaccessibility of the mechanical port. 
The transfer characteristic of the throat-wall (supraglottal sound 
pressure resulting from a force applied on the external surface of the neck) I 
is determined experimentally and is represented as an autoregressive moving 
average (ARMA) model. Using a Maximum Likelihood approach, the parameters 
of the model are estimated from the measured samples of the external force I











 a predominantly low-frequency noise in the tract. Using this model and
 also the measurements of the inside pressure and the external vibration
 
during phonation of a neutral vowel into the glottal tube, it has been 
determined that the mechanical component of vibration is about 3-7 timesI larger than the acoustic component, depending upon the pitch and intensity of phonation. 
I The tract shape is determined from the measurements of the microphone 
I 
pressure at the lips and the acceleration of the external surface of the 
neck near the glottis. The ARMA model for the throat wall characteristics 
is used to calculate an approximation to the supraglottal pressure. Preliminary 
results indicate that the input/output procedure gives reasonable tract 
shapes for vowel phonation at normal pitch and intensity, even though the 
details of the shapes do not seem to be accurate. The procedure has alsoI been tested by introducing controlled changes in the tract shape, for example inserting a wooden piece of known dimensions into the tract and taking it 
out, creating a tongue hump toward the front and removing the hump, etc. 
I Analysis of these measurements show corresponding changes in the computed tract shapes.(2) 
I (l)K. Ishizaka, J. C. French, and J. L. Flanagan, "Determination of the 
Vocal Tract Wall Impedance," IEEE Transactions on Acoustics, Speech and 
I




(2)N. R. Vemula, A. M. Engebretson, and D. L. Elliott, "Models for the Human
 
Throat-Wall and a Study of the Vocal Tract from Input/Output Measurements,"
 
Proceedings of the 1978 IEEE Conference on Decision and Control, San Diego,
 
California, pp. 946-948, January 10-12, 1979. 
I
 
I E-4. Voice Source Characteristics 
I Personnel: R. B. Monsen, Ph.D., Central Institute for the Deaf A. M. Engebretson, BCL and Central Institute for the Deaf 
N. R. Vemula, M.S., Central Institute for the Deaf 
I Support: RR 00396 NS 03856 
I 
I In continuance of this project (PR 14, E-4), newly designed equipment 
for the measurement of the glottal wave has been used to study the effect 
of hearing impairment on the generation of voice and to study the character­
istics of various functional voice disorders, such as hoarseness or breathiness. 









from normally hearing adults. These data were used to establish what the 
characteristics of the glottal vibration are in the normally functioning I 
larynx. By comparing such data with synthetic glottal waveforms generated 
by the Ishizaka-Flanagan 2-mass model of vocal-fold vibration, the relative 
participation of vocal-fold tension and subglottal air pressure as the con­ Itrolling parameters in voice production were indirectly inferred. A detailed 
description of the method and the conclusions reached concerning the normal 
characteristics of glottal vibration may be found in the published sources. I 
The equipment has not been altered since previous reports. When 
phonation is examined by use of this device, we find that the glottal waveform 
has an appearance basically similar to those observed by other methods. I 
For male speakers and for females who phonate at a relatively low fundamental 
frequency, the waveform is distinctly triangular and somewhat humped. In 
most cases, a well-defined closed period does not occur, whereas measurement Iof the glottal waveform by other methods usually shows a fairly clear and 
flat closed period. To some extent, this is due to the phase response of 
the system at low frequencies. Therefore, we have added a correction for 
the phase response of the system by applying the inverse of the phase response I 
curve to the recorded samples. This has the effect of making the observed 
waveforms more nearly resemble the "textbook" variety of triangular pulse. 
However, an additional possible explanation for the general appearance of Ithe observed waveforms is that when the vocal folds are tightly closed, 
the system (from the glottis to vocal tract to reflectionless termination) 
is then effectively terminated at one end with a high acoustic impedance, 
and thus some reflections may be present. We believe this is the case because I 
we can observe some traces of formants in the glottal spectrum when a subject 
phonates in the "loud" voice mode, a mode in which the vocal folds presumably 
collide forcefully with each other and remain rather tightly together during I 
the closed portion of each cycle. Formant traces are usually difficult 
to observe in normal voice phonation and are not at all apparent in soft 
voice. In summary, when a subject phonates in a soft voice, neat closed Iperiods in the glottal volume velocity waveform are not observed because 
there may not be any; in the loud voice or normal voice mode, we observe 
a hump in the opening phase of the waveform, and this hump we believe may 
lie astride the closed portion of the waveform. I 
During the past year, the new reflectionless tubes were used to gather 
glottal waveform data from a group of 20 hearing-impaired adolescents. I
The subjects each provided samples of phonation in normal and soft voice 
modes and in a three-syllable word with primary stress on the medial syllable. 
Analysis of these data in comparison with the characteristics of phonation Iproduced by normally-hearing subjects indicates that deafness affects primarily 
the time-varying characteristics of the glottal source. Among the hearing­
impaired subjects the following abnormalities were noted: higher-than-normal 
rates of jitter and shimmer (frequency and intensity perturbations) for I 
some subjects; diplophonia and creaky voice episodes at the onset or middle 
of phonation; and irregular patterns of change in the frequency and intensity 










to normal, but may prevent a speaker from learning the phonatory consequences
I of the muscular gestures which maintain and alter vocal-fold tension (as
 well as subglottal air pressure) in the production of speech.
 
I
 Recently, a study of functional voice disorders among the normally­
hearing was begun by recording samples of abnormal voice simulated by a 
speech pathologist. Functional disorders with simulated abnormalities were 
I
 chosen (1) to assure that there is no accompanying organic abnormality,
 and (2) so that the differences observed are not attributable to differences 
in subjects. The following types of voice were recorded and analyzed: 
(1) normal, soft, very soft, and loud voice; (2) soft-breathy voice; (3)I breathy voice; (4) dry-hoarse voice; (5) ventricular-hoarse voice; (6) harsh-hoarse voice. These samples of functionally-deviant voice were compared 
I 
with normal in several different ways: the appearance of the waveform, 
the amount of perturbations of frequency and intensity, including diplophonic 
I 
perturbations, and the amount of noise in the spectrum. The glottal waveforms 
of these voice types are all recognizably different one from the other by 
either the appearance of the waveform, the periodicity of the waveform, 
or the amount of noise in the spectrum. 
On the basis of the appearance of the glottal waveform, it is possibleI to distinguish between normal voice on the one hand and either breathy voice 
I 
types or hoarse voice types on the other. The waveforms of breathy voice 
types are roughly similar to normal, except for the superimposed presence 
of noise. In contrast, the hoarse voice types are all diplophonic, which 
is indicated in the waveform by the regular alternation of longer and shorter 
pitch periods. 
I The period-to-period fluctuations of frequency are the greatest 
I 
for breathy voice, and less for soft-breathy voice. Diplophonia is a particular 
extreme kind of pitch-period alternation, and the nature of the diplophonia 
appears to distinguish well between the different types of hoarse voice. 
I 
To see this relation, it is necessary to distinguish between major and minor 
pitch periods. For dry hoarse voice, the major period is relatively stable 
at 83 Hz (well below the subjects' normal voice phonation range of 120-140 Hz), 
and the two minor periods alternate regularly between 176 and 155 Hz. For 
harsh-hoarse voice, the major period is erratic, and has an average frequency 
of about 132 Hz. The minor periods are also erratic, and span a range ofI about 100 Hz, from 220 to 320 Hz. For ventricular-hoarse voice, the major period has considerable frequency fluctuation, and centers around 115 Hz, 
I 
while the minor periods are quite regular and alternate between 210 and 
250 Hz o 
I 
The amount of noise in the spectrum was measured in the following 
way: five successive periods were selected, and the amplitude spectrum 
of each period was calculated. In each of these five successive spectra, 
the level of each individual harmonic was compared to that of the fundamental. 
We assume that if there is little noise in the spectrum, then the levelI of a given harmonic will be relatively constant from one period to the next with respect to the fundamental. If, on the other hand, there is considerable 
I 





noise present in the spectrum, then the level of a given harmonic will vary 
considerably from period to period due to the randomness of the noise sample. I 
The statistical variance of the level of the first five harmonics was calculated 
for each of the different voice types. As expected, the variance of the 
level of harmonics in normal voice is quite low, indicating quantitatively Ithat the noise is low. The average variance of the first five harmonics 
for normal voice was 0.8 dB; for soft-breathy voice, the average variance 
was 13.4 dB; for breathy voice, the average variance was 22.3 dB. According 
to this measure of noise, the hoarse voice types are not particularly "noisy," I 
but this measure of noise was applied only to the major periods. It is 
interesting that the spectra of successive minor periods in the diplophonic 
hoarse-voice samples are very different from each other, and the regular I
repetition of such periods may well be a primary source of the roughness 
of the hoarse voice types. IThe reflectionless tube appears from these studies to be a useful 
tool for investigating voice disorders, and it perhaps can be put to diagnostic 




E-5. Identification of Changing Elliptical Shapes in Relation to Lipreading IPersonnel:	 R. M. Sachs, Ph.D., Central Institute for the Deaf 
Support:	 RR 00396 
NS 03856 I 
In an effort to increase our understanding of perception of changing II 
mouth openings during speech, we examined subjects' identification of elliptical 
shapes differing only in maximum vertical size. An analog circuit was used 
to present an elliptical lissajous pattern on an oscilloscope screen. The I 
horizontal and vertical extension of the ellipse were under computer control. 
Using the PC-1200 based Speech and Hearing computer system, a visual identifi­
cation experiment was programmed. Between trials t a static shape remained I 
on the screen (e.g. a 48 rom horizontal line to mimic a closed mouth). During 
each trial, the line "opened" to an ellipse and then closed again to the 
line configuration. The observer's task was to label the extent of maximum 
opening with an assigned number. Several different stimulus durations were II 
tried t as well as different ranges of ellipse size and vertical spacing. 
In later experiments, a duration of 200 msec was used, and the 48 rom wide 
ellipse opened and closed according to a raised cosine function with no I 
intermediate steady state. Twelve maximum vertical openings were presented t 
spaced logarithmically from 2 to 24 mID. After about 100 trials with feedback t 
two observers each were processing about 2.3 bits (=log25) of information. I 
That is, it is predicted that they would have identified all shapes correctly 










Elliptical stimuli of longer duration were easier to label, and up to 3 bitsI of information (8 alternatives) could be processed. When linear increments in vertical size were used, the overall difficulty of the task was comparable, 
but the smaller shapes were easier to identify because of the larger proportional
I steps. This perceptual task, in general, may be closely related to the ability to identify front (spread) vowels in /b/ context (e.g. Ii, I, E, ae, a/). 
Further studies of shape identification as it relates to lipreading of vowels 
I




E-6. Further Development of Computer-Drawn Faces for Lipreading Research 
I Personnel: R. M. Sachs, Ph.D., Central Institute for the Deaf 
I Support: RR 00396
 NS 03856
 
I Present available facilities do not permit computer generation of animated faces in real time. Nevertheless, we decided to use the FORTRAN 
graphic capability of the Speech and Hearing computer system to display 
I
 a rather detailed "face." One reason was that availability of a synthetic
 "face" would assist in developing computer-aided methods for analysis of 
films of talker articulation. Once oral/facial dimensions were entered 
into the computer, either as a table of numbers or from a graphic tablet,I a "face" generated with those dimensions could be compared immediately with the original film image for confirmation. A second purpose was to determine 
the fewest straight line segments (vectors) required to produce a satisfactory
I "face," below which number it would be apparent to an observer that straight lines had been used in synthesis. This finding would aid in estimating 
future computer needs. 
I A face synthesis program has been written. The synthetic image, 
which appears on an oscilloscope screen, depicts head and jaw outline, eyes, 
eyebrows, nose, and mouth. The mouth details include inner and outer lipI edges (with philtrum) and two straight horizontal lines representing tooth edges. All curved face components are based on ellipses, but in reality 
are constructed from straight-line segments, and a common cosine/sine table 
I subroutine is used to specify x/y locations of the vector endpoints. The basic elliptical curvature is altered as needed by raising the sine values 
to a predetermined exponent between 0.35 and 2.3, the former for the head 
I outline, and the latter to define lip borders. A 60-vector approximation to the largest border (a life-size head and jaw outline) could not be distin­guished from any approximation composed of more vectors. When all vectors 









E-7. General Software Development 
IPersonnel:	 N. R. Vemula, M.S., Central Institute for the Deaf 
Support:	 RR 00396 
NS 03856 I 
Several routines have been written in FORTRAN language, and added Ito the software library for the Speech and Hearing system. They can be 
divided into (1) scope display routines, (2) mathematical routines, (3) 
signal processing routines, and (4) waveform synthesizers. I 
The scope display routines can be used to read a disk file of sampled 
data, to modify systematically the number of samples to fit the data into 
the available memory, and to display the signal between specified initial I 
and final times. The signal is appropriately scaled along the time and 
the amplitude axes, and the axes are marked conveniently. Other routines 
display the magnitude transfer function characteristic of a digital filter, Ithe magnitude and the phase information of the discrete Fourier transform 
of a signal on linear or logarithmic frequency scale, a specified RAP track 
of data, the location of poles and zeros of a digital filter in the unit 
circle in the z-plane. A variety of types of lines can be specified such I 
as: solid, dotted, dashed, dashed with dots in between consecutive dashes, 
and dashed with alternating long and short dashes. Other routines are avail­
able to display pointers that are controlled from knobs on the keyboard. I 
The mathematical routines do the following operations: simulation 
of discrete time systems, analysis and synthesis of digital and analog filters, Iand matrix inversion to solve a set of algebraic equations. 
The signal processing routines apply a Kaiser-Bessel window, a Hamming 
window, a cosine pedestal, or a 6 dB/octave pre-emphasis characteristic I 
on a given signal. The routines also can be used to process a given signal 
through a specified pole-zero digital filter. The routines can determine 
the zero crossing points of a signal. This is useful in selecting one period I
of a periodic wave for analysis. Other routines have been written to synthesize 
a variety of waveforms such as: triangular waves, an impulse train differenced 
a specified number of times, or any periodic wave for which the fundamental 
frequency and the amplitudes and the phases of the fundamental and the harmonics I 










F. Central Nervous System Diseases and Electroencephalogram Analysis 
I The Biomedical Computer Laboratory's involvement in clinical neu­
I 
rology, neurosurgery, and in neurophysiological research reaches back 
to the Laboratory's beginnings. In 1965 and 1966 a LINC computer at BCL 
was applied in processing radioisotope brain-scan data transmitted over 
I
 
telephone lines from the hospital radiology unit, and in 1966 a LINC­

controlled evoked-response display system was installed, providing neuro­





via closed-circuit television. In 1969 and 1970 a LINC computer was inter­

faced to a six-probe system designed by the radiology department for in­

vivo cerebral blood-flow and oxygen-metabolism studies employing cyclotron­

produced radioisotopes. The next two years saw further development of
 
this approach with the construction of a twenty-six-probe brain blood-
flow and metabolism unit capable of increased spatial resolution.I 
I
 
At this juncture it was recognized at BCL that new initiatives
 
in central nervous system and other radiotracer studies must stem, in
 




physiological phenomena reveal themselves through gamma rays and annihi­

lation photons to the external data-gathering instruments. Thus, in col­

laboration with scientists at Washington University and at other institutions,
 
the Laboratory undertook a substantial augmentation of its program in tracer
 
kinetics by expanding its activities in physiological modeling and parameter
 
estimation. These collaborative efforts led to successful quantitative




and metabolism, blood-brain-barrier permeation of water, alcohols, ammonia,
 





Research efforts at BCL in application of computers and mathematical 
models to CNS disease management and EEG analysis, reported last year 
in PR 14, have continued to be productive and this year's results are 
summarized here. Progress has been made in projects previously described:
 
in regional in-vivo studies of hemodynamics and metabolism in brain and
 
I in development of computerized systems for automatic processing and monitoring




surgical procedures. Additionally, the two new projects reported for the
 
first time last year have each made impressive strides: (a) the Visually
 




undergoing evaluation tests, and (b) control algorithms for the auto radio­

graphic-image-processing system have been completed and their performance
 











F-l. Visual Evoked Response 
1: G. J. I 
H. W. 
L. A. 
J. K. IS. R. 
H. W. 
L. J. I 
Support:	 RR 00396 
MH 31054 I 
The visual evoked response (VER) is used as an indicator of cerebral 
physiology. Electrophysiological responses evoked by repeated visual stimuli Iare separated from other ongoing electrical activity by a signal-averaging 
process. Features extracted from the averaged responses to stationary 
white-flash and to reversing black-and-white checkerboard patterns are 
to be included with behavioral measures and cerebral structure metrics I 
in a temporal study of patients with senile dementia. 
A system consisting of a programmable acquisition instrument for I
on-site use in the visual evoked response laboratory and a minicomputer­
based editing facility for off-line data analysis are being developed. 
The programmable acquisition instrument samples, digitizes and averages 
two channels of EEG data. The instrument provides artifact rejection and I 
randomization of stimuli triggers as well as spectrum analysis for the 
resting EEG signals. The instrument can be preprogrammed for a multi-step 
clinical protocol to eliminate "knob-and-dial" manipulations of various I 
parameters which vary with the protocol. Both an oscilloscope display 
and an x-y recording capability are provided for on-site monitoring of 
evoked responses. A floppy-disk storage unit is used to store the averaged Ievoked responses, the Fourier coefficients of the resting EEG and test­
specific information. The acquisition instrument implementation, which 
is based on an M6800 microprocessor, is currently in the test-and-evaluation 
phase of development. I 
The minicomputer system is configured to accept digitized data 
from the remote acquisition instrument and to provide a computer-assisted I 
editing facility, thereby enabling the clinical investigator to specify 
the latencies for the selected waves in the evoked response. IThe VER editor is an interactive system that allows the operator to 
review the VER features identified by the VER automatic feature-extraction 
program. Through a set of single-key commands, the operator has the 
ability to examine each response, and, if desired, to modify the latencies I 
of the points of interest of the responses presented. A typical output 
is shown in Figure 1. When editing is complete, the results may be printed 










magnetic tape for transport to the main-campus computing facility. This 
will facilitate incorporation of the VER results in the long-term temporal 
study of the senile dementia syndrome. 
I 
:~.4 
I Test No. Nl P2 N2 P3 N3 
76 106 138 188 2183I 
I 500 MSEC 
I
 Figure 1. Sample VER output.
 
I A brief pilot study was conducted to compare bipolar derivations obtained from locations Ol-Cz, Cz-A2 and Ol-A2. The study was facilitated 
through the use of a universal storage device (G-3) to acquire and digitize 
I the three EEG channels as well as a fourth channel containing a stimulus 
I 
reference marker. The results suggest that the best choices are the Ol-Cz 
and the 02-Cz bipolar derivations for recording P2, N2, P3 and N3 latencies. 
The Cz-A2 derivation exhibits lower amplitude potentials than any of the 
other derivations tested. Monopolar derivations using either the ear ipsi­
lateral or the ear contralateral to the stimulated eye as reference give 
lower amplitudes than does the Ol-Cz bipolar derivation. This is true forI the responses to both checks and flashes. Our characterizations of these 
I 
electrode locations are consistent with the results of investiyations of 
other workers, e.g., the field studies of Fender and Santoro. ( ) Given 
the limited number of channels, however, the choice of electrode site is 
arbitrary and largely dictated by considerations of convenience and repro­
ducibility. Similarly, the limited spatial resolution achievable with the 
I small number of electrodes employed makes the choice between bipolar and unipolar configurations a matter of personal preference. 










F-2.	 Development of an Automated System for the Monitoring of Epileptic 
Patients with Indwelling Electrodes I 
Personnel:	 C. F. Pieper, M.S., Neurological Surgery 
S. A. Golden, B.S., Neurological Surgery 
S. Goldring, M.D., Neurological Surgery I 
Support:	 RR 00396 
NS 06947 
Washington University I 
Development	 of the crosspoint switching matrix (PR 14, F-2) has I 
continued with its expansion to 48 inputs by 64 outputs. Completed are 
the previously proposed patient-protection circuits, calibration circuits 
and auto-testing circuits. Hardware and software have been expanded to Ipermit gating of the stimulus voltage to the desired electrodes during 
direct cortical stimulation. Several schemes to reduce EEG amplifier 
saturation during direct cortical stimulation have been considered; their 
realizations have been constructed and are currently under evaluation. I 
The system has been used successfully with several patients, both in the 
operating room and during extended bedside recording. IThe augmented output capacity will be used to drive additional 
EEG amplifiers currently under development. These additional amplifiers 
will permit collection of the averaged sensory evoked response to median Inerve stimulation without interruption of patient monitoring. The gain 
and filter settings will be controlled by the microprocessor, thereby 













F-3. In-Vivo Measurements of Regional Blood Flow and Metabolism in Brain 
I Personnel: M. E. Raichle, M.D., Neurology and Radiology 
R. L. Grubb, Jr., M.D., Neurosurgery 
C. S. Higgins, A.B., RadiologyI K. B. Larson, BCL B. E. Laux, B.S., Radiology 
J. Markham, BCL 
I N. A. Mullani, BCL A. Roos, M.D., Physiology and Biophysics 
M. M. Ter-Pogossian, Ph.D., Radiology 
I T. J. Tewson, Ph.D., Radiology M. J. Welch, Ph.D., Radiology 
Support: RR 00396
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We have continued our previously reported efforts in the study 
of central-nervous-system hemodynamics and metabolism. Our immediate 
objective has been the development of techniques employing biochemically 
significant compounds labeled with cyclotron-produced isotopes (PR 14, F-4) , 
suitable exteraal-radiation-detection systems (PR 14, B-4, B-5; B-5), andI appropriate mathematical models (PR 14, F-4) for the in-vivo and regional 
I 
study of basic biological processes and pathology within brain. Our ultimate 
goal is to use these techniques to provide the quantitative physiological 
and biochemical measurements in humans necessary to understand central­
nervous-system disease, as well as to formulate specific therapies and 
monitor their results. 
I Our previously reported studies of glucose metabolism (PR 13, H-l; PR 14, F-4) have been complemented by quantitative measurements in the 
I 
rhesus monker of brain-tissue acid-base status employing llC-labeled carbon 
dioxide and 50-labeled water. Measurement of the mean-transit times of 
I 
these two tracers, together with prior knowledge of the partition coefficient 
of water, enable us to derive the partition coefficient of total carbonate 
(i.e., dissolved carbon dioxide plus bicarbonate anion). This determination, 
in turn, has enabled us to obtain, for the first time, in-vivo values of 
total-carbonate concentration in brain. Our method of computing the total­
carbonate partition coefficient is based on a mathematical model that showsI under what conditions the central-volume principle of tracer kinetics, (1,2,3) 
1/ 
which had previously been derived only for a single labeled species, can 
be generalized to include the case of a tracer distributed among several 
species that are locally in mutual chemical equilibrium within vascular 
and extravascular spaces. 
I Our preViously reported studies of ammonia uptake and metabolism (PR 14, F-4) have also progressed. The observed blood-pH dependence of 








derive values for the blood-brain-barrier permeabilities of both the un­
charged and the anionic species. We have interpreted our data on the 
basis of a mathematical model that is a dynamic distributed-parameter I
 
representation of the vasculature. With it, we have shown that the clas­
sical outflow-detection method of measuring capillary permeability(4) 
can be sUitably modified for use with radioactive tracers detected externally. I
 
(l)p. Meier and K. L. Zierler, "On the Theory of the Indicator-Dilution I
Method for Measurement of Blood Flow and Volume," Journal of Applied 
Physiology, vol. 6, pp. 731-744, 1954.
 I
 (2)K. L. Zierler, "Equations for Measuring Blood Flow by External Monitoring
 
of Radioisotopes," Circulation Research, vol. 16, pp. 309-321, 1965.
 I
 
(3) G. W. Roberts, K. B. Larson, and E. E. Spaeth, "The Interpretation of
 
Mean-Transit Time Measurements for Multiphase Tissue Systems," Journal
 
of Theoretical Biology, vol. 39, pp. 447-475, 1973.
 I
 
(4)D. G. Levitt, "Evaluation of the Early-Extraction Method of Determining 
Capillary Permeability by Theoretical Capillary and Organ Models," Circulation I





F-4. Studies of an Image-Processing System for Neuroanatomy I
 
Personnel: A. J. Gray, BCL 
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E. G. Jones, M.D., Ph.D., Anatomy 
J. L. Price, Ph.D., Anatomy 
L. J. Thomas, Jr., BCL I

D. F. Wann, D.Sc., Electrical Engineering 
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One of the more important research techniques used in neuroanatomical 
studies is autoradiography. This is a technique by means of which spatial I
 
distributions of radioactively labeled compounds in central-nervous-system
 
tissue can be inferred in specially prepared tissue samples as a result
 
of the action of the radioactivity on photosensitive materials. Exposure
 
to the ionizing radiation causes the formation of silver grains, whose
 I
 
distribution density reflects that of the radiolabel. The latter can, in turn,
 











on the spatial distributions of rates of physiological processes of interest.
 
Examples of such processes are blood-flow and metabolism.
 
Since manual analysis of auto radiographic material is tedious and
 
conducive to error t automatic or semiautomatic counting techniques can be
I of potential value. For this reason t a semiautomatic grain-counting system
 was developed at Washington University in the mid-seventies. This system
 
consisted of a PDP-12 computer t a plumbicon TV camera t and some special­
I




image processing have led to the development of a second-generation grain­

counting system. The experience gained in bUilding and operating the original
 
device, as well as contemporary advances in microelectronic components t
 
have been strong incentives in this undertaking.
 
Of primary importance in the design of the system is the degree to
I which it can be "human-engineered." Thus t criteria such as modularitYt




system architecture. As presently envisioned t the automatic grain-counter
 




This partitioning of functions allows a high degree of parallelism and
 
hence high counting speed: we hope to achieve a complete count of two or
 
more video frames per second.
 
The system consists of a stage-control processor that positions
 
the microscope stage t a video processor and image analyzer (VPIA) that
I accepts video data from the imaging device and extracts grain counts and
 other image parameters t and a st~ervisory processor and mass-storage manager.
 
The supervisor controls overall system coordination t mass-storage management t
 
I
 and all high-level user interaction. It will be programmable in a high­
level language. These modules are interconnected by means of an IEEE-488 
bus. All elements are software-controlled; the bus is generalized t allowing 
I a high level of flexibility to be achieved. Of special interest is the use of a solid-state charge-coupled-device (CCD) TV camera instead of the 
more conventional tube-equipped type. The CCD camera exhibits much better 
I 
lag t burnt and shading characteristics than tube cameras and is very easily 
interfaced to digital hardware. 
I 
The new system incorporates several features not found on the original 
system t including automatic segmentation-threshold selection t improved 
graphics capability for enhanced data presentation t an improved focusing 
algorithm using an image-sharpness criterion t and user-prompting single­
stroke key selection for most system interaction. FinallYt provisions areI made to allow portions or all of the system to be changed t improved t or deleted with few t if anYt hardware changes and rninimal software side effects. 
I Algorithms to accomplish automatic microscope focusing t dynamic 
I 
thresholding t and grain counting are being evaluated on the DECSYSTEM 20 
at the Engineering School utilizing data acquired through the video digitizing 
system (C-7) at BCL. The microscope and scanning stage have been delivered 









An operational specification for the completed system which delineates 
performance and user interface details, has been developed in collaboration 




F-5. A Correlation Technique for the Study of Visually Evoked Responses 
Personnel:	 H. W. Shipton, BCL and Department of Electrical Engineering I 
Support:	 RR 00396 
Washington University I 
Classical studies of visually evoked responses (VER) have used Iflash stimulation and simple response averaging. These choices were largely 
dictated by convenience. While VER studies have yielded clinically significant 
information (F-l), they have not yet contributed much to the knowledge of 
the functional anatomy of the visual system. Recently, in an effort to I 
enhance VER as a research tool for visual neurophysiology, stimuli thought 
to be more physiologically plausible than brief light flashes have been 
introduced. An example is the "checkerboard" light pattern. I 
We have performed preliminary experiments to devise more controllable 
and presumably more appropriate visual stimuli. In order to provide sequential 
stimulation of different parts of the retina believed to have different I 
thresholds, stimuli consisting of expanding and contracting circles or arcs 
are being tried. These patterns, displayed on a cathode-ray tube, are 
generated in such a way as to be confined to any desired quadrant of the I 
visual field. A suitable stimulus generator has been designed and built 
in "bread-board" form. In the expectation that responses to this type of 
stimulation will be relatively sharply localized, a correlation technique Ihas been implemented using a "hard-wired" digital correlator.(l) Responses 
and ongoing background activity are correlated with a saw-tooth waveform 
whose amplitude is a linear function of the stimulus diameter. The equipment 
is operational and a few preliminary experiments have been performed. I 
I(1) J. W. Emde and H. W. Shipton, "An On-Line Correlator for Electro­
encephalography," Electroencephalography and Clinical Neurophysiology, 









F-6. Design and Construction of an Emde Low-Level Calibrator 




I The low-level time-locked calibrator described by Emde(l) is of 
I 
value in the interpretation of visually evoked responses. The calibration 
pulses are generated at biological levels and in series with the recording 
electrodes. In use, a square pulse of known amplitude appears at a fixed 
point after the stimuli. Deviations from the nominal "square-wave" shape 
indicate high and/or reactive electrode impedances. In the presence of 
residual noise, the confidence with which the amplitude may be estimatedI is an indicator of the reliability of the averaged signals. 
I 
The system as described by Emde, while fundamentally sound, dates 
from the vacuu~tube era. A solid-state version has been designed, built 
and evaluated. 
I (l)J. W. Emde, "A Time-Locked, Low-Level Calibrator," Encephalography 

















G. Supporting Activities IActivities at BCL which contribute to the goals of more than one 
of the major programs of the laboratory or to the needs of individual users 
who can benefit from the special expertise of the staff and the inventory 
of computer and test equipment are called supporting activities. Service I 
to users does not follow the usual computation-center pattern. No fee schedule 
has been established, nor is there a centralized facility. Instead, senior 
laboratory staff members consider requests from investigators for assistance Iin biomedical computing. Some investigators may be directed to commercial 
vendors or existing fee-for-service facilities. Others may be advised of 
the unavailability of appropriate technology. The remaining investigators 
may have problems that match the special capabilities within BCL. Usually, I 
such a project is assigned to a staff member with similar previous experience o 
If the project can be completed quickly, the investigator has his results 
and a short note describing the work will appear in the annual report and I 
in the open literature if appropriate. Other projects occasionally prove 
impractical and the best alternative is recommended. A few of the user 
projects may develop into major initiatives within the laboratory. Most Iof the present successful projects began in this fashion and we value the 
opportunities that such projects provide. 
IAlthough the projects reported in this section span a variety of 
topics, they can be grouped conveniently as biomedical applications, system 
development aids, or digital hardware designs. The biomedical applications 
represent new initiatives in which basic exploration is being conducted, I 
which mayor may not ultimately result in a major, long term program. The 
collaborative effort with the Department of Anatomy relating to a microprocessor­
controlled cinemicrography system, and the investigation of new techniques Ifor radiation dose calculation with the Division of Radiation Oncology are 
examples. Even in cases where an extended effort does not materialize, 
the relationships which are cultivated frequently prove beneficial to future 
work. I 
System development aids mostly benefit the BCL staff, but also are 
utilized by other groups where appropriate. An excellent example here is Ithe microprocessor development support system which, although still evolving, 
is an almost routine tool used in data acquisition, signal processing, and 
control applications. System software development for the PC-1200 and the 
AUGAT wirelist program reported here are also widely used in supporting I 
a variety of projects. 
The digital hardware designs reported in this section are frequently I' 
one-time, special purpose designs. The design of electronic switching equipment 
for peripheral access fits this description. In contrast, other designs 
may have wide appeal and construction of multiple copies can easily be en­ Ivisioned. The USD (Universal Storage Device) is such a design and is widely 










G-L Microprocessor Development SupportI 
Personnel:	 G. J. 
Ro M.I	 M. W. S. A. 
R. K. 








I Support: RR 00396 
Our microprocessor development support includes a FORTRAN-based cross­I assembler, FOCRAS, intelligent console, InC, and a small library of "standard" M6800 system modules. At present FOCRAS provides cross-assembler support 
for the 6800, 8080, and 6502 instruction sets and is currently operational 
I on Texas Instruments Model 980B, Artronix Modulex, and Digital Equipment Corporation	 Model PDP-II minicomputers. A collection of generally useful 
I 
subroutines into a shared microprocessor library which is accessed by the 
FOCRAS linking loader has been established. The Intelligent Console is 
itself a microprocessor-based instrument which is used to assist both hardware 
and software development of systems based on the 6800 and 8080 microprocessors. 
I
 Minor extensions to both the InC and FOCRAS were made to alyow pro­
gramming of the type 2716 (2K byte) EPROM. Memory test programs(l were 
written to aid in the identification of random access memory (RAM) failures 
I at the chip level. Nonfunctionality, faulty write recovery, access time deficiency and addressing problems are included. 
Preliminary studies have been initiated to determine feasibilityI of extending both InC and FOCRAS support to the 16 bit microprocessors such as the 6800 and the 8086, and to examine commercially available software 
for high-level language support for both 8 and 16 bit microprocessors.
I 
I 
(l)J. K. Montrose, "User's Guide for Memory Test Programs: 













G-2o System Software Development for the PC-1200 I 
Personnel: S. A. Garfield, BCL 
G. H. Brandenburger, BCL 
D. C. Sawyer, A.B., Radiology I 
S. M. Shatz, BCL 
Support: RR 00396 I 
Final versions of as/pc and BCL/LIB (PR 14, G-2) were released in I 
August, 1978. Development of a new operating syytem then begano The new 
system is called BDOS, for BCL Disk Operating System. It represents a merger 
of as/pc and BCL/LIB with extensive modifications, enhancements, and additions. I 
The major motivating factors for the new system were: 
1)	 as/pc commands and routines did not incorporate the bank structure 
of the BCL disk. I 
2)	 as/pc files could not be longer than 1019 blocks. 
3)	 Redundant copies of as/pc were required on the BCL disk, thus I 
filling it needlessly. 
4)	 as/pc could not search more than one index for a file o I 
5)	 The as/pc date code would expire at the end of 1979. 
IThe	 design objectives for BDOS were: 
1)	 All commands and routines should be able to access the full
 
disk by adding bank arguments.
 I 
2)	 Files should not be restricted in length, but should be segmented 
to allow easy backup on LINC tape. I 
3)	 Compatibility with as/pc file structure should be maintained. 
4)	 Commands should appear to work the same way as they did in as/pc I 
through the use of appropriate default actions. 
5)	 Only one copy of the operating system should be required on I 
a disk o 
6)	 Files should be allowed to reside anywhere on a disk and should 
be searched for by the operating system. I 
7)	 The system date should continue beyond 1979. I 
8)	 Performance of the system should be improved in speed, memory 
usage, functionality, and ease of use. I 





I BDOS was first released in January 1979. A second release came in April, 1979. BDOS requires a PC-1200 with a floating point unit and 12K 
words of memory. It makes full use of the BCL disk but does not require 
I such a disk. BDOS can run on LINC tape, LINC DISK, or diskette. The system is supplied on two LINC tapes and there is also a separate documentation 
tape. 
I Some of the key features of BDOS are:
 
1) All relevant commands and routines have a bank argument.
 
I 2) A search table defines the order in which indexes are searched 
for a file. 
I 3) Module lists allow arbitrarily large files to exist. 
4) A base year allows years through 1999.I Major changes made to OS/PC include: 
I 1) The ability to print a file while simultaneously using the text editor was added. 
I 2) The FORTRAN compiler now optionally produces in-line one-dimensional subscripting and has four new format types. 
I 
3) The linking loader now links two to three times faster and can 
find relocatable modules on any set of units by using the search 
table. 
I
 4) BCL/LIB has been added.
 
The system is configured as follows: 
I I. Commands (46) 
A. Programming
I 1. Text editor and overlapped print utility 
2. FORTRAN compiler 
I 3. Assembler 4. Linking loader 
B. SystemI 1. Batch monitor 
2. Exit 
I 3. Set date
 4 0 Set memory site
 
5. Set monitor 







C. File I 
1. Save file 
2. Copy file or blocks 
3. Compact/update, copy unit I 
4. Module list copy/delete 
5. Library merge/split 
6. Dump/edit I7. Compare files or blocks 
D. Index I 
1. Index display, file deletion 
2. Index information 
3. Index concordance I
4. Index update 
5. Create, destroy, rename index 
6. Rename, update, delete, allocate index entry I 
E. Manuscript 
1. Print I 
2. List all 
3. Update 
4. String substitute I 
F. Search 
I1. Find all occurrences of file 
2. Search for manuscripts
 
30 Help (list documentation)
 
4. Load programs I 
G. Special I1 0 Floating point conversion 
2. Display converted knob values 
3. Display hardware configuration 
4. Disk formatter I 
50 Create loadable tape 
6. Mag tape map 
7. Mag tape dump I 
8 0 Mag tape read 
9. Mag tape write 
10. Mag tape plot I11. Universal storage device read 
12. Plot vector file 












 II. Runtime library (303 entry points, 207 relocatable modules)
 
A. Inline (6) 
B. System (28)I C. Index (9)
 D. Overlay (3)
 
E. File I/O (12)

I
 F. Peripheral and Control (11)
 G. Character I/O (33) 
H. Character String Processing (11) 
I
 I. Scope Display (13)
 J. Logical (6) 
K. Mathemati.cal (63) 
L. Data Conversion (23)I M. Data Storage (15)
 N. Keyboard Handler (4)
 
O. Mag Tape (3)
 
I
 P. Universal Storage Device (1)
 Q. Terminal (4) 
R. Pen Plotter (25) 
I
 S. Versatec Generation Phase (25)
 T. Versatec Plot Phase (8) 
III. Work Areas (4)
I A. Editor text 
B. FORTRAN compiler output 
I C. Assembler output D. Linking loader output 
IV. Documentation (46 files)I 
I 
One of the major areas of effort was the software package for use 
of the Versatec printer/plotter. This package allows users to produce plots 
by using calling sequences analogous to those used for scope displays. 
I 
A file containing vectors is created in a user program. It can then be 
sortpd, rasterized, and plotted using the plot command. Plots can be directed 
to the scope or to any model of Versatec plotter up to 20 inches wide. 
BDOS has been well-received and is now in use at BCL, Radiology, 










G-3 A Universal Storage Deviceo I 
Personnel: R. W. Hagen, BCL 
R. J. Arnzen, BCL 
M. W. Browder, BCL IS. R. Phillips, BCL 
B. F. Spenner, BCL 
Support: RR 00396 I 
During the past year, several medical research activities have utilized I
the Universal Storage Device (USD) as a convenient tool for acquiring, storing, 
and transferring information. In two situations, the USD was applied to 
the crucial first step in synthesizing instrumentation systems when medical 
objectives are transformed into a set of system problem definitions. The I 
problem definitions become the basis for algorithm definitions. The degree 
to which these definitions reflect the real medical objectives has much 
to do with an activity's ultimate succeSS:- The analog acquisition capabilities I 
of the USD were used to refine those initial system definitions for both 
the Visual Evoked Response and Thermodilution Cardiac Output activities 
as reported in F-l and C-9 respectively. The USD's analog signal acquisition Ifeature enables the user to store digitized analog signals on floppy disk 
media for subsequent retrieval over a standard RS-232 serial communications 
interface. In the two projects just mentioned, analog signals were acquired 
using existing laboratory instrumentation. These data are then retrieved I 
by a minicomputer system in order to analyze and refine problem and algorithm 
definitions for new and ongoing research activities. I 
The Intraocular Pressure Measurement activity, described in C-4, 
applies the USD in two roles. The first role is as a bootstrap loader for 
the TI-980 series minicomputer. Through the use of the USD's digital data Iacquisition, storage, and retrieval features, application programs are 
transferred from a program development system to a distant instrumentation 
system. When the instrumentation system is completed, the USD's analog 
signal acquisition and portability features will be used to transfer experimental I 
information from an ophthalmology laboratory to one of BCL's minicomputer 
systems where physiological modeling work will be carried out. IThe past year has seen the construction of five USD's using new dual­
sided, double-density floppy disk drives. The new drives have doubled the 
USD's storage capacity. Two USDs are fully operational while the remaining Ithree await the delivery and evaluation of alternate power supplies. Packaging 
and weight considerations suggested modifications in the original power 
supply configuration. A checkout procedure has been perfected which, in 
addition to reducing checkout time, revealed minor hardware and software I 
problems that were subsequently corrected. Instrument documentation has 
improved. A User's Guide to the Universal Storage Device has been prepared 
and will soon be released as a BCL Monograph. The disk controller design Iin the USD was utilized in the implementation of instrumentation systems 
for the study of Visual Evoked Responses and Extracellular Cardiac Potentials 
as reported in F-l and C-3 respectively. I 










Early results indicate that USD-to-USD, floppy disk media compatibility
 
may be realizable within this set of instruments. A minor change to USD
 
software was recently completed. This change enables the USD to respond
 
to the ASR33 paper tape loader that is resident as firmware in TI-980s.
 
As a result, first bootstrap and then application programs can be loaded 
into stand alone TI-980s. Suggestions for other enhancements which makeI the USD a more useful tool in support of specific activities are encouraged and will be considered for future incorporation. 
I 
I G-4. Radiation-Treatment Planning 
Personnel: K. B. Larson, BCL 
I W. C. Chen, BCL S. A. Garfield, BCL 
V. W. Gerth, Jr., BCL 
I R. L. Hill, III, M.S., Radiology R. G. Jost, M.D., Radiology 
C. A. P~rez, M.D., Radiology 
S. C. Prasad, Ph.D., RadiologyI J. A. Purdy, Ph.D., Radiology D. C. Sawyer, A.B., Radiology 
I Support: RR 00396 Washington University 
I (1)We have completed our validation of the mathematical model that 
is the basis of our method of calculating absorbed dose in the presence 
of inhomogeneities (PR 13, 1-3; PR 14, G-6). For this purpose, we comparedI our computed values of absorbed dose with the published experimental results 
I 
of Young and Gaylord, (2) who used 5-cm absorbing blocks of widely varying 
electron densities in a water phantom to simulate the effects of inhomogeneities. 
Since our intent was to verify the physical validity of our dose-calculation 
I 
model, we employed exact analytical expressions rather than numerical approxi­
mations for evaluating attenuations of primary and scattered radiation along 
ray paths in the absorbing media and in water. The measurements of Young 
and Gaylord(2) used in our previously reported validation work (PR 13, 1-3) 
I 
were those taken along the central axis of a 10- by 10-cm 60Co gamma-ray 
field at varying depths below inhomogeneity blocks spanning the entire field. 
The average fractional deviation between their data and our results calculated 
I 
for points on the central axis was 0.2%. Our subsequent validation calculations, 
the results of which we report here, correspond to their measurements in 
which blocks spanned only one-half the radiation field and with dosimetry 
points off the central axis. As was the case for the whole-field central-
axis results, those for the less symmetrical configurations also show excellent 







After confirming the physical validity of our absorbed-dose model, 
we next wished to determine whether an exclusively numerical implementation I 
of it, which would be obligatory for actual clinical use, would lead to 
unacceptable degradation of accuracy in the computed results. We therefore 
wrote a program for the PC that employs stepwise summations of incremental Iattenuation for three-dimensional electron-density matrices of arbitrary 
shapes, sizes, and density distributions. When we tested this numerical 
implementation of our model against both the symmetrical and the asymmetrical 
Young-Gaylord phantom data, we found relative numerical concordance of very I 
nearly the same quality as that achieved with the analytical implementation. 
The largest discrepancy between experimental and theoretical results was 
107%; this occurred with the asymmetric configuration for a point 2.5 mm I 
from the edge of the inhomogeneity shadow, and is probably attributable 
to the dispersive effect due to the finite size (8-mm diameter) of the 
ionization chamber used for the dosimetry. (2) I 
Because of the success in validation and numerical implementation 
of our model, we expect it to perform well in actual clinical use, and are 
encouraged to proceed with investigation of special-purpose high-speed digital I 
hardware to render the method practical. 
I 
(l)Ko B. Larson and S. C. Prasad, "Absorbed-Dose Computations for Inhomogeneous 
Media in Radiation-Treatment Planning Using Differential Scatter-Air Ratios," 
Proceedings of the Second Annual Symposium on Computer Applications in Medical I 
Care, IEEE Computer Society, Long Beach, California, PP. 93-99, 1978. 
(2)M. E. J. Young and J. D. Gaylord, "Experimental Tests of Corrections I 
for Tissue Inhomogeneities in Radiotherapy," British Journal of Radiology, 




G-5. Physiologic Signal Processing 
Personnel: R. E. Hitchens, BCL I 
J. S. Cheng, BCL 
C. N. Mead, BCL 
B. F. Spenner, BCL IL. J. Thomas, Jr., BCL 
Support: RR 00396 I 
Work has continued on investigation of the characteristics of electro­
cardiograms (ECG) in the frequency domain (PR 14, G-7, A-I). Additional I
signal processing techniques have been used to extract features in order 
to classify individual QRS events. Troublesome baseline shifts and high I 





frequency noise are now removed from the ECG using a finite impulse responseI bandpass filter (1-30 Hz) implemented with a hardware convolution filter 
I 
(G-6). Several features of the amplitude spectrum have shown promise for 
the detection of PVCs: 1) the "first spectral moment" of the normalized 
spectrum from 6 to 24 Hz, 2) the value of the maximum coefficient of the 
I 
normalized spectrum, 3) the location of the maximum coefficient of the spectrum 
from 2 to 6 Hz, 4) the location of the maximum coefficient of the spectrum 
from 6 to 25 Hz, and 5) the phase of the maximum coefficient. Several one 
hour segments of ECG recordings have been analyzed using these features 
with encouraging results. 
I We are continuing to gather statistics on the use of these features for PVC detection by analyzing a diverse set of one hour ECG recordings. 
I 
I G-6. A High-Performance Digital Convolution Filter 
Personnel: J. A. Ritter, BCLI Support: RR 00396 
I Recent interest in digital signal processing has resulted in several 
applications requiring rapid convolution capabilities. Even with hardware 
arithmetic instructions, performing convolution in software is prohibitivelyI slow for many applications. The desire for higher speed prompted the develop­ment of a hardware realization of the traditional digital convolution algorithm: 
I Y(i) = L H(j) * X(i-j) 
j=l, 2, ••. 
I In this expression, the H(j) are a set of fixed coefficients, and the XCi) 
and Y(i) are the input and output signals, respectively. 
I 
I As implemented, the DCF can be programmed to perform convolutions 
of up to 1023 points. For generality, the coefficients are stored in read/write 
memory, providing the user with a flexible tool. The DCF performs convolutions 
at the rate of 200 nanoseconds per iteration. Therefore, a 256-point con­
volution is performed in approximately 51 microseconds, while a full, 1023­
point, convolution requires about 205 microseconds. 
I 
I Two applications are currently being explored. First, a DCF interfaced 
to the Argus/2H system is being used to digitally filter electrocardiographic 
signals before processing (A-2). A second, planned application is to use 









G-7. Digital Data Communication IPersonnel: D. Lo Snyder, BCL 
G. J. Blaine, BCL 
ISupport: RR 00396 
Washington University 
I 
Substantial experience with many aspects of digital data communication 
has been gained over the years in various Resource projects. For example, I 
source digitization, source compression, error control, and local networking 
techniques were important facets of projects spanning high speed electrocardio­
graphic processing, patient monitoring in the surgical intensive care unit, 
and medical information systems. This experience is presently being transferred I 
to seniors and graduate students in Electrical Engineering and Computer 
Science through a course, EE 420, Digital Data Communication. The topics 
include source digitization, source compression for efficient transmission I 
and storage of data, error control for reliable transmission and storage 
of data, data transmission standards and protocols, and data transmission 
architecture. Course notes are being written in collaboration with Professor I 
James Massey of the University of California at Los Angeles. 
I 
G-8. Raster Scan Video Technology IPersonnel: V. W Gerth, Jr., BCLo 
G. Ho Brandenburger, BCL 
J. R. Cox, Jr., BCL I 
Support: RR 00396 
I 
The requirement for information display continues to be a major con­
sideration in many systems under development or in the planning stages at 
BCL. In the past these needs have been met by CRT terminals, x-y refresh Idisplays, both storage tube and silicon target scan converters, direct-view 
x-y storage tubes, and special-purpose raster scan systems for display of 
physiological waveforms. All these systems have strengths and weaknesses 
which make them more or less suitable for specific applications. I 
Raster scan video technology is attractive for a number of reasons. 
The cost of a raster scan monitor is considerably less than a comparably I
sized x-y monitor of similar video bandwidth. Another economic factor is 
a result of the mass production of CCTV transmission hardware and related 
accessories. Also, as a result of the widespread use of the CRT terminal Ias a computer peripheral, integrated circuit manufacturers now provide LSI 










I The added dimension of color display, made practical by the home entertainment industry, is another motivation for considering raster scan video technology for new display systems. Color display in x-y systems is limited almost 
exclusively to beam penetration tubes which are both expensive and criticalI in adjustment while providing only a limited range of color. The continuing reduction in price of digital memory devices also affects the cost of a 
raster scan display system in a favorable way. Because of the refresh re­
I quirement on a rigid schedule, virtually all raster scan systems employ integral memory in order not to burden the computer main memory with significant 
overhead. 
I There are currently three areas of activity relating to raster scan display technology at BCL. The first goes back to the display system developed 
for the SICU monitoring project (PR 8, D-2) and a color display system used 
I in operating room monitoring (PR 10, C-14). This activity is aimed at the moving, non-fade display of physiologic waveforms. A special purpose system 
addressed to this class of needs is justified because of economics and human 
I factors in the monitoring environment. Another more recent development activity is addressed to a wider variety of needs and promises to eliminate 
many of the instability and alignment problems inherent in storage tube 
and silicon target scan converters by using semiconductor digital storage.I Finally, techniques for overcoming or reducing some of the artifact inherent in raster scan displays are being investigated by theoretical analysis and 
experiment. 
I 
I Many of the design features employed in the BCL systems for display 
of physiologic waveforms are now present in commercial systems. The color 
display system mentioned above, in fact, is being transferred and integrated 
into the new Barnes Hospital West Pavillion operating room complex for cardio­
thoracic surgery. It is with aome satisfaction that we note that this system, 
designed over five years ago, is still considered to be state-of-the-artI by the users. 
I 
The general purpose display system (G-9) under development last year 
is now reported separately and has met all expectations. A few of the I/O 
options remain to be completed, but the system in its current state is being 
used in support of Ultrasonic Tomography (B-1). 
I As suggested earlier, the discrete nature of raster scan displays 
I 
is responsible for potentially annoying artifact. Even if wideband monitors 
are used to allow good response along a scan line, the finite number of 
scan lines imposes a type of "sampling" process on an arbitrary image. 
I 
The nature of some of these artifacts and potential means of reducing them 
are being investigated. One approach under consideration utilizes beam 
shaping by Z-axis modulation derived from an algorithmic procedure accomplished 
dynamically and, if successful, would trade high speed hardware for the 
large memory requirements of a high resolution bit map architecture. 








is a development which promises to become a useful tool in raster scan 





G-9. A General Purpose Digital Display System: Digivision 
Personnel: W. A. Roloff, BCL IG. H. Brandenburger, BCL 
T. J. Marshall, BCL 
B. Zvolanek, BCL I 
Support: RR 00396 
I 
A recent survey of the Washington University Medical Center revealed 
a wide range of need for alphanumeric-graphic displays. Detailed analysis 
of the survey indicated that a particular subset of needs was common to Ia substantial number of applications and could be met by a modest video-graphic 
device with gray-scale display capability. A vendor survey revealed that 
while all the observed needs could be met with commerically available devices, 
a device fulfilling our particular set of minimum requirements would necessarily I 
contain many unwanted features, and at a very large cost (>$10,000). 
A final survey revealed a growing number of vendors supplying digital I 
memory modules capable of providing continuous readout at rates compatible 
with the refreshed-video resolution required: 512 by 512 display elements. 
The 512 by 512 by 1 bit memory modules chosen were inexpensive and required Ionly modest external logic to generate standard composite video signals. 
The resulting requirements to be fulfilled by the new video display 
system (Digivision) are briefly outlined below: I 
I.	 Video Requirements IA.	 512 by 512 picture element resolution (512 horizontal by 480 
vertical for standard 525 line video). 
IB.	 Gray-scale capability expandable in I-bit increments to 8-bits 
resolution. 
II. Interface Requirements I 
A.	 General purpose medium speed «60~s per command) intelligent 
parallel I/O port. I 
B.	 Low speed RS-232 intelligent I/O port for standard interfacing 
common to most host computers. I 





C. Low speed IEEE-488 (GPIB) bus intelligent port.I D. Medium speed (1.6~s per command) parallel I/O port. 
I
 E. High speed video-rate input (for use with video-rate A/D con­
verters). 
I
 III. Graphic Support Intelligence (supports IIA through IIC).
 
A. Vector generation. 
I B. Character and page-formatted character handling.
 
C. Gray-scale raster generation with programmable pixel size.
 
I D. Electrostatic (Versatec 1200 compatible) plotter hard copy output.
 
I
 E. Programmable and front panel controlled diagnostic routines.
 IV. Cost approximately $5,000 for basic 4-bit gray scale resolution.
 
I The video display with 4-bit resolution using the medium speed parallel
 I/O port (see II-A) has been used extensively in the ultrasonic tomographic 
scanner (B-1, B-2). Digivision has been incorporated successfully in the 
I PC-12 Versatec software package (G-2). Implementation of the remaining 
I 
I/O ports and software is underway.
 
Future applications at this laboratory include:
 
I. Real-time digital echocardiography (A-17). 
II. Ventricular boundary extraction (C-7).
I Other future applications include use in electron microscopy and 













G-IO. A System for Multiplexed Time-Lapse Cinemicrography of Cultured Cells I 
Personnel: V. W. Gerth, Jr., BCL 
R. J. Arnzen, BCL 
R. R. Heye, Radiology IE. W. Kiebler, Radiology 
L. J. Tolmach, Ph.D., Anatomy and Radiology 
ISupport: RR 00396 
CA 04483 
I 
Time-lapse cinemicrography is a powerful tool for the study of cell 
growth and proliferation, and of the response of cultured cells to radiation 
and/or chemotherapeutic agents. A time-lapse system that has been used Ifor some time in the Anatomy Department employs a light microscope, 16 rom 
motor-driven camera, and a,solid state timer to expose single, sequential 
frames every few minutes over a period of several days. The resulting time­
lapse film is analyzed, using a film viewer whose frame counter is interfaced I 
to a PDP-II computer. The operator enters data related to cell activity 
via PDP-II interactive software. ISince the camera-microscope system is configured for single field 
operation, all experiments must proceed in serial fashion. In order to 
remove this single-field limitation and allow multiple experiments to proceed Iin parallel, a new system has been designed and is currently under development. 
The new system allows multiple field operation through the use of 
a motor-driven x-y stage controlled by an M6800 microprocessor. The microscope I 
fine-focus is also controlled by the microprocessor to allow for irregularities 
in the dish surface from field to field. The original camera could have 
been used, but some type of post experiment sorting of frames would have Ibeen required in order to generate n separate time-lapse films for n separate 
fields of interest. As an alternative, a new camera has been designed which 
is capable of fast, random access to any frame under microprocessor control. 
This allows the frames to be sorted at the time of exposure so that analysis I 
can begin immediately following film development. Since the microprocessor 
also controls the camera shutter, exposure time can be varied conveniently 
with software parameters. I 
The operator interacts with the system during experiment setup through 
a control console which contains a joystick for x, y, and fine-focus control Iand buttons for mode selection and parameter entry. As each field is selected 
and focused, its coordinates are stored for later retrieval. The film length, 
and exposure interval and duration, are selected with rotary hex-encoded 
switches. After the setup is complete and verified by the operator, selection I 
of the automatic mode turns control over to the microprocessor which moves 
the stage to each field in sequence, focuses, positions the film to the 









I The fabrication of all hardware and the adaptation of the microscope and automatic stage for limit switches is complete. Most of the software 
modules have been designed, coded, and tested. The final software employing 





 G-ll. A Microprocessor-Based System for Time-Lapse Film Processing 
I Personnel: V. W. Gerth, Jr., BCL R. J. Arnzen, BCL 
E. W. Kiebler, Radiology 
I L. J. Tolmach, Ph.D., Anatomy and Radiology S. Von Rump, Radiology 
I Support: RR 00396
 CA 04483
 
I In order to provide a convenient means for the processing of 16 mID 
I 
film generated by the Time-Lapse Cinemicrography system (G-lO), a system 
has been designed which employs an M6800 microprocessor as a control element 
to generate signals for moving the film through a developing tank and opening 
and closing valves for filling and draining developing solutions. The timing 
is also under control of the processor. 













G-12. Computers in Ophthalmology Meeting IPersonnel: R. H. Greenfield, BCL 
A. Colenbrander, M.D., Pacific Medical Center 
W. M. Hart, Jr., M.D., Ph.D., Ophthalmology IM. A. Kass, M.D., Ophthalmology 
C. A. Kulikowski, Ph.D., Rutgers University 
B. H. McCormick, Ph.D., University of Illinois at Chicago Circle 
A. M. Potts, Ph.D., M.D., University of Louisville I 
D. R. Reddy, Ph.D., Carnegie-Mellon University 
A. Safir, M.D., Mount Sinai Medical Center 
C. Y. Suen, Ph.D., Concordia University IL. J. Thomas, Jr., BCL 
J. T. Wilensky, M.D., University of Illinois at the Medical Center 
Support: IEEE Computer Society I 
Washington University 
I 
The first "Computers in Ophthalmology" meeting was held at Stouffer's 
Riverfront Towers, in St. Louis on 5-6 April 1979. One hundred and twenty­
five people attended from the U.S., Canada (6), England (2), Germany (1), Iand Italy (1). Eight sessions (Clinical Data Bases, Perimetry, Human Factors 
& Coding Schemes, Automated Patient Testing, Computer Based Decision Making, 
Devices & Computer Aids, Image Processing, and Delivery of Ophthalmic Services) 
were sequentially presented in two days. Each session had a session keynote I 
lecture and from four to six papers, for a total of 48 presentations including 
an after-dinner meeting keynote lecture on "Knowledge Based Systems and 
Medical Signal Processing" by Raj Reddy. After the meeting, short tours I
of BCL and Ophthalmology labs were conducted. Proceedings of the meeting 




G-13. An LSI-II Microcomputer System for Laboratory Automation 
Personnel: M. C. Jost, BCL IW. F. Holmes, BCL 
D. L. Rempel, BCL 
ISupport: RR 00396 
This project is concerned with the development of a flexible set I
of hardware and software modules for use in automation of control, data 
collection, and data processing for certain analytical instruments used 
routinely in biochemical research, such as amino acid analyzers, gas chromato­ Igraphs, spectrophotometers, and ultracentrifuges. These applications typically 
require on-line data acquisition and control with modest speed requirements. 
I 





I Most applications require relatively simple on-line data reduction, although some require more sophisticated post-run calculations. Costs must generally be kept to a few thousand dollars, even less for the simpler instruments. 
I Previous reports CPR 12, F-l; PR 13, F-l; and PR 14, G-12 and G-19) have described the selection of system components and the development of 
hardware and software modules for analog input, keyboard entry, and printer 
I and plotter output. To permit quick and easy development and testing of hardware and software modules, we have assembled a dual floppy disk-based 
development system housed in a 24Yz in. x 25Yz in. x 36Yz in. mobile cart. 
I A sliding shelf holds the Keytronic C-1400 alphanumeric keyboard, Bowmar TP-3l00 Thermal Printer, and Axiom EX-8l0 plotter. A specially-designed 
computer drawer immediately below the sliding shelf contains the LSI-II 
central processor, RAM and core memory, parallel and serial I/O modules,
I the floppy disk interface, and interfaces for analog input, the keyboard, 
I 
printer, and plotter. The Charles River Data Systems FDll Dual Floppy Disk 
unit is housed below the computer drawer, with system power supplies located 
on the base of the cabinet. The DEC VT55 CRT terminal is placed on the 
top of the mobile cart, and terminals for connecting a Teletype are provided 
at the rear of the computer drawer. This cart may easily be moved to the 
site of the laboratory instrument, and is of a size and shape which shouldI permit on-site system development, maintenance, or improvement without inter­fering excessively in routine laboratory and instrument operation. 
I Once an application is complete, hardware for that application will be housed in a box with a control and monitoring panel on the front and 
connectors in the rear for analog and digital I/O and whatever peripheral 
I
 devices are required, e.g. keyboard, alphanumeric printer, and/or plotter.
 This dedicated system will be left at the instrument site. 
I Additional software modules have been written for data acquisition and for graphic display on the VT55 terminal. During data acqusition the digitized signal can be presented simultaneously on any combination of the 
I 
Bowmar printer, the Axiom plotter, and the VT55 terminal, yielding both 
immediate observation of data collection and a hard copy plot of the values 
obtained. 
I We are beginning work on our first ~pplication, a high speed, sensitive amino acid analyzer developed in Dr. Leonard Banaszak's laboratory, and 
now used routinely by Dr. William Frazier. A very recent development has 
greatly broadened the potential impact of our laboratory automation projects.I The Department of Biochemistry has just been awarded funds for a DEC VAX 11/780 computer to serve as a departmental resource. This computer will 
function as a large multiuser system with adjustable access priorities. 
I
 Adequate memory, disk, and tape storage will be available to serve the needs
 of the many departmental users. The VAX is not designed for high speed
 
real-time data acquisition or control. Thus on-line instruments must have
 
a data buffer with preprocessing, and a controller. The LSI-II-based systems




mass storage will be required, the VAX supplying the additional storage.
 










G-14. A Wiring List System for Augat Hardware I 
Personnel:	 J. A. Ritter, BCL 
M. W. Browder, BCL ISupport:	 RR 00396 
IOriginally developed in 1976, the wiring list system was rewritten 
in DEC Standard MUMPS in 1978. In the fall of 1978, several users expressed 
interest in being able to use the wiring list system for design configurations 
other than the Augat cards for which it was originally structured. A set I 
of utilities was developed to allow the user to create a cross-reference 
dictionary between the desired configuration and an analogous Augat configuration. 





G-15. Biological Amplifiers: A Reappraisal 
Personnel:	 H. W. Shipton, BCL I 
Support:	 RR 00396 
Washington University I 
Most biological amplifiers are variations on the so-called "Differential 
Amplifiers," described first in the 1930's. These have been adapted to I
use solid state devices, which in this application, are not always superior 
to vacuum tubes. 
IThe use of computers to process biological signals argues for signal 
conditioning amplifiers that are computer controlled and which can serve, 
without modification a wide range of applications. An experimental study 
is in progress to develop a "Universal" amplifier. Gain and bandwidth are I 
set by standard logic levels and several modes of operation are possible. 
In the "AC coupled" mode only a single time constant, outside the signal 












I G-16. Design Study for an Optical Da~a Acquisition Module 
Personnel: J. S. Massey, BCL 
G. J. Blaine, BCLI V. W. Gerth, Jr., BCL M. J. Schlesinger, Ph.D., Microbiology and Immunology 
I Support: RR 00396 
I The acquisition and processing of optical data are used in a number of biomedical projects. Such data may be classified as either image data 
or photometric data. 
I One technique W?fch uses photometric data is the enzyme-linked immuno­
I 
sorbent assay (ELISA), ) which operates on a principle similar to the 
radioimmunoassay (RIA). In the ELISA, enzymes are linked to antibodies 
or antigens to form a complex which has both immunological and enzymatic 
activity. The enzyme labels are detected by the addition of a chromagenic 
I 
or fluorogenic substrate, and the amount of color change or fluoroscence 
provides a measure of the quantity of antigen or antibody present. 
I 
Image data are generally involved when some form of linear or spatial 
measurement is being made. The analysis of angiographic data (C-7) is one 
such project which has been pursued at BCL. 
I 
Other applications use both types of optical data. One example is 
autoradiographic analysis (F-4) which can be done with photometry or silver 
grain counting techniques. Another is banded-chromosome karyotyping, in 
which chromosomes are classified by size, shape, and intensity profile. 
In fluoroscent antibody techniques, the fluoroscent intensity of a specifiedI area (e.g. a cell nucleus) provides a measure of the amount of antibody present. 
I Acquisition of photometric and image data with a single system poses 
I 
a variety of problems. Conventional television cameras and flying spot 
scanners have photometric response curves which are far from ideal, and 
tend to show shading, a variation of response across the image area. Such 
devices require considerable modification to make them acceptable for photo­
metric data acquisition. 
I Photodetectors used to acquire image data, on the other hand, must 
I 
detect the light from one small portion of the sample at a time, and this 
requires using highly sensitive detectors. A sophisticated mechanical stage 
is used to move the sample, and some means of keeping track of the stage 
position is also necessary. All of these features make such systems expensive, 
as well as considerably slower than optical scanning systems. 
I Television cameras with solid state imaging devices have been introduced in the past few years, and several of the newer ones have image resolutions 








are fabricated on a single piece of silicon and are scanned using solid 
state techniques, which results in good photometric response and virtually I 
no problems with shading. In addition, one such camera is available with 
a digital data output, eliminating the need for high-speed analog-to-digital 
converters when the data are to be digitally processed. I 
In June, we began a design study for a general-purpose optical data 
acquisition module which will use a solid state array video camera. The 
module will be able to capture and store a video frame from the camera, I 
perform a limited amount of preprocessing, and transfer the data to a host 
system, storage, or display device. I 
We are examining a variety of potential applications, such as those 
listed above, so that we may draw up a list of desirable features for the 
module. Such features include preprocessing algorithms, the amount and Itype of operator interaction, and the ability of the module to interface 
with various systems, such as the Clinical Physiologic Research System (C-l). 
These features will be evaluated in light of engineering constraints such 
as computational power, memory size, speed, and cost, before design of the I 
module begins. 
I 
{l)Ao H. W. M. Schuurs and B. K. van Weemen, "Enzyme-immunoassay," Clinica 
Chimica Acta, vol. 81, pp. 1-40, 1977. I
 
I
G-17. An 160 Megabyte Disk Interface for the IBM System/7 
Personnel: R. E. Hitchens, BCL I 
Support: RR 00396 
I 
The design of an interface between the System/7 channel interface 
and a System Industries Model 9500 disk system has been completed CPR 14, 
G-15). Construction of the interface is finished, and testing is partially Icomplete. The second 80 megabyte drive has been added, allowing a 












I G-18. Implementation of an Instructional Model of Pulmonary Mechanics for Teaching 
Personnel: Ro D. Livengood, B.S., Electrical Engineering
I L. J. Thomas, Jr., BCL 
I 
Support: RR 00396 
Washington University 
A computer-aided instructional program was added to the PhysiologyI Department's CAl system. The program provides an educational tool for first year medical students to assist them in learning some of the concepts of 
respiratory ~echanics with emphasis on factors affecting uneven ventilation 
I and "alveolar diadapace." Lung resistance (R), lung compliance (C), and 
I 
respiration rate are the variable inputs to a "two-lung" model in the CAl 
program. For each set of lung conditions, two types of output results are 
produced. One is a numerical display of the amplitude of breathing and 
the alveolar pendelluft and total ventilations which attend the RC properties 
specified for the two lungs individually. The other is a pictorial display 
of circles changing shape to simulate, in real time, the volume changesI of the lungs during respiration. 
I
 
I G-19. Electronic Switching for Peripheral Access Personnel: S. R. Phillips, BCL 
I Support: RR 00396 
I Since the cost of peripheral devices represents a significant portion of most minicomputer systems, there is a desire to share peripherals where 
I 
feasible. This sharing requires a means of switching the peripheral between 
two or more computers. During the past year, three such systems have been 
implemented and electronic rather than electromechanical switching was employed 
for reasons of reliability and maintainability. Each unit also employs 
its own internal power supply so no external power is required from either 
I peripheral or computer. Peripheral drivers are used where long cable runs are needed to bridge the distance between computers and peripherals. 
I One of the units is used to allow the sharing of a Centronics printer between multiple computers. Another unit allows the sharing of a Versatec 
Printer/Plotter as well as a Centronics printer. The third unit provides 









G-20. General Purpose High Speed Digitization System for the PC-12 IPersonnel: G. Ho Brandenburger, BCL 
J. Ro Klepper, BCL 
ISupport: RR 00396 
A Biomation 8100 fast-transient-recorder was interfaced to the PC-12 I 
in conjunction with the CUTAR ultrasonic tomographic scanner (B-1). The 
Biomation/PC-12 interfacing was expanded and fully supported with a FORTRAN­
accessible software library to form a general purpose programmable high I
speed data acquisition system. 
The full repertoire of Biomation 8100 remote control functions is 
supported by FORTRAN-callable subroutines. The system functions include: I 
1)	 8-bit resolution analog-to-digital conversion of waveforms up 
to 20 MHz, with sampling rates up to 100 MHz. I 
2)	 Conversion bursts programmable from 1 to 2024 samples and buffered 
in the Biomation 8100 internal memory. I 
3)	 Programmable: 
a) input range and offset (.05 volts to 5 volts), I 
b) sample interval: .Ol~sec to 5 seconds,
 
c) trigger range, offset, slope and coupling,
 
d) dual time base rates and dual trigger delays.
 I 
The currently available software library consists of the following 
FORTRAN-callable subroutines and BDOS commands (G-2): I 
1)	 Sample buffer read subroutine (transfers 2000 samples in 120 ms). 
2)	 Biomation 8100 status-read subroutines. I 
3)	 Programmable-function preset and control subroutines. I4)	 Digital oscilloscope command with keyboard and knob control 
and digital sample value display. 
I5)	 Waveform spectrum analyzer command with graphic and tabulated 
output. 
6)	 Biomation 8100 (8-bit two's-complement) to PC-12 (12-bit one's I 
















(l)R. K. Elsley, "Accurate Ultrasonic Measurements With the Biomation 8100
 
Transient Recorder," abstract in "Program and Abstracts, Third International
 
Symposium on Ultrasonic Imaging and Tissue Characterization," National Bureau
 



































VI. INDUSTRIAL COLLABORATION 
IOne of the goals of the Biomedical Computer Laboratory is to foster 
the commercial development of useful medical computer systems. Industrial 
collaboration provides an additional outlet for laboratory developments 
and benefits the staff by keeping it abreast of the practical considerations I 
of reliability, maintainability, and cost. Progress being made in this 
important phase of the laboratory's activities is summarized here. I 
A. Arrhythmia Monitoring. Following evaluation of the Mennen­
Greatbatch ARGUS/SENTINEL computerized arrhythmia detection system, it was 
installed in the Barnes Hospital Coronary Care Unit. Subsequent to the I
successful completion of a battery of acceptance tests administered by BCL, 
it was released to CCU personnel for clinical use. The system has been 
in routine clinical use for over three years. This collaboration has continued 
through sharing algorithm improvements of mutual interest. During the past I 
year, algorithm sharing has been focused on the new PRIMITIVE QRS detector 
reported in project A-I. (BCL personnel: K. W. Clark, C. N. Mead, L. J. 
Thomas, Jr.) I 
B. Collaborative Drug Study. A research project has been in progress 
during the past three years with Sandoz-Wander Inc., for a pilot study to Ievaluate the safety and efficacy of a new beta-adrenergic antagonist, LB-46, 
on ventricular irritability. Following FDA approval of the experimental 
design the study was initiated in May, 1976. This Phase II study consists 
of a double-blind crossover against placebo, of four weeks duration for each I 
of twenty ambulatory patients with twenty or more premature ventricular 
contractions per hour. In addition to the appropriate clinical observations 
and laboratory tests, seven 24-hour Holter tapes have been collected and, I 
as planned, three for each patient have been analyzed via Argus/H. Beyond 
a substantial participation in the study design, the primary role of the 
laboratory is analysis of the Holter tapes. Analyses have included time­ Iof-day independent PVC rates, as well as frequencies of couplets, runs, 
and early PVCs. Preliminary analyses of variance have considered as dependent 
variables the number of couplets, runs, or early PVCs per 24-hour period, 
and the sources of variation as treatment, order of treatment, and patients. I 
The advisability of processing the remaining four tapes per patient before 
completing the statistical analyses, is now under consideration. (BCL 










VII. TRAINING ACTIVITIES 
I 
I 
During the year the Biomedical Computer Laboratory engaged in the 
following training activities: 
Introductory MUMPS Programming Course for Beginners, Fall 1978. 
I A high-level programming language (~assachusetts General Hospital Qti1ity ~u1ti-frogramming~stem - MUMPS), especially well suited for 
medical information systems and other textual and database applications, 
I was presented by Joan Zimmerman, D.Phi1. An Interactive MUMPS teaching program and access to a computer which supports Standard MUMPS were pro­
vided for laboratory exercises. 
I Attending the course were: 
I
 






Thomas J. Dill, B.S.
 









































































Biomedical Computer Laboratory 
Informational Resource Electronics Corp. 
Radiology 
Surgery 






Health Care Research 
Allergy & I~no1ogy 
The Jewish Hospital of St. Louis 
Radiation Oncology 
Lipid Research Center 
Clinical Research Center 
Ophthalmology 
Biostatistics 




Milliken Communication Corp. 
Radiology-Physics 
Biomedical Computer Laboratory 
Radiation Oncology 
Surgical Pathology 
Biomedical Computer Laboratory 







Introductory MUMPS Computer Programming Course for Programmers, Fall 1978 
An introductory course for those having prior knowledge of a MUMPS Idialect or another higher-level computer programming language was presented 
by Dr. Robert H. Greenfield. DSM-ll (~igital ~tandard MUMPS), a popular 
dialect of Standard MUMPS, was used. Study notes and problems were provided. 
Access to Standard MUMPS was provided by the Medical Computing Facilities, I 
Washington University School of Medicine for the purpose of completing 
the assigned programming problems. 
Cathrine A. Branyan 
R. Pat Bucy, B.A.
 
Kristin E. Carey, B.A.
 
Jone Min Chen, M.S.
 




Mike H. Huang, D.Sc.
 
Mary C. Kramer, B.S., ASCP
 
Georgia A. Parkes, M.Mus.
 
George E. Short, Jr., M.S.
 
Attending the course were: I 
Computer Science and Electrical Engineering 
Medical Scientist Training Program Student 
Psychiatry IImmunology 
V. A. Medical Center 
V. A. Medical Center IV. A. Medical Center 
Microbiology, Barnes Hospital 
Rehabilitation 
V. A. Medical Center I 
Introduction to Programming the Laboratory Computer, Spring 1979 IStudents were introduced to computers, hardware terminology, and 
programming. Topics covered included a comparison of different types 
of computers, examples of computer applications, introductory programming 
concepts, and use of a computer operating system. Programming was done I 
using the PC-1200 computer with the BDOS operating system and its FORTRAN 
compiler. The course was taught by Mr. Stanley A. Garfield. 
Attending the course were: 
Lori Adams, M.S. 
David Albee, B.A. 
Chris Anderson-Protzel, M.D. 
Steve Bergmann, Ph.D. 
Isabelle Bohman, M.S. 
Chuck Boylan, B.A. 
Barbara Clark, B.S. 
Lloyd Cook, M.D. 
David Doran, M.A. 
Loretta Findysz, M.S. 
Al Fischer, M.S. 
Howard Gebel, Ph.D. 
Glenn Glasgow, Ph.D. 
Marc Goldford, B.S. 
Lisa Grundhauser, B.A. 
Jason Gutenschwager 
Mike Hartman, B.A. 
Stephen Johnson, M.S. 
I 
Obstetrics/Gynecology ICentral Institute for the Deaf 
Pathology 
Cardiology 
Physical Therapy I 
Pathology 
Diabetes Center 






Central Institute for the Deaf I 














Ram Kakaiya, M.D. 
Phil Kelley, M.A. 
Silvia Lipkin, M.S. 
Steven Luepker, B.S. 
Steve Monroe, B.S. 
Don Murch, B.A. 
Barbara Nash, M.S. 
Patrick Rice, B.S. 
Helen Sullivan, M.S. 
Joseph Udell, B.S. 






Washington University Technology Associates 


















During the year the following seminars 
VIII. SEMINARS 
were sponsored by the 
I 
I 
Biomedical Computer Laboratory: 
"System Design for Data Acquisition 
and Imaging in Neuroanatomy" 
January 16, 1979 
"Introduction/Software Views -­
Microprocessor/Microcomputers" 
April 11, 1979 
"The Tandem Computer System" 
April 19, 1979 
"Support -- Microprocessor/ 
Microcomputers" 
April 26, 1979 
"Aboard the Bus with the M6800 
and the PET" 
May 3, 1979 
"Chips/Cards - 16 Bits and Beyond" 
May 10, 1979 
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I 
Dr. Donald Woodward 
University of Texas Health 
Science Center I 
Dallas, Texas 
IDr. G. James Blaine 
Mr. Stanley A. Garfield 
Biomedical Computer Laboratory 
Washington University Medical School I 
St. Louis, Missouri 
I
Mr. David A. Bridger 
Department of Pathology 
St. Louis University Medical School ISt. Louis, Missouri 
Dr. R. Martin Arthur I 
Mr. Michael A. Browder 
Biomedical Computer Laboratory 
Washington University Medical School ISt. Louis, Missouri 
IMr. Ronald W. Hagen 
Mr. Wayne R. Roloff 
Mr. Sol M. Shatz 
Biomedical Computer Laboratory I 
Washington University Medical School 
St. Louis, Missouri I 
Dr. Robert J. Arnzen 
Computer Systems Laboratory 
and I 
Mr. Richard E. Hitchens 
Biomedical Computer Laboratory 
Washington University I 













































"BDOS: The BCL Disc Operating 
System" 
May 17, 1979 
"A Survey of Word Processing 
Systems" 
May 31, 1979 
"CPRS: Clinical Physiologic 
Research System" 
June 7, 1979 
"Pitfalls in the Development of 
a Large Microprocessor-based 
System" 
June 21, 1979 
"MIST-980 Revisited" 
June 28, 1979 
Mr. Stanley A. Garfield 
Biomedical Computer Laboratory 
Washington University Medical School 
St. Louis, Missouri 
Dr. Barry R. Hieb 
Jewish Hospital 
St. Louis, Missouri 
Mr. Michael A. Browder 
Biomedical Computer Laboratory 
Washington University Medical School 
St. Louis, Missouri 
Mr. Ross K. Hartz 
Biomedical Computer Laboratory 
Washington University Medical School 
St. Louis, Missouri 
Mr. Gerald C. Johns 
Computer Systems Laboratory 
Washington University 







IX. PUBLICATIONS AND ORAL PRESENTATIONS 
IAbbrecht, P. H., Cox, Jr., J. R., and Ferguson, F. P., "Future Directions for 
Biomedical Engineering Research: Recommendations of an Evaluation Workshop 
for the NIGMS Physiology and Biomedical Engineering Program," IEEE Transactions Ion Biomedical Engineering, vol. BME-25, no. 6, pp. 490-493, November 1978. 
Ahumada, G. G., Karlsberg, R. P., Jaffe, A. S., Ambos, H. D., Sobel, B. E., 
and Roberts, R., "Reduction of Early Ventricular Arrhythmia by Acebutolol in I 
Patients with Acute Myocardial Infarction," British Heart Journal, in press. 
Ambos, H. D., Moore, P., and Roberts, R., "A Database for Analysis of Patient IDiagnostic Data," Proceedings of the IEEE Conference on Computers in Cardiology, 
IEEE Catalog No. 78-CH139l-2C, Stanford, California, pp. 365-368, September 
12-14, 1978. I 
Ambos, H. D., Sampathkumaran, K. S., Jones, S. A., and Hitchens, R. E., "A 
Gated Radionuclide Cardiac Imaging System," Proceedings of the IEEE Conference 
on Computers in Cardiology, IEEE Catalog No. 78-CH139l-2C, Stanford, California, I 
pp. 423-424, September 12-14, 1978. 
Arthur, R. M., "Assessment of Electrocardiographic Signal Quality During IAcquisition," Proceedings of the IEEE Conference on Computers in Cardiology, 
IEEE Catalog No. 78-CH139l-2C, Stanford, California, pp. 255-258, September 
12-14, 1978. I 
Arthur, R. M., Hermes, R. E., Thomas, Jr., L. J., Geselowitz, D. B., and 
Oliver, G. C., "Status of the American Heart Association Database," accepted 
for presentation at the IEEE Conference on Computers in Cardiology, Geneva, I 
Switzerland, September 26-28, 1979. 
Bauwens, D., O'Donnell, M., Miller, J. G., Sobel, B. E., and Mimbs, J. W., I
"Quantitative Alterations in Ultrasonic Backscatter in Ischemic Myocardium 
Induced with Collagenase," Clinical Research, vol. 27, p. l52A, 1979 (abstract). 
IBergmann, S. R., Clark, R. E., and Sobel, B. E., "An Improved Isolated Heart 
Preparation for External Assessment of Myocardial Metabolism," American 
Journal of Physiology: Heart and Circulatory Physiology. vol. 5, pp. H644­
H65l, 1979. I 
Bergmann, S. R., Hack, S. N.~ Tewson, T. J., Welch, M. J., and Sobel, B. E., 
"Limitations in the Use of 1 NH3 for Measurement of Myocardial Perfusion," IClinical Research, vol. 27, p. 437A, 1979 (abstract). 
Bergmann, S. R., Sanofsky, S. J., Clark, R. E., and Sobel, B. E., "An 
Improved Isolated Heart Preparation for External Assessment of Metabolism," I 
Clinical Research, vol. 26, p. 2l9A, 1978 (abstract). 
Bergmann, S. R., and Sobel, B. E., "Salutary Performance of a Sanguinous, IPerfused, Isolated Heart Preparation," Physiologist, vol. 21, no. 4, p. 8, 
1978 (abstract). I 





Biello, D. R., Ambos, H. D., Sampathkumarin, K. S., and Hitchens, R. E., 
I "A Cost Effective, Portable, Digital Data Collection System," Journal of Nuclear Medicine Technology, vol. 7, in press. 
Branconi, J. M., Bowen, W. G., Cain, M. E., Goldstein, R. A., Brodarick,I S. A., Ambos, H. D., Jaffe, A. S., and Roberts, R., "The Effect of Intra­venous Nitroglycerin on Pain and Ventricular Arrhythmias in Patients with 
I
 






Byrne, J. D., and Ludbrook, P. A., "Cardiovascular Division, Washington
 
University School of Medicine, St. Louis, Missouri, Facility Report,"
 
Analyzer, vol. 9, pp. 12-17, 1979.
 
Cain, M. E., Sobel, B. E., Snyder, D. W., and Corr, P. B., "Similarities
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